Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1434
Encontrada(s) 15 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Tesis doctoral (DoctoralThesis)

Efecto de la actividad física, la obesidad y el sueño en la calidad de vida relacionada con la salud en Individuos con Síndrome Metabólico, Effect of physical activity, obesity and sleep on health-related quality of life in individuals with Metabolic Syndrome

  • Marcos Delgado, Alba
218 p., [ES] Introducción La calidad de vida relacionada con la salud (CVRS) se ha convertido en un parámetro indispensable para la salud pública, pudiendo estimar la carga de enfermedad global en las poblaciones, siendo un buen predictor de mortalidad. Debido al aumento en la prevalencia del síndrome metabólico (SMet) en la población resulta imprescindible averiguar cuál es la relación entre el SMet y la CVRS. Por este motivo, el objetivo principal de la presente tesis doctoral es estimar la CVRS en adultos que padecen SMet y los factores relacionados que influyen en la misma. Metodología Se utilizó la información disponible del estudio PREDIMED-Plus, un ensayo clínico aleatorizado multicéntrico, que recoge los datos sobre CVRS mediante el cuestionario SF-36, así como medidas antropométricas, nivel de actividad física y duración de sueño mediante acelerometría. Se realizó un análisis descriptivo transversal de la CVRS. Mediante modelos de regresión lineal ajustados por potenciales factores confusores, se evaluó la asociación entre la CVRS, el nivel de actividad física, el grado de obesidad y la duración del sueño, al comienzo del estudio y al año de seguimiento. Además, se realizaron modelos de regresión logística para averiguar si la actividad física, el índice de masa corporal (IMC) y la duración del sueño predicen cambios clínicamente significativos en la CVRS. Resultados Nuestros resultados reflejan que el aumento en la actividad física conlleva un incremento en las puntuaciones medias de la CVRS. En las mujeres, se encontraron hasta 10 puntos de diferencia entre la actividad física ligera y la moderada-vigorosa en la función física, rol físico, vitalidad, función social y rol emocional. Además, aquellos sujetos que mejoraron sus niveles de actividad física a lo largo del año de seguimiento, tuvieron un 91% de posibilidades de mejora clínicamente significativa de su componente agregado físico (PCS), respecto a aquellos que se mantuvieron inactivos durante un año (OR = 1,91; IC 95%: 1,23-2,96). En cuanto al grado de obesidad, cuanto mayor es el IMC, menores son las puntuaciones medias en las esferas físicas. Sin embargo, un IMC >30kg/m2, predice una mejora de dichas esferas a un año y son aquellos sujetos que pierden peso a lo largo del año los que más probabilidades tienen de mejorar su CVRS, respecto a aquellos que no modificaron su IMC (PCS OR = 1,85; IC 95% = 1,43-2,40). Se observa que los valores extremos en la duración de sueño de noche (<6h/>9h) afectan negativamente a la PCS. También, se ha encontrado una correlación entre dormir la siesta y la mejora del componente agregado mental (MCS) en aquellos individuos con un sueño nocturno corto (<7h) (Coeficiente β = 6,3 (1,3-11,3) p= 0,01). Conclusiones Nuestros resultados ponen de manifiesto que el SMets afecta negativamente en las esferas físicas de la CVRS. El nivel de actividad física, el IMC y la duración del sueño son factores relacionados que influyen en la misma. Se sugiere que una mejora en estos factores provoca una mejoría de la CVRS en individuos que padecen SMets. No obstante, se precisan más ensayos clínicos para evaluar estas asociaciones., [EN] Introduction Health-related quality of life (HRQoL) has become an essential parameter for public health, given its ability to estimate the global burden of disease in populations makes it a good predictor of mortality. Due to the increased prevalence of metabolic syndrome (MetS) in the population, it is vital to discern the relationship between MetS and HRQoL. As such, the main objective of this doctoral thesis is to estimate HRQoL in adults with MetS and the related factors that influence it. Methods Available information was used from the PREDIMED-Plus study, a multicenter randomized clinical trial that collects data on HRQoL using the SF-36 questionnaire, anthropometric measurements, level of physical activity and sleep duration using accelerometry. A cross-sectional descriptive analysis of HRQoL was performed. Through linear regression models adjusted for potential confounding factors, the association between HRQoL, level of physical activity, degree of obesity, and sleep duration was evaluated at the start of the study and at a one-year follow-up. Additionally, logistic regression models were fit to discern whether physical activity, body mass index (BMI), and sleep duration predict clinically significant changes in HRQoL. Results Our results reflect that increased physical activity leads to an increase in the mean HRQoL scores. In women, up to a 10-point difference was found between light and moderate-to-vigorous physical activity in physical function, physical role, vitality, social function, and emotional role. Furthermore, subjects who improved their physical activity levels throughout the follow-up year had a 91% chance of clinically significant improvement in their physical aggregate component (PCS), compared to those who remained inactive during that year (OR = 1.91; 95% CI: 1.23-2.96). In terms of obesity, the higher the BMI, the lower the average scores in physical areas. However, a BMI >30kg/m2 predicts an improvement in these areas at one year and subjects who lose weight throughout the year are more likely to improve their HRQoL, compared to those whose BMI was unchanged (PCS OR = 1.85, 95% CI = 1.43-2.40). We observed that extreme values in nightly sleep duration (<6h/>9h) negatively affect the PCS. A correlation was also found between napping and improving the physical aggregate component (MCS) in individuals with a short night's sleep (<7h) (Coefficient β = 6.3 (1.3-11.3) p= 0.01). Conclusions Our results show that MetS negatively affects the physical domains of HRQoL and physical activity level, BMI and sleep duration are related factors that influence it. Results suggest that improving these factors leads to an improved HRQoL in individuals with MetS. However, more clinical trials are needed to evaluate these associations.
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Tesis doctoral (DoctoralThesis)

Efecto de la ingesta de polifenoles en biomarcadores y riesgo cardiovascular, Effect of polyphenol intake on biomarkers and cardiovascular risk

  • Rubín García, María
174 p., [ES] Introducción La enfermedad cardiovascular es la principal causa de muerte en todo el mundo y, a pesar de las estrategias preventivas llevadas a cabo, continúa siendo un problema de salud pública. La dieta mediterránea ha demostrado numerosos beneficios cardiosaludables dada su riqueza en moléculas antioxidantes y antiinflamatorias y, muy especialmente, en polifenoles. Estos compuestos bioactivos han mostrado beneficios a nivel cardiovascular debido a sus propiedades antitrombóticas, antiinflamatorias y antiagregantes. Sin embargo, el estudio de su potencial en humanos es limitado. Dado el gran número de compuestos que existen, y, por ende, sus variadas biodisponibilidades y mecanismos de acción, aún hay muchos puntos que necesitan ser esclarecidos. Por este motivo, el objetivo principal de la presente tesis doctoral es evaluar la asociación entre el consumo de polifenoles, y el riesgo y biomarcadores de riesgo cardiovascular (RCV). Metodología Se utilizó la información disponible de 6.633 participantes del estudio PREDIMED-Plus, un ensayo clínico aleatorizado multicéntrico, que recopiló información sobre hábitos alimentarios y estilos de vida, así como muestras sanguíneas para análisis bioquímicos. El consumo de polifenoles se estimó utilizando los datos de consumo de alimentos del cuestionario semicuantitativo de frecuencia alimentaria de 143 ítems y el contenido de polifenoles de cada alimento contenido en la base de datos Phenol-Explorer. Los consumos estimados se ajustaron por la ingesta total de energía de acuerdo al método de residuales. Mediante modelos de regresión lineal multivariante, se evaluó la asociación entre la ingesta de polifenoles y el RCV (estimado mediante ecuaciones de riesgo). Además, se evaluó la asociación entre la ingesta de polifenoles y, el ácido úrico (mediante regresión lineal multivariante) y, mediante modelos de regresión de Cox con un tiempo de seguimiento constante (t=1) se estimó los Prevalence Ratio de la hiperuricemia. Por otro lado, se establecieron patrones de consumo de polifenoles mediante análisis factorial y análisis clúster, comparando ambos métodos y relacionando la adherencia a cada patrón con el RCV estimado. Todos los análisis se realizaron para hombres y mujeres por separado, además de en la población total. Resultados La ingesta total de polifenoles (βQ5vs.Q1= 0,10, IC 95%: 0,04 a 0,17) y flavonoides (βQ5vs.Q1= 0,17, IC 95%: 0,10 a 0,24) se asoció directa y significativamente con una mejor salud cardiovascular óptima (Life’s Simple 7). Se encontraron asociaciones inversas entre el consumo de la clase otros polifenoles y, el RCV estimado mediante Framingham (βQ5vs.Q1= -1,22%, IC 95%: -2,37 a -0,07) y SCORE (βQ5vs.Q1=-0,32, IC 95%: -2,37 a -0,07). En las mujeres, las asociaciones entre el consumo de polifenoles y todas las ecuaciones de riesgo, tienden a ser protectoras. La ingesta de ácidos fenólicos (βQ5vs.Q1= -0,17, IC 95%: -0,27 a -0,06), ácidos hidroxicinámicos (βQ5vs.Q1= -0,19, IC 95%: -0,3 a -0,09), alquilmetoxifenoles (βQ5vs.Q1= 0,2, IC 95%: -0,31 a -0. 1) y metoxifenoles (βQ5vs.Q1= -0,24, IC 95%: -0,34 a -0,13) -0,24, IC 95%: -0,34 a -0,13) mostró una asociación inversa con los niveles de ácido úrico en suero y, la hiperuricemia (PRQ5vs.Q1=0,82, IC 95%:0,71-0,95; PRQ5vs.Q1=0,82, IC 95%:0,71-0,95; PRQ5vs.Q1=0,80, IC 95%:0,70-0,92 y PR=0,79, IC 95%:0,69-0,91, respectivamente). Los patrones de polifenoles revelaron diferencias entre hombres y mujeres, así como en su asociación con el RCV. Respecto a aquellos derivados del análisis factorial: para el total de la muestra, y los hombres, el patrón 3 (aceitunas y aceite de oliva) se asoció positivamente con el RCV, también presentaron, mayor prevalencia de diabetes y mayores consumos de sodio. El patrón 4 formado por el café en todos los grupos, también se asoció con mayor RCV. En cuanto al análisis clúster, el clúster 2 en el total y en hombres, caracterizados por consumo de polifenoles del café y las aceitunas y aceite de oliva, también mostraron mayor RCV. Conclusiones La clase otros polifenoles mostró asociaciones inversas con el riesgo cardiovascular estimado, encontrándose resultados similares con las ecuaciones de Framingham, Framingham-REGICOR y Life’s Simple 7 (después de eliminar el componente de dieta) y diferentes con la SCORE, pero los predictores que se incluyen en esta herramienta son escasos. Una mayor ingesta subclases de polifenoles presentes en el café: ácidos hidroxicinámicos, alquilmetoxifenoles y metoxifenoles se asoció de forma inversa a los niveles de ácido úrico y la hiperuricemia. Encontramos diferencias en los patrones de ingesta de polifenoles entre hombres y mujeres, y en sus asociaciones con la RCV. Estas diferencias de sexo pueden explicarse por el hecho de que llevan estilos de vida diferentes, ya que un patrón no se refiere sólo a los hábitos dietéticos. Además, los sujetos que presentaban un mayor riesgo al inicio del estudio podrían sentirse más motivados para mejorar su hábito dietético (causalidad inversa). Nuestros hallazgos añaden nuevos conocimientos en el estudio de los compuestos fenólicos, destacando la importancia de analizarlos por sexo y de estudiar los determinantes de las elecciones alimentarias y los patrones dietéticos en relación con la percepción de riesgo y los estilos de vida específicos., [EN] Introduction Cardiovascular disease is the leading cause of death worldwide and, despite preventive strategies, continues to be a public health problem. The Mediterranean diet has demonstrated numerous benefits in this regard given its richness in antioxidant and anti-inflammatory molecules, and most especially, in polyphenols. These bioactive compounds have shown cardiovascular benefits due to their antithrombotic, anti-inflammatory and antiplatelet properties. However, the study of their potential in humans is limited. Given the large number of compounds that exist and, therefore, their varied bioavailability and mechanisms of action, there are still many points that need to be clarified. For this reason, the main objective of this doctoral thesis is to evaluate the association between polyphenol intake and cardiovascular risk (CVR) and biomarkers. Methods The information available from 6,633 participants in the PREDIMED-Plus study was used, it is a multicenter randomized clinical trial, which collected information on dietary habits and lifestyles, as well as blood samples for biochemical analysis. Polyphenol intakes were estimated using food consumption data from the 143-item semi-quantitative food frequency questionnaire and the polyphenol content of each food contained in the Phenol-Explorer database. Estimated intakes were adjusted for total energy intake according to the residuals method. The association between polyphenol intake and CVR (estimated using risk equations) was evaluated using multivariate linear regression models. In addition, the association between polyphenol intake and uric acid was evaluated (using multivariate linear regression) and, using Cox regression models with a constant follow-up time (t=1), the prevalence ratio of hyperuricemia was estimated. On the other hand, polyphenol consumption patterns were established by factor analysis and cluster analysis, comparing both methods and relating adherence to each pattern with the estimated CVR. All analyses were performed for men and women separately, as well as in the total population. Results Total polyphenol (βQ5vs.Q1= 0.10, 95% CI: 0.04 to 0.17) and flavonoid (βQ5vs.Q1= 0.17, 95% CI: 0.10 to 0.24) intakes were directly and significantly associated with improved optimal cardiovascular health (Life's Simple 7). Inverse associations were found between other polyphenols class intake and, CVR estimated by Framingham (βQ5vs.Q1= -1.22%, 95% CI: -2.37 to -0.07) and SCORE (βQ5vs.Q1=-0.32, 95% CI: -2.37 to -0.07). In women, the associations between polyphenol intake and all risk equations tended to be protective. The intake of phenolic acids (βQ5vs.Q1= -0.17, 95% CI: -0.27 to -0.06), hydroxycinnamic acids (βQ5vs.Q1= -0.19, 95% CI: -0.3 to -0.09), alkylmethoxyphenols (βQ5vs.Q1= 0.2, 95% CI: -0.31 to -0. 1) and methoxyphenols (βQ5vs.Q1= -0.24, 95% CI -0.34 to -0.13) showed an inverse association with serum uric acid levels and, hyperuricemia (PRQ5vs.Q1=0.82, 95% CI:0.71-0.95; PRQ5vs.Q1=0.82, 95% CI:0.71-0.95; PRQ5vs.Q1=0.80, 95% CI:0.70-0.92 and PRQ5vs.Q1=0.79, 95% CI:0.69-0.91, respectively). The polyphenol patterns revealed differences between men and women, as well as, in their association with CVR. Regarding those derived from the factorial analysis: for the total sample and the men, pattern 3 (olives and olive oil poyphenols) was positively associated with CVR, they also had a higher prevalence of diabetes and higher sodium intake. Pattern 4, formed by coffee polyphenols in all groups, was also associated with higher CVR. As for the cluster analysis, cluster 2 in the total and in men, characterized by consumption of coffee polyphenols and olives and olive oil, also showed higher CVR. Conclusions The other polyphenols class showed inverse associations with estimated cardiovascular risk, finding similar results with the Framingham, Framingham-REGICOR and Life's Simple 7 equations (after eliminating the diet component), and different with the SCORE, but predictors included in this scale are scarce. Higher intakes of polyphenols present in coffee: hydroxycinnamic acids, alkylmethoxyphenols, and methoxyphenols, were inversely associated with serum uric acid levels and hyperuricemia. We found differences in polyphenol intake patterns between men and women, and in their associations with CVR. These sex differences may be explained by the fact that they lead different lifestyles, since a pattern does not refer only to dietary habits. Moreover, subjects who were at higher risk at baseline might be more motivated to improve their dietary habit (reverse causality). Our findings add new insights in the study of phenolic compounds, highlighting the importance of analyzing them by sex and studying the determinants of food choices and dietary patterns in relation to risk perception and specific lifestyles.
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation

  • Juárez Fernández, María
  • Porras Sanabria, David
  • Petrov, Petar
  • Román Sagüillo, Sara
  • García Mediavilla, María Victoria
  • Soluyanova, Polina
  • Martínez Flórez, Susana
  • González Gallego, Javier
  • Nistal González, Maria Esther
  • Jover Atienza, Ramiro
  • Sánchez Campos, Sonia
[EN] Gut microbiota plays a key role in obesity and non-alcoholic fatty liver disease (NAFLD), so synbiotics could be a therapeutic alternative. We aim to evaluate a nutritional intervention together with the administration of the bacteria Akkermansia muciniphila and the antioxidant quercetin in an in vivo model of early obesity and NAFLD. 21-day-old rats were fed with control or high-fat diet for six weeks. Then, all animals received control diet supplemented with/without quercetin and/or A. muciniphila for three weeks. Gut microbiota, NAFLD-related parameters, circulating bile acids (BAs) and liver gene expression were analyzed. The colonization with A. muciniphila was associated with less body fat, while synbiotic treatment caused a steatosis remission, linked to hepatic lipogenesis modulation. The synbiotic promoted higher abundance of Cyanobacteria and Oscillospira, and lower levels of Actinobacteria, Lactococcus, Lactobacillus and Roseburia. Moreover, it favored elevated unconjugated hydrophilic BAs plasma levels and enhanced hepatic expression of BA synthesis and transport genes. A. muciniphila correlated with circulating BAs and liver lipid and BA metabolism genes, suggesting a role of this bacterium in BA signaling. Beneficial effects of A. muciniphila and quercetin combination are driven by gut microbiota modulation, the shift in BAs and the gut-liver bile flow enhancement., SI, This work was supported by grants from Ministerio de Economía y Competitividad/FEDER (BFU2017-87960-R; PID2020-120363RB-I0), Junta de Castilla y León (FEDER) (GRS2126/A/2020; LE063U16; LE017P20), and Instituto de Salud Carlos III (PI17/01089, PI20/00690, cofunded by European Regional Development Fund “A way to achieve Europe”). MJF was supported by a fellowship from Ministerio de Ciencia, Innovación y Universidades (FPU18/06257); DP and SRS by a fellow-ship from Junta de Castilla y León cofunded by the European Social Fund; PP by Sara Borrell Postdoctoral Contract CD18/00158 from the Instituto de Salud Carlos III, cofunded by the European Social Fundation. CIBERehd is funded by the Instituto de Salud Carlos III, Spain.
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

A Network Involving Gut Microbiota, Circulating Bile Acids, and Hepatic Metabolism Genes That Protects Against Non‐Alcoholic Fatty Liver Disease

  • Petrov, Petar Dianov
  • García Mediavilla, María Victoria
  • Guzmán, Carla
  • Porras Sanabria, David
  • Nistal González, Maria Esther
  • Martínez Flórez, Susana
  • Castell, José Vicente
  • González Gallego, Javier
  • Sánchez Campos, Sonia
  • Jover Atienza, Ramiro
[EN] Scope: Gut microbiota contributes to non-alcoholic fatty liver disease (NAFLD) pathogenesis by multiple mechanisms not yet completely understood. Novel differential features between germ-free mice (GFm) transplanted with protective or non-protective cecal microbiota against NAFLD are investigated. Methods and results: Gut microbiota composition, plasma, and fecal bile acids (BAs) and liver mRNAs are quantified in GFm recipients from four donor mice differing in NAFLD severity (control diet, high-fat diet [HFD]-responder, HFD-non-responder, and quercetin-supplemented HFD). Transplanted GFm are on control or HFD for 16-weeks. Multivariate analysis shows that GFm colonized with microbiota from HFD-non-responder and quercetin supplemented-HFD donors (protected against NAFLD) clusters together, whereas GFm colonized with microbiota from control and HFD-responder mice (non-protected against NAFLD) establishes another cluster. Protected phenotype is associated with increased gut Desulfovibrio and Oscillospira, reduced gut Bacteroides and Oribacterium, lower primary and higher secondary BAs in plasma and feces, induction of hepatic BA transporters, and repression of hepatic lipogenic and BA synthesis genes. Conclusion: Protective gut microbiota associates with increased specific secondary BAs, which likely inhibit lipogenic pathways and enhance bile flow in the liver. This novel cross-talk between gut and liver, via plasma BAs, that promotes protection against NAFLD may have clinical and nutritional relevance, SI, P.D.P. and M.V.G.-M. share first authorship. S.S.-C. and R.J. share se-nior authorship. The authors thank Drs. G ́erard and Rabot, from MI-CALIS Institute (INRA), for providing germ-free mice. The authors wouldalso like to thank the Analytical Unit of Instituto de Investigaci ́on San-itaria La Fe, Valencia, for performing the bile acid profiling in plasmaand feces. This study has been funded by Instituto de Salud Carlos IIIthrough the project “PI17/01089” (cofounded by European Regional De-velopment Fund “A way to achieve Europe”) and by grants from Minis-terio de Econom ́ıa y Competitividad/Fondo Europeo de Desarrollo Re-gional (FEDER) (BFU2013-48141-R and BFU2017-87960-R) and Junta deCastilla y Le ́on/FEDER (LE063U16 and GRS1888/A/18). P.D.P. was sup-ported by Sara Borrell Postdoctoral Contract CD18/00158 from the Insti-tuto de Salud Carlos III, cofounded by the European Social Fund. D.P.was supported by a fellowship from Junta de Castilla y Le ́on cofinancedby the European Social Fund. E.N. was supported by Fundaci ́on de Inves-tigaci ́on Sanitaria of Le ́on. M.V.G.-M. was supported by CIBERehd con-tracts. CIBERehd is funded by the Instituto de Salud Carlos III, Spain
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Metabolic syndrome criteria and severity and carbon dioxide (CO2) emissions in an adult population

  • García, Silvia
  • Pastor, Rosario
  • Monserrat Mesquida, Margalida
  • Álvarez Álvarez, Laura
  • Rubín García, María
  • Martínez González, Miguel Ángel
  • Salas Salvadó, Jordi
  • Corella, Dolores
  • Goday, Albert
  • Martínez, J. Alfredo
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • Lopez Miranda, José
  • Estruch, Ramon
  • Tinahones, Francisco J.
  • Lapetra, José
  • Serra Majem, Lluís
  • Riquelme Gallego, Blanca
  • Pintó, Xavier
  • Gaforio, José J.
  • Matía, Pilar
  • Vidal, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros, Emilio
  • Sayón Orea, Carmen
  • Guillem Saiz, Patricia
  • Valle Hita, Cristina
  • Cabanes, Robert
  • Abete, Itziar
  • Goicolea Güemez, Leire
  • Gómez Gracia, Enrique
  • Tercero Maciá, Cristina
  • Colom, Antoni
  • García Ríos, Antonio
  • Castro Barquero, Sara
  • Fernández García, José C.
  • Santos Lozano, José Manuel
  • Cenoz, Juan Carlos
  • Barragán, Rocío
  • Khoury, Nadine
  • Castañer, Olga
  • Zulet, María Ángeles
  • Vaquero Luna, Jessica
  • Bes-Rastrollo, Maira
  • Heras Delgado, Sara de las
  • Ciurana, Ramón
  • Martín Sánchez, Vicente
  • Tur, Josep A.
  • Bouzas, Cristina
[EN] Background Metabolic syndrome (MetS) has become a growing risk factor of some non-communicable diseases. Increase of greenhouse gas emissions affects the planet. Aims To assess the association between MetS severity and amount of carbon dioxide ( CO2) emitted in an adult population. Design Cross-sectional study (n = 6646; 55-76-year-old-men; 60-75-year-old-women with MetS). Methods Dietary habits were assessed using a pre-validated semi quantitative 143-item food frequency questionnaire. The amount of CO2 emitted due to the production of food consumed by person and day was calculated using a European database, and the severity of the MetS was calculated with the MetS Severity Score. Results Higher glycaemia levels were found in people with higher CO2 emissions. The risk of having high severe MetS was related to high CO2 emissions. Conclusions Low CO2 emissions diet would help to reduce MetS severity. Advantages for both health and the environment were found following a more sustainable diet. Trial registration ISRCTN, ISRCT N8989 8870. Registered 05 September 2013., SI, We thank all PREDIMED-Plus participants and investigators. CIBEROBN, CIBERESP, and CIBERDEM are initiatives of the Instituto de Salud Carlos III (ISCIII), Madrid, Spain. The Hojiblanca (Lucena, Spain) and Patrimonio Comunal Olivarero (Madrid, Spain) food companies donated extra-virgin olive oil. The Almond Board of California (Modesto, CA), American Pistachio Growers (Fresno, CA), and Paramount Farms (Wonderful Company, LLC, Los Angeles, CA) donated nuts for the PREDIMED-Plus pilot study., Funding This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (six coordinated FIS projects leaded by JS-S and JVi, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S; the European Research Council (Advanced Research Grant 2014–2019; agreement #340918) granted to MÁM-G.; the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/017 grant from the Generalitat Valenciana; the SEMERGEN grant. J.S-S is partially supported by ICREA under the ICREA Academia programme. C.B. was granted by Juan de la Cierva grant. None of the funding sources took part in the design, collection, analysis, interpretation of the data, or writing the report, or in the decision to submit the manuscript for publication., info:eu-repo/grantAgreement/MINECO/ Programa Estatal de I+D+I Orientada a los Retos de la Sociedad /PI16/01120/ES/ Efecto de una pérdida de peso con dieta mediterránea hipocalórica y promoción de la actividad física en la prevención primaria cardiovascular: Estudio PREDIMED-PLUS, info:eu-repo/grantAgreement/MINECO/ Programa Estatal de I+D+I Orientada a los Retos de la Sociedad /PI16/01522//ES/ Efecto de una pérdida de peso con dieta mediterránea hipocalórica y promoción de la actividad física en la prevención primaria cardiovascular: Estudio PREDIMED-PLUS
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity

  • Fernández Tussy, Pablo
  • Rodríguez Agudo, Rubén
  • Fernández Ramos, David
  • Barbier Torres, Lucía
  • Zubiete Franco, Imanol
  • Davalillo, Sergio López de
  • Herráez, Elisa
  • Goikoetxea Usandizaga, Naroa
  • Lachiondo Ortega, Sofía
  • Simón, Jorge
  • Lopitz Otsoa, Fernando
  • Gutiérrez de Juan, Virginia
  • McCain, Misti V.
  • Perugorría, María J.
  • Mabe, Jon
  • Navasa Mayo, Nicolás
  • Rodrigues, Cecilia M. P.
  • Fabregat, Isabel
  • Boix, Loreto
  • Sapena, Víctor
  • Anguita, Juan
  • Lu, Shelly C.
  • Mato, José M.
  • Banales, Jesus M.
  • Villa, Erica
  • Reeves, Helen L.
  • Bruix, Jordi
  • Reig, María
  • Marín, José J. G.
  • Delgado, Teresa C.
  • Martínez Chantar, María L.
[EN]Dysregulation of miRNAs is a hallmark of cancer, modulating oncogenes, tumor suppressors, and drug responsiveness. The multi-kinase inhibitor sorafenib is one of the first-line drugs for advanced hepatocellular carcinoma (HCC), although the outcome for treated patients is heterogeneous. The identification of predictive biomarkers and targets of sorafenib efficacy are sorely needed. Thus, selected top upregulated miRNAs from the C19MC cluster were analyzed in different hepatoma cell lines compared to immortalized liver human cells, THLE-2 as control. MiR-518d-5p showed the most consistent upregulation among them. Thus, miR-518d-5p was measured in liver tumor/non-tumor samples of two distinct cohorts of HCC patients (n = 16 and n = 20, respectively). Circulating miR-518d-5p was measured in an independent cohort of HCC patients receiving sorafenib treatment (n = 100), where miR-518d-5p was analyzed in relation to treatment duration and patient’s overall survival. In vitro and in vivo studies were performed in human hepatoma BCLC3 and Huh7 cells to analyze the effect of miR-518d-5p inhibition/overexpression during the response to sorafenib. Compared with healthy individuals, miR-518d-5p levels were higher in hepatic and serum samples from HCC patients (n = 16) and in an additional cohort of tumor/non-tumor paired samples (n = 20). MiR-518d-5p, through the inhibition of c-Jun and its mitochondrial target PUMA, desensitized human hepatoma cells and mouse xenograft to sorafenib-induced apoptosis. Finally, serum miR-518d-5p was assessed in 100 patients with HCC of different etiologies and BCLC-stage treated with sorafenib. In BCLC-C patients, higher serum miR-518d-5p at diagnosis was associated with shorter sorafenib treatment duration and survival. Hence, hepatic miR-518d-5p modulates sorafenib resistance in HCC through inhibition of c-Jun/PUMA-induced apoptosis. Circulating miR-518d-5p emerges as a potential lack of response biomarker to sorafenib in BCLC-C HCC patients., SI, This work was supported by grants from NIH (US Department of Health and Human services) R01CA172086 (to S.C.L., J.M.M. and M.L.M.-C.) and P01CA233452 (to S.C.L.), Gobierno Vasco-Departamento de Salud 2013111114 (to M.L.M.-C), MINECO: SAF2017-87301-R, SAF2014-52097-R, RTI2018-096759-A-100, SAF2016-75197-R and SAF2015-64149-R, integrated in the Plan Estatal de Investigación Cientifica y Técnica e Innovación 2017-2020 cofounded by FEDER funds/Development Fund—a way to build Europe (to M.L.M.-C., J.M.M., T.C.D., J.J.G.M., and I.F., respectively), Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain: PI16/00598 and PI19/00819 (to J.J.G.M.), PI15/01132 and PI18/01075 (to J.M.B.), PI14/00399 and PI17/00022 (to M.J.P.), PI18/0358 (to M.R.), BIOEF (Basque Foundation for Innovation and Health Research): EITB Maratoia BIO15/CA/014 and BIO15/CA/016/BD (to M.L.M.-C and J.M.B., respectively); Mitotherapeutix (to M.L.M.-C), Consejería de Educación, Junta de Castilla y León: SA063P17 (J.J.G.M.), Asociación Española Contra el Cáncer (T.C. D, P.F.-T., and M.L.M-C), Basque Government Postdoctoral Program (P.F.-T.), Daniel Alagille award from EASL (to T.C.D.), Asociación Española contra el Cáncer, Canceres raros (M.L.M.-C., J.M.B., and J.J.G.M.), La Caixa Foundation (to M.L.M.-C. and J.M.B.), Ayudas Fundación BBVA a equipos de Investigación Científica 2018 (to M.L.M.-C.), Fondo Europeo de Desarrollo Regional’ (FEDER) (to J.M.B.); CIBERehd, Spain (to J.M.B.); IKERBASQUE, Basque foundation for Science, Spain (to J.M.B.), Department of Health of the Basque Country (2017111010) (to J.M.B.), Euskadi RIS3 (2019222054, 2020333010) (to J.M.B.); Department of Industry of the Basque Country (J.M.B.: Elkartek: KK-2020/00008) (to J.M.B.), Ayudas para apoyar grupos de investigación del sistema Universitario Vasco IT971, Instituto de Salud Carlos III PI18/00768 (J.B.), AECC PI044031 (J.B.), Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement 2014 SGR 605 (J.B.), WCR (AICR) 16-0026 (J.B.), Programma di ricerca Regione-Università 2007–2009 and 2011–2012, Regione Emilia- Romagna (E.V.).
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis

  • Fernández Ramos, David
  • Fernández Tussy, Pablo
  • Lopitz Otsoa, Fernando
  • Gutiérrez de Juan, Virginia
  • Navasa Mayo, Nicolás
  • Barbier Torres, Lucía
  • Zubiete Franco, Imanol
  • Simón, Jorge
  • Fernández, Agustín F.
  • Arbelaiz, Ander
  • Aransay, Ana M.
  • Lavín, José Luis
  • Beraza, Naiara
  • Perugorria, Maria J.
  • Banales, Jesus M.
  • Villa, Erica
  • Fraga, Mario F.
  • Anguita, Juan
  • Ávila, Matías A.
  • Berasain, Carmen
  • Iruzibieta, Paula
  • Crespo, Javier
  • Lu, Shelly C.
  • Varela Rey, Marta
  • Mato, José M.
  • Delgado, Teresa C.
  • Martínez Chantar, María L.
[EN]Glycine N-methyltransferase (GNMT) is the most abundant methyltransferase in the liver and a master regulator of the transmethylation flux. GNMT downregulation leads to loss of liver function progressing to fibrosis, cirrhosis, and hepatocellular carcinoma. Moreover, GNMT deficiency aggravates cholestasis-induced fibrogenesis. To date, little is known about the mechanisms underlying downregulation of GNMT levels in hepatic fibrosis and cirrhosis. On this basis, microRNAs are epigenetic regulatory elements that play important roles in liver pathology. In this work, we aim to study the regulation of GNMT by microRNAs during liver fibrosis and cirrhosis. Luciferase assay on the 3ʹUTR-Gnmt was used to confirm in silico analysis showing that GNMT is potentially targeted by the microRNA miR-873-5p. Correlation between GNMT and miR-873-5p in human cholestasis and cirrhosis together with miR-873-5p inhibition in vivo in different mouse models of liver cholestasis and fibrosis [bile duct ligation and Mdr2 (Abcb4)-/- mouse] were then assessed. The analysis of liver tissue from cirrhotic and cholestatic patients, as well as from the animal models, showed that miR-873-5p inversely correlated with the expression of GNMT. Importantly, high circulating miR-873-5p was also detected in cholestastic and cirrhotic patients. Preclinical studies with anti-miR-873-5p treatment in bile duct ligation and Mdr2-/- mice recovered GNMT levels in association with ameliorated inflammation and fibrosis mainly by counteracting hepatocyte apoptosis and cholangiocyte proliferation. In conclusion, miR-873-5p emerges as a novel marker for liver fibrosis, cholestasis, and cirrhosis and therapeutic approaches based on anti-miR-873-5p may be effective treatments for liver fibrosis and cholestatic liver disease., SI, This work was supported by grants from NIH (US Department of Health and Human services)- R01AT001576 (S.C.L., J.M.M., and M.L.M.-C.), Ministerio de Economía, Industria y Competitividad: SAF2017-87301-R (M.L.M.-C.), Gobierno Vasco-Departamento de Salud 2013111114 (to M.L.M.-C.), BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia BIO15/CA/016/BD (M.L.M.-C.), ELKARTEK 2016, Departamento de Industria del Gobierno Vasco (to M.L.M.-C.), Asociación Española contra el Cáncer (to T.C.D, P.F.-T. and M.L.M.-C.), Mitotherapeutix (to M.L.M.-C.), Daniel Alagille award from EASL (to T.C.D), Fundación Científica de la Asociación Española Contra el Cancer (AECC Scientific Foundation) Rare Tumor Calls 2017 (to M.L.M, J.M.B., and M.A), La Caixa Foundation Program (to M.L.M, J.M.B.), FIS: PI15/00892 (to M.F.F), FIS: PI15/01132 and FIS PI18/01075 (to J.M.B.), (to J.M.B.), FIS: PI14/00399 and PI17/00022 (to M.J.P.), Miguel Servet Program (CON14/00129 to J.M.B.), Ramon y Cajal Program (RYC-2015-17755 to M.J.P.), GRUPIN14-052 (to M.F.), PI14/00962 Instituto Carlos III (to J.B.), AECC Scientific Foundation (to J.B.), World Wide Cancer Research (to J.B.), Programma di Ricerca Regione-Università 2007-2009 and 2011-2012, Regione Emilia-Romagna (to E.V.), “Diputación Foral Gipuzkoa” (DFG15/010, DFG16/004 to J.M.B.), BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia BIO15/CA/016/BD to J.M.B.), Department of Health of the Basque Country (2013111173 to J.M.B.; 2015111100 to M.J.P.). Ciberehd_ISCIII_MINECO is funded by the Instituto de Salud Carlos III. “Hepacare Project” from Fundación La Caixa, Spain (to M.A.A and C.B.), BiO-Eusko Fundazioa project BIO15/CA/011 (to M.A.A and C.B.). We thank this work produced with the support of a 2017 Leonardo Grant for Researchers and Cultural Creators, BBVA Foundation (to M.V.R.). We thank MINECO for the Severo Ochoa Excellence Accreditation (SEV-2016-0644).
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Prospective association of changes in (poly)phenol intake, body weight and physical activity with inflammatory profile

  • Rubín García, María
  • Vitelli Storelli, Facundo Ezequiel
  • Álvarez Álvarez, Laura
  • Fitó, Montserrat
  • Vázquez Ruiz, Zenaida
  • Salas Salvadó, Jordi
  • Corella, Dolores
  • Serra-Majem, Lluis
  • Wärnberg, Julia
  • Romaguera, Dora
  • Estruch, Ramón
  • Pintó, Xavier
  • Martínez, José Alfredo
  • Vázquez, Clotilde
  • Vidal, Josep
  • Tur, Josep A.
  • Alonso Gómez, Ángel M.
  • Ros, Emilio
  • Vioque, Jesús
  • López Miranda, José
  • Bueno Cavanillas, Aurora
  • Tinahones, Francisco J.
  • Lapetra, José
  • Daimiel, Lidia
  • Delgado Rodríguez, Miguel
  • Matía Martín, Pilar
  • Babio, Nancy
  • Schröder, Helmut
  • Lamuela Raventós, Rosa M.
  • Martín Sánchez, Vicente
  • Zamora Ros, Raúl
[EN] Backgrounds and aim: To prospectively evaluate the associations between changes in (poly)phenol intake, body weight(BW), and physical activity(PA) with changes in an inflammatory score after 1-year. Methods and results: This is a prospective observational analysis involving 484 participants from the PREDIMED-Plus with available inflammatory measurements. (Poly)phenol intake was estimated using a validated semi-quantitative food frequency questionnaire and the Phenol-Explorer database. An inflammatory score was calculated based on 8 blood biomarkers (IL-6, IL-8, IL-18, MCP-1, C-peptide, hs-CRP, leptin, and RANTES). The association between BW, PA, (poly)phenol intake and inflammatory score was evaluated using structural equations. Mediation analyses were performed to assess the relationship between change in (poly)phenol intake and inflammatory score was mediated by the change in BW. A higher increase in total (poly)phenol intake was related to a decrease in the inflammatory score (β = −0.005mg/1000 Kcal; CI95 % = -0.100,0.000) along with a decrease in BW (β = −0.006mg/1000 Kcal; CI95 % = -0.010,-0.003). Increased PA was associated with a lower inflammatory score (β = −0.129MET-min/d; CI95 % = −0.238,-0.021) and BW (β = −0.248MET-min/d; CI95 % = -0.343,-0.152). Finally, a decrease in BW was associated with a decrease in the inflammatory score (β = 0.240 kg; CI95 % = 0.155,0.325). Mediation analyses revealed that changes in BW explained 22 % of the overall association between changes in (poly)phenol intake and inflammatory score. Conclusions: An inverse association between changes in (poly)phenol intake and inflammatory status was observed, with BW playing a significant mediating role, emphasising the impact of BW reduction on inflammation reduction, SI, This work was supported by the Spanish Ministry of Health (Carlos III Health Institute) through the Fondo de Investigaci´on para la Salud (FIS), which is cofounded by the European Regional Development Fund (2 coordinated FIS projects [led by J.S.-S. and J.V.] funded by the following grant codes: PI13/00673, PI13/00492, PI13/00272, PI13/ 01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/ 01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/ 00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI16/ 00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/ 00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/ 00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/ 01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/ 01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/ 01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/ 01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/ 00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Eu- ropean Research Council (Advanced Research Grant 2013–2018, grant number 340918); Recercaixa (2013ACUP00194); Consejería de Salud de la Junta de Andalucía (PI0458/2013); and a SEMERGEN grant. CIBERobn (Centros de Investigaci´on Biom´edica en Red: Obesidad y Nutrici´on), CIBEResp (Centros de Investigaci´on Biom´edica en Red: Epidemiologia y Salud Publica), and CIBERdem (Centros de Inves- tigaci´on Biom´edica en Red: Diabetes y Enfermedades Metab´olicas aso- ciadas) are initiatives of Carlos III Health Institute, Madrid, Spain. We thank CERCA Program/Generalitat de Catalunya for the institutional support to IDIBELL and IISPV, and PROMETEO 21/2021 from the Generalitat Valenciana. RZ-R was supported by the “Miguel Servet II” (CPII20/00009) program from the Instituto de Salud Carlos III (Co- funded by European Social Fund (ESF) investing in your future). J.S.-S. is partially supported by the ICREA Academia program. None of the funding sources took part in the design, collection, analysis or inter- pretation of the data, or in the decision to submit the manuscript for publication. The remaining authors have no disclosures to report
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study

  • Becerra Tomás, Nerea
  • Mena Sánchez, Guillermo
  • Díaz López, Andrés
  • Martínez González, Miguel Ángel
  • Babio, Nancy
  • Corella, Dolores
  • Freixer, Gala
  • Romaguera, Dora
  • Vioque, Jesús
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Martínez, J. Alfredo
  • Serra Majem, Lluís
  • Estruch, Ramon
  • Fernández García, José Carlos
  • Lapetra, José
  • Pintó, Xavier
  • Tur, Josep A.
  • López Miranda, José
  • Bueno Cavanillas, Aurora
  • Gaforio, José Juan
  • Matía Martín, Pilar
  • Daimiel, Lidia
  • Martín Sánchez, Vicente
  • Vidal, Josep
  • Vázquez, Clotilde
  • Ros, Emili
  • Razquin, Cristina
  • Abellán Cano, Iván
  • Sorli, Jose V.
  • Torres, Laura
  • Morey, Margarita
  • Navarrete Muñoz, Eva Mª
  • Tojal Sierra, Lucas
  • Crespo Oliva, Edelys
  • Zulet, M. Ángeles
  • Sánchez Villegas, Almudena
  • Casas, Rosa
  • Bernal López, M. Rosa
  • Santos Lozano, José Manuel
  • Corbella, Emili
  • Bibiloni, María del Mar
  • Ruiz Canela, Miguel
  • Fernández Carrión, Rebeca
  • Quifer, Mireia
  • Prieto, Rafel M.
  • Fernandez Brufal, Noelia
  • Salaverria Lete, Itziar
  • Cenoz, Juan Carlos
  • Llimona, Regina
  • Salas Salvadó, Jordi
  • Álvarez Álvarez, Laura
  • García González, Marta Eva
  • Marcos Delgado, Alba
[EN] Purpose: To assess the association between the consumption of non-soy legumes and different subtypes of non-soy legumes and serum uric acid (SUA) or hyperuricemia in elderly individuals with overweight or obesity and metabolic syndrome. Methods: A cross-sectional analysis was conducted in the framework of the PREDIMED-Plus study. We included 6329 participants with information on non-soy legume consumption and SUA levels. Non-soy legume consumption was estimated using a semi-quantitative food frequency questionnaire. Linear regression models and Cox regression models were used to assess the associations between tertiles of non-soy legume consumption, different subtypes of non-soy legume consumption and SUA levels or hyperuricemia prevalence, respectively. Results: Individuals in the highest tertile (T3) of total non-soy legume, lentil and pea consumption, had 0.14 mg/dL, 0.19 mg/dL and 0.12 mg/dL lower SUA levels, respectively, compared to those in the lowest tertile (T1), which was considered the reference one. Chickpea and dry bean consumption showed no association. In multivariable models, participants located in the top tertile of total non-soy legumes [prevalence ratio (PR): 0.89; 95% CI 0.82–0.97; p trend = 0.01, lentils (PR: 0.89; 95% CI 0.82–0.97; p trend = 0.01), dry beans (PR: 0.91; 95% C: 0.84–0.99; p trend = 0.03) and peas (PR: 0.89; 95% CI 0.82–0.97; p trend = 0.01)] presented a lower prevalence of hyperuricemia (vs. the bottom tertile). Chickpea consumption was not associated with hyperuricemia prevalence. Conclusions: In this study of elderly subjects with metabolic syndrome, we observed that despite being a purine-rich food, non-soy legumes were inversely associated with SUA levels and hyperuricemia prevalence. Trial registration: ISRCTN89898870. Registration date: 24 July 2014, SI, The PREDIMED-Plus trial was supported by the official funding agency for biomedical research 349 of the Spanish government, ISCIII, through the Fondo de Investigación para la Salud (FIS), which 350 is co-funded by the European Regional Development Fund (four coordinated FIS projects led by 351 J.S.-S. and J.Vid., including the following projects: PI13/00673, PI13/00492, PI13/00272, 352 PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, 353 PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, 354 PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, 355 PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, 356 PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/ 01827, PI17/00532, 357 PI17/00215, PI17/01441, PI17/00508, PI17/01732, and PI17/00926), the Especial Action Project 358 entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física 359 Cohorte PREDIMED-Plus grant to J.S.-S., the European Research Council (Advanced Research 360 Grant 2013–2018, 340918) to M.Á.M.-G., the Recercaixa grant to J.S.-S. (2013ACUP00194), 361 grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, and 362 PI0137/2018), a grant from the Generalitat Valenciana (PROMETEO/2017/017), a SEMERGEN 363 grant, and funds from the European Regional Development Fund (CB06/03). O.C. is supported 364 by ISCIII grant JR17/00022
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Sex differences in (poly)phenol intake patterns and cardiovascular risk in Spanish adult population at high risk of cardiovascular disease: Cross-sectional findings

  • Rubín García, María
  • Vitelli Storelli, Facundo Ezequiel
  • Toledo, Estefanía
  • Álvarez Álvarez, Laura
  • Martínez González, Miguel Ángel
  • Corella, Dolores
  • Salas Salvadó, Jordi
  • Zomeño, María Dolores
  • Martínez, J. Alfredo
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch, Ramón
  • Tinahones, Francisco J.
  • Santos Lozano, José Manuel
  • Serra Majem, Lluís
  • Bueno Cavanillas, Aurora
  • Tur, Josep A.
  • Pintó, Xavier
  • Gaforio, José Juan
  • Matía Martín, Pilar
  • Vidal, Josep
  • Mas Fontao, Sebastián
  • Daimiel, Lidia
  • Ros, Emilio
  • Vázquez Ruiz, Zenaida
  • Fernández de la Puente, María
  • Álvarez Sala, Andrea
  • Pérez Vega, Alejandra
  • García Ríos, Antonio
  • González Palacios, Sandra
  • Gómez Pérez, Ana M.
  • Zulet, María Ángeles
  • Chaplin, Alice
  • Casas, Rosa
  • Cano Ibáñez, Naomi
  • Tojal Sierra, Lucas
  • Cueto Galán, Raquel
  • Buil Cosiales, Pilar
  • Gutiérrez Carrasquilla, Liliana
  • Sorli, Jose V.
  • Malcampo, Mireia
  • Ortiz Morales, Ana M.
  • Mira Castejón, Luis Alfredo
  • Ríos, Santiago
  • Fitó, Montserrat
  • Martín Sánchez, Vicente
[EN] Background Men and women tend to follow different dietary patterns, but this is often disregarded when relating diet to health outcomes. Objective Our aim was to analyze (poly)phenol intake patterns and their association with cardiovascular risk (CVR) according to sex. Methods 6633 participants were included in this cross-sectional study. The intake of 26 (poly)phenol classes/subclasses was included in the factor analysis obtaining for the total sample, men and women. Linear regression models were performed with the estimation of absolute CVR (Framingham equation) as the dependent variable, and each (poly)phenol pattern categorized into quintiles as the independent variable. Results For the total sample, (poly)phenol pattern three (olives and olive oil) was positively associated with CVR (βQ5vs.Q1 = 2.71%, 95% CI = 1.45, 3.96), presenting a higher risk of diabetes prevalence, smoking more and consuming more salt. In men, pattern three (olives and olive oil) was also positively associated with CVR (βQ5vs.Q1 = 3.17%, 95% CI = 1.58, 5.64), exhibiting higher prevalence of diabetes and higher sodium intake. Also in men, pattern four (coffee) was positively associated (βQ5vs.Q1 = 1.99 %, 95% CI = 0.26, 3.73) presenting a higher diabetes and current smokers prevalence and higher sugar intake. In women, greater adherence to pattern four (coffee) was associated with higher CVR (βQ5vs.Q1 = 2.19%, 95% CI = 1.05, 3.34). Conclusions We found sex differences in (poly)phenol intake patterns and in their associations with CVR. These differences may be explained by the fact that subjects at higher risk at baseline may be motivated to improve their dietary habit (reverse causality)., SI
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways

  • Petrov, Petar Dianov
  • Soluyanova, Polina
  • Sánchez Campos, Sonia
  • Castell, José Vicente
  • Jover Atienza, Ramiro
[EN] Treatment of β-lactamase positive bacterial infections with a combination of amoxicillin (AMOX) and clavulanic acid (CLAV) causes idiosyncratic drug-induced liver injury (iDILI) in a relevant number of patients, often with features of intrahepatic cholestasis. This study aims to determine serum bile acid (BA) levels in amoxicillin/clavulanate (A+C)-iDILI patients and to investigate the mechanism of cholestasis by A+C in human in vitro hepatic models. In six A+C-iDILI patients, significant elevations of serum primary conjugated BA definitely demonstrated A+C-induced cholestasis. In cultured human Upcyte hepatocytes and HepG2 cells, CLAV was more cytotoxic than AMOX, and, at subcytotoxic concentrations, it altered the expression of more than 1,300 genes. CLAV, but not AMOX, downregulated the expression of key genes for BA transport (BSEP, NTCP, OSTα and MDR2) and synthesis (CYP7A1 and CYP8B1). CLAV also caused early oxidative stress, with reduced GSH/GSSG ratio, along with induction of antioxidant nuclear factor erythroid 2-related factor 2 (NRF2) target genes. Activation of NRF2 by sulforaphane also resulted in downregulation of NTCP, OSTα, ABCG5, CYP7A1 and CYP8B1. CLAV also inhibited the BA-sensor farnesoid X receptor (FXR), in agreement with the downregulation of FXR targets BSEP, OSTα and ABCG5. We conclude that CLAV, the culprit molecule in A+C, downregulates several key biliary transporters by modulating NRF2 and FXR signaling, thus likely promoting intrahepatic cholestasis. On top of that, increased ROS production and GSH depletion may aggravate the cholestatic injury by A+C, SI, Patients in this study were part of a large DILI cohort recruited during the Project HECATOS (EU Grant Agreement No: 602156) and were diagnosed by Dr. Isabel Conde (Unit of Clinical Hepatotoxicity, Hospital La Fe), during her engagement to that project. This research was supported by Instituto de Salud Carlos III through the projects PI17/ 01089 and PI20/00690 (co-founded by European Regional Development Fund “A way to achieve Europe”). PDP is currently supported by Sara Borrell Postdoctoral Contract CD18/00158 from the Instituto de Salud Carlos III, co-founded by the European Social Fund
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Residential proximity to industrial pollution sources and colorectal cancer risk: A multicase-control study (MCC-Spain)

  • García Pérez, Javier
  • Fernández de Larrea Baz, Nerea
  • Lope, Virginia
  • Molina de la Torre, Antonio José
  • O’Callaghan Gordo, Cristina
  • Alonso, María Henar
  • Rodríguez Suárez, Marta María
  • Mirón Pozo, Benito
  • Alguacil, Juan
  • Gómez Acebo, Inés
  • Ascunce, Nieves
  • Vanaclocha Espí, Mercedes
  • Amiano, Pilar
  • Chirlaque, María Dolores
  • Simó, Vicente
  • Jiménez Moleon, José Juan
  • Tardón, Adonina
  • Moreno, Víctor
  • Castaño Vinyals, Gemma
  • Martín Sánchez, Vicente
  • Aragonés, Nuria
  • Pérez Gómez, Beatriz
  • Kogevinas, Manolis
  • Pollán, Marina
[EN] Background: Colorectal cancer is the third most frequent tumor in males and the second in females worldwide. In Spain, it is an important and growing health problem, and epidemiologic research focused on potential risk factors, such as environmental exposures, is necessary. Objectives: To analyze the association between colorectal cancer risk and residential proximity to industries, according to pollution discharge route, industrial groups, categories of carcinogens and other toxic substances, and specific pollutants released, in the context of a population-based multicase-control study of incident cancer carried out in Spain (MCC-Spain). Methods: MCC-Spain included 557 colorectal cancer cases and 2948 controls in 11 provinces, frequency matched by sex, age, and region of residence. Distances were computed from subjects’ residences to each of the 134 industries located in the study area. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (95%CIs) for categories of distance (from 1 km to 3 km) to industrial facilities, adjusting for matching variables and other confounders. Results: Excess risk (OR; 95%CI) of colorectal cancer was detected near industries overall for all distances analyzed, from 1 km (2.03; 1.44–2.87) to 3 km (1.26; 1.00–1.59). In general, industries releasing pollutants to air showed higher excess risks than facilities releasing pollution to water. By industrial sector, excess risk (OR; 95%CI) was found near (≤3 km) production of metals (2.66; 1.77–4.00), surface treatment of metals (1.48; 1.08–2.02), glass and mineral fibers (2.06; 1.39–3.07), organic chemical industry (4.80; 3.20–7.20), inorganic chemical industry (6.74; 4.38–10.36), food/beverage sector (3.34; 2.38–4.68), and surface treatment using organic solvents (6.16; 4.06–9.36). By pollutants, the main excess risks (OR; 95%CI) were found near (≤3 km) industries releasing nonylphenol (9.19; 5.91–14.28), antimony (5.30; 3.45–8.15), naphthalene (3.11; 2.16–4.49), organotin compounds (2.64; 1.76–3.98), manganese (2.53; 1.63–3.93), dichloromethane (2.52; 1.74–3.66), and vanadium (2.49; 1.59–3.91). Conclusions: Our results support the hypothesis that residing in the proximity of industries may be a risk factor for colorectal cancer, SI, The authors thank all those who took part in this study providing questionnaire data. This study was funded by: Scientific Foundation of the Spanish Association Against Cancer (Fundación Científica de la Asociación Española Contra el Cáncer (AECC) – EVP-1178/14); “Acción Transversal del Cáncer”, approved on the Spanish Ministry Council on the 11th October 2007; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP); Spain's Health Research Fund (Fondo de Investigación Sanitaria - FIS 12/01416); Carlos III Institute of Health (ISCIII) grants, cofunded by ERDF funds–a way to build Europe– (grants PI08/0533, PI08/1359, PI08/1770, PS09/00773- Cantabria, PS09/01286-Leon, PS09/01662-Granada, PS09/01903- Valencia, PS09/02078-Huelva, PI11/00226, PI11/01403, PI11/01810, PI11/01889-FEDER, PI11/02213, PI12/00150, PI12/00265, PI12/ 00488, PI12/00715, PI12/01270, PI14/00613, PI14/01219, PI15/ 00069, PI15/00914, PI15/01032, PI17-00092); the Fundación Marqués de Valdecilla (API 10/09); the Fundación Caja de Ahorros de Asturias; the University of Oviedo; the Junta de Castilla y León (LE22A10-2); the Regional Government of the Basque Country; the Conselleria de Sanitat of the Generalitat Valenciana (AP_061/10); the Consejería de Salud of the Junta de Andalucía (PI-0571-2009, PI-0306-2011, salud201200057018tra); the Catalan Government DURSI grant 2014SGR647; the European Commission grants FOOD-CT-2006- 036224-HIWATE; the Recercaixa (2010ACUP 00310); Agency for Management of University and Research Grants (AGAUR) of the Catalan Government grant 2017SGR723; and the Spanish Association Against Cancer (AECC) Scientific Foundation. ISGlobal is a member of the CERCA Program, Generalitat de Catalunya
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Effect of dietary phenolic compounds intake on mortality in the “Seguimiento Universidad De Navarra” (SUN) Mediterranean cohort

  • Vázquez Ruiz, Zenaida
  • Toledo, Estefanía
  • Vitelli Storelli, Facundo Ezequiel
  • Bes Rastrollo, Maira
  • Martínez González, Miguel Ángel
[EN] Plant-based dietary patterns have been demonstrated to reduce the risk of non-communicable disease (NCD), including cardiovascular disease (CVD), type 2 diabetes, cancer, and all-cause mortality. Phenolic compounds (PC), abundant in plant-based foods, have been considered as instrumental in this attenuation of NCD risk. We evaluated the association between dietary intake of PC and the risk of all-cause mortality in a relatively young Mediterranean cohort of 18,173 Spanish participants in the “Seguimiento Universidad de Navarra” (SUN) project, after a median follow-up of 12.7 years. Intake of PC was estimated at baseline and repeatedly after 10-year follow-up using a 136-item validated food frequency questionnaire and the Phenol-Explorer database. During 236,329 person-years, 544 deaths were confirmed. Cox regression models compared low intake (lowest quintile) vs. high intake (the four upper quintiles merged, as a reference category) of total energy-adjusted PC intake. Adjusted hazard ratios (HR) for low PC intake among those participants aged over 45 years during follow-up were 1.32; 95% CI 1.02–1.71 for all-cause mortality, HR:1.44; 95% CI 1.02–2.02 for cancer mortality; HR: 0.88; 95% CI 0.47–1.66 for CVD mortality and HR: 1.69 95% CI 1.04–2.74 for causes of death other than cancer or CVD. In conclusion, a low intake of total PC was associated with a significantly higher risk of all-cause mortality, and, specifically, a higher risk for cancer in a relatively young cohort. Among PC classes a low intake of flavonoids and phenolic acids showed significant effects for non-cancer/non-CVD mortality. Cherries, chocolate, apples and pears, olives, and coffee, were the major sources of between-person variability for total PC intake in our Mediterranean cohort, SI, Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. The project SUN has received funding from the Spanish Government - Instituto de Salud Carlos III, and the European Regional Develop- ment Fund (FEDER) (RD 06/0045, CIBER-OBN, Grants PI10/02658, PI10/02293, PI13/00615, PI14/01668, PI14/01798, PI14/01764, PI17/01795, PI20/00564 and G03/140), the Government of Navarra (27/2011, 45/2011, 122/2014), the National Plan on Drugs (2020 / 021) as well as the University of Navarra
BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

Sarcopenic Obesity and Longitudinal Trajectories on Cognitive Performance and Subtle Cognitive Impairment Over 6 Years in Older Adults

  • Vázquez Lorente, Héctor
  • Paz Graniel, Indira
  • Margara Escudero, Hernando J.
  • Martínez González, Miguel Ángel
  • Romaguera, Dora
  • Martínez Urbistondo, Diego
  • Estruch, Ramón
  • Martín Sánchez, Vicente
  • Vidal, Josep
  • Fitó, Montserrat
  • Goñi, Nuria
  • Chaplin, Alice
  • Zulet, María Ángeles
  • Sacanella, Emilio
  • Paz Fernández, José Antonio de
  • Altés, Andreu
  • García Gavilán, Jesús Francisco
  • Konieczna, Jadwiga
  • Martínez, J. Alfredo
  • Salas Salvadó, Jordi
[EN] Background: Sarcopenic obesity has been suggested as a potential risk factor for cognitive decline; however, few prospective studies have been conducted to test this hypothesis. We aimed to assess the relationship between baseline sarcopenic obesity and 6-year trajectories of cognitive performance and subtle cognitive impairment in older adults. Methods: This longitudinal study comprised 1097 older adults aged 55–75 years (mean [SD] age, 65.3 [4.9] years; 506 females [46.1%] and 591 males [53.9%]) exhibiting baseline overweight/obesity and metabolic syndrome. Baseline lower-limb muscle strength was determined by the validated 30-s Chair Stand Test. Baseline total body weight, fat mass percentage and appendicular lean mass were obtained through dual-energy x-ray absorptiometry scans. Baseline sarcopenic obesity (n = 364 [33.2%]) was subsequently defined based on the new European Society for Clinical Nutrition and Metabolism and the European Association for the Study of Obesity consensus criteria. Cognitive performance was assessed at baseline, 2, 4 and 6 years of follow-up through five composite scores derived from a comprehensive battery of eight validated neuropsychological tests, encompassing global cognitive function, general cognitive function, executive function, attention and language. Subtle cognitive impairment was defined for those z-scores 0.5 standard deviations below the mean for each cognitive performance composite score at baseline. Linear and logistic two-level mixed models including lost to follow-up participants were fitted as main analyses. Complete case analyses were additionally performed. Results: After adjusting for multiple covariates, main analyses showed that, compared to older adults without sarcopenic obesity, those with sarcopenic obesity showed a higher decline in global cognitive function (between-group difference, −1.0 [95% CI, −2.2 to 0.2] after 6 years; overall p = 0.048) and general cognitive function (between-group difference, −2.5 [95% CI, −4.4 to 0.5] after 6 years; overall p = 0.028) and had a higher risk of subtle global cognitive function impairment (between-group difference, 2.3 [95% CI, 0.9 to 5.6] after 6 years; overall p = 0.038) over 6 years of follow-up. Associations remained consistent in the complete case analysis and attenuated when comparing those participants with baseline sarcopenic obesity with those only presenting sarcopenia, obesity or overweight. Of note, participants with baseline sarcopenia or obesity, compared to the absence of these conditions, showed no relationship with cognitive performance and subtle cognitive impairment over 6 years of follow-up. Conclusions: Sarcopenic obesity may be considered a potential independent risk factor for cognitive decline over the long term that warrants further evaluation in clinical settings, SI, This study was supported by the official Spanish Institutions for FundingScientific Biomedical Research, CIBER Fisiopatología de la Obesidad yNutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), throughthe Fondo de Investigación para la Salud (FIS), which is co-funded bythe European Regional Development Fund (six coordinated FIS proj-ects led by J.S.-S. and J.V., including the following projects: PI13/00673,PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184,PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618,PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972,PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094,PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120,PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827,PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926,PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017,PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138,PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158and PI23/00220); the Especial Action Project entitled: Implementación yevaluación de una intervención intensiva sobre la actividad física CohortePREDIMED-Plus grant to J.S.-S.; the European Research Council(Advanced Research Grant 2014–2019; agreement #340918) grantedto M.A.M.-G.; the Agencia Catalana de Recerca i Universitats, AGAUR(2021SGR00336 to J.S.-S; the Recercaixa (number 2013ACUP00194) grantto J.S.-S.; grants from the Consejería de Salud de la Junta de Andalucía(PI0458/2013, PS0358/2016 and PI0137/2018); the PROMETEO/21/2021and the AICO/2021/347 grants from the Generalitat Valenciana; theMINECO (CNS2022–135862) grant to D.R. and the Horizon 2020 PRIMEstudy (Prevention and Remediation of Insulin Multimorbidity in Europe;grant agreement #847879). J.K. received funding from ISCIII, throughthe Miguel Servet Project (CP24/00089), co-funded by the EuropeanUnion. H.V.-L. was funded by a research grant from the Agència de Gestiód‘Ajuts Universitaris de Recerca via Unión Europea, Next Generation EU(AGAUR, record number: 2023POST-INV- 01).H.J.M.-E holds a ContratoPre-doctoral de Formacion en Investigacion en Salud (PFIS FI24/00038)funded by the ISCIII. None of the funding sources took part in the design,collection, analysis, interpretation of the data or writing of the report orin the decision to submit the manuscript for publication. J.S.-S., senior au-thor, gratefully acknowledges the financial support by ICREA under theICREA Academia program.Ethics StatementThe study protocol was approved by the Research Ethics Committees ofall recruiting centres. In addition, all participants signed an informedconsent form upon entry into the study.Conflicts of InterestThe authors declare no conflicts of interest.Data Availability StatementData described in the manuscript, codebook and analytic code will bemade available upon request pending application and approval of thePREDIMED-Plus Steering Committee. There are restrictions on theavailability of data for the PREDIMED-Plus trial, due to the signed con-sent agreements around data sharing, which only allow access to exter-nal researchers for studies following the project purposes. Requestorswishing to access the PREDIMED-Plus trial data used in this study canmake a request to the PREDIMED-Plus trial Steering Committee chair:jordi.salas@urv.cat. The request will then be passed to members of thePREDIMED-Plus Steering Committee for deliberation
Docta Complutense
Publicación Artículo científico (JournalArticle)

Tunable degrees of neurodegeneration in rats based on microsphere‑induced models of chronic glaucoma, Grados ajustables de neurodegeneración en ratas basados ​​en modelos de glaucoma crónico inducidos por microesferas

  • Bravo Osuna, Irene
  • Aragón Navas, Alba
  • García Herranz, David
  • Herrero Vanrell, María Del Rocío
  • Rodrigo María, Jesús
  • Subias, Manuel
  • Montolío, Alberto
  • Cegoñino, José
  • Martínez-Rincón, Teresa
  • Méndez-Martínez, Silvia
  • Pablo Luis, Emilio
  • Pérez del Palomar, Amaya
  • García-Martín, Elena
This study compares four different animal models of chronic glaucoma against normal aging over 6 months. Chronic glaucoma was induced in 138 Long–Evans rats and compared against 43 agedmatched healthy rats. Twenty‑five rats received episcleral vein sclerosis injections (EPIm cohort) while the rest were injected in the eye anterior chamber with a suspension of biodegradable microspheres: 25 rats received non‑loaded microspheres (N‑L Ms cohort), 45 rats received microspheres loaded with dexamethasone (MsDexa cohort), and 43 rats received microspheres co‑loaded with dexamethasone and fibronectin (MsDexaFibro cohort). Intraocular pressure, neuroretinal function, structure and vitreous interface were evaluated. Each model caused different trends in intraocular pressure, produced specific retinal damage and vitreous signals. The steepest and strongest increase in intraocular pressure was seen in the EPIm cohort and microspheres models were more progressive. The EPIm cohort presented the highest vitreous intensity and percentage loss in the ganglion cell layer, the MsDexa cohort presented the greatest loss in the retinal nerve fiber layer, and the MsDexaFibro cohort presented the greatest loss in total retinal thickness. Function decreased differently among cohorts. Using biodegradable microspheres models it is possible to generate tuned neurodegeneration. These results support the multifactorial nature of glaucoma based on several noxa.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Assessment of school anti-bullying interventions: A Meta-analysis of randomized clinical trials

  • Fraguas Herráez, David
  • Díaz Caneja, Covadonga M.
  • Ayora, Miriam
  • Durán Cutilla, Manuel
  • Abregú Crespo, Renzo
  • Ezquiaga Bravo, Iciar
  • Martín Babarro, Javier
  • Arango López, Celso
Importance: Bullying is a prevalent and modifiable risk factor for mental health disorders. Although previous studies have supported the effectiveness of anti-bullying programs; their population impact and the association of specific moderators with outcomes are still unclear. Objective: To assess the effectiveness of school anti-bullying interventions, their population impact, and the association between moderator variables and outcomes. Data Sources: A search of Ovid MEDLINE, ERIC, and PsycInfo databases was conducted using 3 sets of search terms to identify randomized clinical trials (RCTs) assessing anti-bullying interventions published from database inception through February 2020. A manual search of reference lists of articles included in previous systematic reviews and meta-analyses was also performed. Study Selection: The initial literature search yielded 34 798 studies. Included in the study were articles that (1) assessed bullying at school; (2) assessed the effectiveness of an anti-bullying program; (3) had an RCT design; (4) reported results; and (5) were published in English. Of 16 707 studies identified, 371 met the criteria for review of full-text articles; 77 RCTs were identified that reported data allowing calculation of effect sizes (ESs). Of these, 69 independent trials were included in the final meta-analysis database. Data Extraction and Synthesis: Random-effects and meta-regression models were used to derive Cohen d values with pooled 95% CIs as estimates of ES and to test associations between moderator variables and ES estimates. Population impact number (PIN), defined as the number of children in the total population for whom 1 event may be prevented by an intervention, was used as an estimate of the population impact of universal interventions targeting all students, regardless of individual risk. Main Outcomes and Measures: The main outcomes are the effectiveness (measured by ES) and the population impact (measured by the PIN) of anti-bullying interventions on the following 8 variable categories: Overall bullying, bullying perpetration, bullying exposure, cyberbullying, attitudes that discourage bullying, attitudes that encourage bullying, mental health problems (eg, anxiety and depression), and school climate as well as the assessment of potential assocations between trial or intervention characteristics and outcomes. Results: This study included 77 samples from 69 RCTs (111659 participants [56511 in the intervention group and 55148 in the control group]). The weighted mean (range) age of participants in the intervention group was 11.1 (4-17) years and 10.8 (4-17) years in the control group. The weighted mean (range) proportion of female participants in the intervention group was 49.9% (0%-100%) and 50.5% (0%-100%) in the control group. Anti-bullying interventions were efficacious in reducing bullying (ES,-0.150; 95% CI,-0.191 to-0.109) and improving mental health problems (ES,-0.205; 95% CI,-0.277 to-0.133) at study end point, with PINs for universal interventions that target the total student population of 147 (95% CI, 113-213) and 107 (95% CI, 73-173), respectively. Duration of intervention was not statistically significantly associated with intervention effectiveness (mean [range] duration of interventions, 29.4 [1 to 144] weeks). The effectiveness of anti-bullying programs did not diminish over time during follow-up (mean [range] follow-up, 30.9 [2-104] weeks). Conclusions and Relevance: Despite the small ESs and some regional differences in effectiveness, the population impact of school anti-bullying interventions appeared to be substantial. Better designed trials that assess optimal intervention timing and duration are warranted.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Chronic Glaucoma Using Biodegradable Microspheres to Induce Intraocular Pressure Elevation. Six-Month Follow-Up

  • Rodrigo, María Jesús
  • García Herranz, David
  • Subías, Manuel
  • Martínez-Rincón, Teresa
  • Mendez-Martínez, Silvia
  • Bravo Osuna, Irene
  • Carretero, Ana
  • Ruberte, Jesús
  • García Feijoo, Julián
  • Pablo, Luis Emilio
  • Herrero Vanrell, María Del Rocío
  • García-Nartín, Elena
To compare two prolonged animal models of glaucoma over 24 weeks of follow-up. A novel pre-trabecular model of chronic glaucoma was achieved by injection of biodegradable poly lactic-co-glycolic acid (PLGA) microspheres (10–20 μm) (Ms20/10) into the ocular anterior chamber to progressively increase ocular hypertension (OHT). Methods: Rat right eyes were injected to induce OHT: 50% received a suspension of Ms20/10 in the anterior chamber at 0, 2, 4, 8, 12, 16 and 20 weeks, and the other 50% received a sclerosing episcleral vein injection biweekly (EPIm). Ophthalmological clinical signs, intraocular pressure (IOP), neuroretinal functionality measured by electroretinography (ERG), and structural analysis of the retina, retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL) protocols using optical coherence tomography (OCT) and histological exams were performed. Results: Both models showed progressive neuroretinal degeneration (p < 0.05), and contralateral eye affectation. The Ms20/10 model showed a more progressive increase in IOP and better preservation of ocular surface. Although no statistical differences were found between models, the EPIm showed a tendency to produce thicker retinal and thinner GCL thicknesses, slower latency and smaller amplitude as measured using ERG, and more aggressive disturbances in retinal histology. In both models, while the GCL showed the greatest percentage loss of thickness, the RNFL showed the greatest and earliest rate of thickness loss. Conclusions: The intracameral model with biodegradable microspheres resulted more like the conditions observed in humans. It was obtained by a less-aggressive mechanism, which allows for adequate study of the pathology over longer periods.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Curcumin-Piperlongumine Hybrids with a Multitarget Profile Elicit Neuroprotection in In Vitro Models of Oxidative Stress and Hyperphosphorylation, Híbridos de curcumina y piperlongumina con un perfil multidiana ejercen neuroprotección en modelos in vitro de estrés oxidativo e hiperfosforilación

  • Cores Esperón, Ángel
  • Carmona Zafra, Noelia
  • Martín Cámara, Olmo
  • Sánchez Cebrián, Juan Domingo
  • Duarte, Pablo
  • Villacampa Sanz, Mercedes
  • Bermejo Bescos, María De La Paloma
  • Martín-Aragón Álvarez, Sagrario
  • León Martínez, Rafael
  • Menéndez Ramos, José Carlos
Curcumin shows a broad spectrum of activities of relevance in the treatment of Alzheimer’s disease (AD); however, it is poorly absorbed and is also chemically and metabolically unstable, leading to a very low oral bioavailability. A small library of hybrid compounds designed as curcumin analogues and incorporating the key structural fragment of piperlongumine, a natural neuroinflammation inhibitor, were synthesized by a two-step route that combines a three-component reaction between primary amines, β-ketoesters and α-haloesters and a base-promoted acylation with cinnamoyl chlorides. These compounds were predicted to have good oral absorption and CNS permeation, had good scavenging properties in the in vitro DPPH experiment and in a cellular assay based on the oxidation of dichlorofluorescin to a fluorescent species. The compounds showed low toxicity in two cellular models, were potent inductors of the Nrf2-ARE phase II antioxidant response, inhibited PHF6 peptide aggregation, closely related to Tau protein aggregation and were active against the LPS-induced inflammatory response. They also afforded neuroprotection against an oxidative insult induced by inhibition of the mitochondrial respiratory chain with the rotenone-oligomycin A combination and against Tau hyperphosphorylation induced by the phosphatase inhibitor okadaic acid. This multitarget pharmacological profile is highly promising in the development of treatments for AD and provides a good hit structure for future optimization efforts.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Enhanced susceptibility of galectin-1 deficient mice to experimental colitis

  • Fernández Pérez, Raquel
  • López Santalla, Mercedes
  • Sánchez Domínguez, Rebeca
  • Alberquilla, Omaira
  • Gutiérrez Cañas, Irene
  • Juarranz Moratilla, Yasmina
  • Bueren, Juan A.
  • Garin, Marina I.
Galectin-1 is a<jats:italic>β</jats:italic>-galactoside-binding lectin, ubiquitously expressed in stromal, epithelial, and different subsets of immune cells. Galectin-1 is the prototype member of the galectin family which shares specificity with<jats:italic>β</jats:italic>-galactoside containing proteins and lipids. Immunomodulatory functions have been ascribed to endogenous galectin-1 due to its induction of T cell apoptosis, inhibitory effects of neutrophils and T cell trafficking. Several studies have demonstrated that administration of recombinant galectin-1 suppressed experimental colitis by modulating adaptive immune responses altering the fate and phenotype of T cells. However, the role of endogenous galectin-1 in intestinal inflammation is poorly defined. In the present study, the well-characterized acute dextran sulfate sodium (DSS)-induced model of ulcerative colitis was used to study the function of endogenous galectin-1 during the development of intestinal inflammation. We found that galectin-1 deficient mice (<jats:italic>Lgals1<jats:sup>−/−</jats:sup></jats:italic>mice) displayed a more severe intestinal inflammation, characterized by significantly elevated clinical scores, than their wild type counterparts. The mechanisms underlying the enhanced inflammatory response in colitic<jats:italic>Lgals1<jats:sup>−/−</jats:sup></jats:italic>mice involved an altered Th17/Th1 profile of effector CD4<jats:sup>+</jats:sup>T cells. Furthermore, increased frequencies of Foxp3<jats:sup>+</jats:sup>CD4<jats:sup>+</jats:sup>regulatory T cells in colon lamina propria in<jats:italic>Lgals1<jats:sup>−/−</jats:sup></jats:italic>mice were found. Strikingly, the exacerbated intestinal inflammatory response observed in<jats:italic>Lgals1<jats:sup>−</jats:sup></jats:italic><jats:sup>/</jats:sup><jats:italic><jats:sup>−</jats:sup></jats:italic>mice was alleviated by adoptive transfer of wild type Foxp3<jats:sup>+</jats:sup>CD4<jats:sup>+</jats:sup>regulatory T cells at induction of colitis. Altogether, these data highlight the importance of endogenous galectin-1 as a novel determinant in regulating T cell reactivity during the development of intestinal inflammation.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Identification of six cardiovascular risk biomarkers in the young population: A promising tool for early prevention

  • Martínez Santos, Paula
  • Baldán Martín, Montserrat
  • López, Juan A.
  • Martín Lorenzo, Marta
  • Santiago Hernández, Aránzazu
  • Agudiez, Marta
  • Cabrera Sierra, Martha
  • Calvo, Eva
  • Vázquez, Jesús
  • Ruiz Hurtado, Gema
  • Vivanco, Fernando
  • Ruilope Urioste, Luis Miguel
  • Barderas, María G.
  • Álvarez Llamas, Gloria
Background and aims The predictive value of traditional CV risk calculators is limited. Novel indicators of CVD progression are needed particularly in the young population. The main aim of this study was the identification of a molecular profile with added value to classical CV risk estimation. Methods: Eighty-one subjects (30–50 years) were classified in 3 groups according to their CV risk: healthy subjects; individuals with CV risk factors; and those who had suffered a previous CV event. The urine proteome was quantitatively analyzed and significantly altered proteins were identified between patients' groups, either related to CV risk or established organ damage. Target-MS and ELISA were used for confirmation in independent patients’ cohorts. Systems Biology Analysis (SBA) was carried out to identify functional categories behind CVD. Results: 4309 proteins were identified, 75 of them differentially expressed. ADX, ECP, FETUB, GDF15, GUAD and NOTCH1 compose a fingerprint positively correlating with lifetime risk estimate (LTR QRISK). Best performance ROC curve was obtained when ECP, GDF15 and GUAD were combined (AUC = 0.96). SBA revealed oxidative stress response, dilated cardiomyopathy, signaling by Wnt and proteasome, as main functional processes related to CV risk. Conclusions: A novel urinary protein signature is shown, which correlates with CV risk estimation in young individuals. Pending further confirmation, this six-protein-panel could help in CV risk assessment.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Inherited human ezrin deficiency impairs adaptive immunity

  • García-Solís, Blanca et al.
  • Rebeca Pérez de Diego
  • Martínez Martínez, Laura María
  • Recio Hoyas, María José
  • Fernández Arquero, Miguel
  • Sánchez Ramón, Silvia María
Background Inborn errors of immunity (IEI) are a group of monogenic diseases that confer susceptibility to infection, autoimmunity, and cancer. Despite the life-threatening consequences of some IEI, their genetic cause remains unknown in many patients. Objective We investigated a patient with an IEI of unknown genetic etiology. Methods Whole-exome sequencing identified a homozygous missense mutation of the gene encoding ezrin (EZR), substituting a threonine for an alanine at position 129. Results Ezrin is one of the subunits of the ezrin, radixin, and moesin (ERM) complex. The ERM complex links the plasma membrane to the cytoskeleton and is crucial for the assembly of an efficient immune response. The A129T mutation abolishes basal phosphorylation and decreases calcium signaling, leading to complete loss of function. Consistent with the pleiotropic function of ezrin in myriad immune cells, multidimensional immunophenotyping by mass and flow cytometry revealed that in addition to hypogammaglobulinemia, the patient had low frequencies of switched memory B cells, CD4+ and CD8+ T cells, MAIT, γδ T cells, and centralnaive CD4+ cells. Conclusions Autosomal-recessive human ezrin deficiency is a newly recognized genetic cause of B-cell deficiency affecting cellular and humoral immunity.
Docta Complutense
Publicación Artículo científico (JournalArticle)

An immuno-fragile profile is associated with mortality risk in patients with chronic kidney disease

  • Ceprián, Noemí
  • Martínez De Toda Cabeza, Irene
  • Jara Caro, Paula
  • Yuste, Claudia
  • Valera Arévalo, Gemma
  • González de Pablos, Ignacio
  • Figuer, Andrea
  • Alique, Matilde
  • Ramírez, Rafael
  • Morales Ruiz, Enrique
  • Carracedo, Julia
Background/Objectives: Patients with chronic kidney disease (CKD) face higher risks of infections, poor vaccine responses, and cardiovascular diseases, leading to increased morbidity and mortality due to immune dysfunction and frailty. This study aims to evaluate immune status and frailty in CKD patients across different treatments, examine the influence of frailty on immune status, and link these factors to mortality. Methods: A total of 174 participants were included (end-stage renal disease, ESRD n = 40; hemodialysis, HD n = 40; peritoneal dialysis, n = 36; kidney transplant patients, n = 40; healthy subjects n = 18). Immunophenotyping of lymphocyte and monocyte subpopulations was performed, and frailty was assessed using the Edmonton Frail Scale. Principal component analysis (PCA) integrated immune and frailty variables to define an “immuno-fragile profile,” and survival was monitored for up to six years. Results: CKD patients, especially those on HD, showed decreased lymphocyte counts and proinflammatory monocyte subpopulations with increased expression of costimulatory molecules B7.2/CD86 and ICAM-1/CD54). Frailty was most prevalent in HD patients (53%), with notable sex differences. PCA identified three components—lymphocyte counts, monocyte co-stimulatory expression, and frailty—that together explained 70% of the variance. Survival analysis revealed that patients with lower lymphocyte counts and higher frailty scores had increased mortality risk, especially in the HD and ESRD groups. Cox regression confirmed that the immuno-fragile profile independently predictedmortality. Conclusions: The integration of immune alterations and frailty defines an immuno-fragile profile strongly associated with mortality in CKD patients, which may serve as a robust prognostic tool to improve risk stratification and guide personalized interventions in clinical practice.
Docta Complutense
Publicación Artículo científico (JournalArticle)

New mechanisms involved in the development of cardiovascular disease in chronic kidney disease

  • Figuer, Andrea
  • Alique, Matilde
  • Valera Arévalo, Gemma
  • Serroukh, Nadia
  • Ceprían, Noemí
  • De Sequera Ortiz, Patricia
  • Morales Ruiz, Enrique
  • Carracedo Añón, Julia María
  • Ramírez, Rafael
  • Bodega, Guillermo
Chronic kidney disease (CKD) is a pathology with a high worldwide incidence and an upward trend affecting the elderly. When CKD is very advanced, the use of renal replacement therapies is required to prolong its life (dialysis or kidney transplantation). Although dialysis improves many complications of CKD, the disease does not reverse completely. These patients present an increase in oxidative stress, chronic inflammation and the release of extracellular vesicles (EVs), which cause endothelial damage and the development of different cardiovascular diseases (CVD). CKD patients develop premature diseases associated with advanced age, such as CVD. EVs play an essential role in developing CVD in patients with CKD since their number increases in plasma and their content is modified. The EVs of patients with CKD cause endothelial dysfunction, senescence and vascular calcification. In addition, miRNAs free or transported in EVs together with other components carried in these EVs promote endothelial dysfunction, thrombotic and vascular calcification in CKD, among other effects. This review describes the classic factors and focuses on the role of new mechanisms involved in the development of CVD associated with CKD, emphasizing the role of EVs in the development of cardiovascular pathologies in the context of CKD. Moreover, the review summarized the EVs’ role as diagnostic and therapeutic tools, acting on EV release or content to avoid the development of CVD in CKD patients
Docta Complutense
Publicación Artículo científico (JournalArticle)

Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance

  • Peña Martínez, Carolina Belén
  • Durán Laforet, Violeta
  • García Culebras, Alicia
  • Ostos, Fernando
  • Hernández Jiménez, Macarena
  • Bravo-Ferrer, Isabel
  • Pérez Ruiz, Alberto
  • Bellenilla, Federico
  • Díaz Guzmán, Jaime
  • Lizasoaín Hernández, Ignacio
  • Moro Sánchez, María Ángeles
Background and Purpose- Recanalization of the occluded artery is a primary goal in stroke treatment. Unfortunately, endovascular treatment is not always available, and tPA (tissue-type plasminogen activator) therapy is limited by its narrow therapeutic window; importantly, the rate of early arterial recanalization after tPA administration is low, especially for platelet-rich thrombi. The mechanisms for this tPA resistance are not well known. Since neutrophil extracellular traps (NETs) have been implicated in this setting, our aim was to study whether NET pharmacological modulation can reverse tPA resistance and the role of TLR4 (Toll-like receptor 4), previously related to NET formation, in thrombosis. Methods- To this goal, we have used a mouse photothrombotic stroke model, which produces a fibrin-free thrombus composed primarily of aggregated platelets and thrombi obtained from human stroke patients. Results- Our results demonstrate that (1) administration of DNase-I, which promotes NETs lysis, but not of tPA, recanalizes the occluded vessel improving photothrombotic stroke outcome; (2) a preventive treatment with Cl-amidine, impeding NET formation, completely precludes thrombotic occlusion; (3) platelet TLR4 mediates NET formation after photothrombotic stroke; and (4) ex vivo fresh platelet-rich thrombi from ischemic stroke patients are effectively lysed by DNase-I. Conclusions- Hence, our data open new avenues for recanalization of platelet-rich thrombi after stroke, especially to overcome tPA resistance.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Body composition and CO2 dietary emissions

  • García, Silvia
  • Monserrat-Mesquida, Margalida
  • Mas-Fontao, Sebastián
  • Cuadrado Soto, Esther
  • Ortiz-Ramos, María
  • Matía Martín, María Del Pilar
  • Daimiel, Lidia
  • Vázquez, Clotilde
  • Tur, Josep A.
  • Bouzas, Cristina
Background: The amount and quality of foods consumed not only impact on individual health, as reflected in body composition, but they could influence on greenhouse gas emissions and then, on environment. Aim: This study aims to assess the relationship between the body composition and the CO2 emissions resulting from the dietary choices of an adult population. Design: A cross-sectional study on baseline data from 778 participants aged 55–75 years old, with metabolic syndrome (MetS) as part of the PREDIMED-Plus study. Methods: Food intake was registered using a validated semi quantitative 143-item food frequency questionnaire. The amount of CO2 emitted was calculated using data from the Agribalyse® 3.0.1 database. Anthropometry (body weight, height, and waist, and hip circumference, and body mass index) was determined by usual measurements, and body composition (fat mass, visceral fat, muscular mass, fat free mass, and total body water) were assessed by bioimpedance. Results: CO2 emissions were linearly and positively associated with weight, waist circumference, visceral fat, fat free mass, total body water and energy intake. Conclusion: Body composition is associated with dietary CO2 emissions. The higher total body water, fat free mass, and body weight, the higher the dietary CO2 emissions were, following a linear relationship.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Development of a scale to gain insight into the experience of living with chronic heart failure: The UNAV-Experience of Living with Chronic Heart Failure Scale

  • Saracíbar Razquin, Maribel
  • Zaragoza Salcedo, Amparo
  • Martín Martín, Jesús
  • Cobo Sanchez, José Luis
  • Pérez García, Santiago
  • Simón Ricart, Aurora
  • Ara Lucea, Pilar
  • Jimeno San Martín, Leticia
  • Ducay Eguillor, Montserrat
  • De La Torre Lomas, Noelia
  • Pérez Herreros, Jesica
  • Olano Lizarraga, Maddi
Background. To date, there are no tools for the nursing staff to gain systematic insight on the experience lived by patients with chronic heart failure. The objective of this study was to develop a scale for this purpose. Methods. The study was conducted between January 2018 and December 2020 in three Spanish hospitals. The process described by DeVellis was used for the development of the scale. The items were built based on a phenomenological study and a systematic review of the literature. Next, feedback from a panel of experts was obtained, the scale was administered to a sample of patients with chronic heart failure, and a cognitive interview and an observational study were conducted to create the final version of the scale. Results. The first version of the scale had in seven domains and 76 items. After its evaluation by a panel of experts, it was reduced to a second version with six domains and 55 items. Following the administration of Version 2 to 17 patients (58.8% male, mean age 59.53, 70.6% classified as NYHA functional class II), five items were modified and two eliminated. Thus, the third version of the UNAV-CHF Experience Scale was composed of six domains and 53 items. Conclusions. This study presents the development of the UNAV-experience of living with chronic heart failure scale. It is an original and novel instrument that allows systematically explore this experience. A larger -scale study is necessary to confirm the validity of our scale.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Association Between Statins Use and Major Bleeding in Patients Using Direct Oral Anticoagulants for Atrial Fibrillation

  • Burgos-González, Airam de
  • Cea Soriano, Trinidad Lucía
  • Huerta Álvarez, María Consuelo Yolanda
Los anticoagulantes orales directos (AOD) se desarrollaron como alternativa a los antagonistas de la vitamina K en el tratamiento de la fibrilación auricular de origen no valvular (FNAV). Las estatinas son fármacos que se prescriben con frecuencia para la prevención de la enfermedad cardiovascular aterosclerótica. Se ha descrito una posible y plausible interacción entre los AOD y las estatinas, sugiriendo que su uso concomitante puede aumentar el riesgo de sangrado mayor. Por tanto, el objetivo de este estudio fue estimar el riesgo de sangrado grave asociado al uso concomitante de AOC y estatinas para evaluar posibles problemas de seguridad producido por la interacción de estos medicamentos. Se realizó un estudio de casos y controles anidado en una cohorte de nuevos usuarios de AOC en BIFAP (https://bifap.aemps.es/?lang=es), la base de datos informatizada y anonimizada de registros médicos de Atención Primaria para la realización de estudios farmacoepidemiológicos, perteneciente a la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) que cuenta con la colaboración de varias Comunidades Autónomas y el apoyo de las principales sociedades científicas implicadas. Los casos se definieron como eventos de sangrado mayor y se emparejaron con cuatro controles mediante muestreo por conjunto de riesgos. Se crearon episodios de tratamiento para definir la exposición de los participantes según su uso en la fecha índice como actual, reciente, pasado o sin uso. La exposición también se evaluó en relación con su continuidad y duración. Se crearon variables basadas en el uso concomitante de AOD y estatinas para estudiar la interacción, utilizando regresión logística condicional para estimar el riesgo de sangrado mayor. Los resultados mostraron que el riesgo (OR) ajustado (IC del 95 %) para el uso actual de AOD o estatinas fue de 1,35 (0,96-1,9) y 0,72 (0,59-0,88). El OR ajustado para su uso concomitante fue de 1,31 (0,83-2,07) en comparación con el no uso de ninguno de ellos. El uso continuo de AOD (1,27; 0,8-2,03) y el tratamiento a largo plazo (1,11; 0,67-1,81) se asociaron con riesgos menores que el tratamiento no continuo (1,40; 0,85-2,32) y a corto plazo (1,43; 0,94-2,45). Los análisis realizados con los AOD individuales y estatinas mostraron resultados similares, excepto en el caso del edoxabán, que presentó cifras bajas de uso, por tanto, no fue valorable. Ante estos resultados concluimos que no se encontraron pruebas que sugirieran una interacción entre los AOC y las estatinas y el riesgo de sangrado mayor. Como recomendación se sugiere que el uso regular de estos medicamentos es importante para minimizar su impacto en la aparición de sangrados.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Development of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids

  • Lo Faro, Alfredo
  • Sprega, Giorgia
  • Beradinelli, Diletta
  • Tini, Anstasio
  • Poyatos, Lourdes|||0000-0002-4641-8600
  • Papaseit, Esther|||0000-0003-2620-4274
  • Berretta, Paolo|||0000-0002-1748-5628
  • Di Giorgi, Alessandro|||0000-0003-2997-221X
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Takaishvili, Nino
  • Farkas, Tivadar
  • Busardo, Francesco Paolo|||0000-0002-3082-4532
  • Chankvetadze, Bezhan
In the present study enantioselective high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods were developed for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its major phase-1 metabolites 4-hydroxy-3-methoxyamphetamine (HMA), 4-hydroxy-3-methoxymethamphetamine (HMMA) and 3,4-methylenedioxyamphetamine (MDA) in human plasma, sweat, oral fluid (OF) and urine. The simultaneous separation of all these compounds and their respective enantioseparation was accomplished on two polysaccharide-based chiral columns. The Lux AMP column with a proprietary chiral selector enabled baseline separation of the enantiomers of MDMA, HMA and HMMA while MDA enantiomers could not be separated with this column under the experimental conditions used in this study. The Lux i-Amylose-3 column based on amylose tris(5-chloro-3-methylphenylcarbamate) as chiral selector baseline-separated the enantiomers of MDMA, HMMA and MDA while the enantiomers of HMA could not be separated. Thus, the various samples were analyzed by using both columns alternatively in combinations with acetonitrile containing 25% (v/v) 5 mM ammonium bicarbonate buffer at pH 11.0 as mobile phase. Analysis time was less than 4 min with the Lux AMP column and less than 6 min with the Lux i-Amylose-3 column. Both methods were validated and applied to the enantioselective determination of MDMA and its phase-I metabolites in human biological fluids, and enantioselective metabolism of MDMA was confirmed.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Novel genotype-phenotype correlations, differential cerebellar allele-specific methylation, and a common origin of the (ATTTC)n insertion in spinocerebellar ataxia type 37

  • Sanchez-Flores, Marina
  • Corral-Juan, Marc|||0000-0001-9407-7516
  • Gasch-Navalón, Esther|||0000-0003-1605-3951
  • Cirillo, Davide
  • Sanchez, Ivelisse|||0000-0002-7605-5337
  • Matilla-Dueñas, Antoni|||0000-0002-3514-4181
Spinocerebellar ataxia subtype 37 (SCA37) is a rare disease originally identified in ataxia patients from the Iberian Peninsula with a pure cerebellar syndrome. SCA37 patients carry a pathogenic intronic (ATTTC)n repeat insertion flanked by two polymorphic (ATTTT)n repeats in the Disabled-1 (DAB1) gene leading to cerebellar dysregulation. Herein, we determine the precise configuration of the pathogenic 5ʹ(ATTTT)n-(ATTTC)n-3ʹ(ATTTT)n SCA37 alleles by CRISPR-Cas9 and long-read nanopore sequencing, reveal their epigenomic signatures in SCA37 lymphocytes, fibroblasts, and cerebellar samples, and establish new molecular and clinical correlations. The 5ʹ(ATTTT)n-(ATTTC)n-3ʹ(ATTTT)n pathogenic allele configurations revealed repeat instability and differential methylation signatures. Disease age of onset negatively correlated with the (ATTTC)n, and positively correlated with the 3ʹ(ATTTT)n. Geographic origin and gender significantly correlated with age of onset. Furthermore, significant predictive regression models were obtained by machine learning for age of onset and disease evolution by considering gender, the (ATTTC)n, the 3ʹ(ATTTT)n, and seven CpG positions differentially methylated in SCA37 cerebellum. A common 964-kb genomic region spanning the (ATTTC)n insertion was identified in all SCA37 patients analysed from Portugal and Spain, evidencing a common origin of the SCA37 mutation in the Iberian Peninsula originating 859 years ago (95% CI 647-1378). In conclusion, we demonstrate an accurate determination of the size and configuration of the regulatory 5ʹ(ATTTT)n-(ATTTC)n-3ʹ(ATTTT)n repeat tract, avoiding PCR bias amplification using CRISPR/Cas9-enrichment and nanopore long-read sequencing, resulting relevant for accurate genetic diagnosis of SCA37. Moreover, we determine novel significant genotype-phenotype correlations in SCA37 and identify differential cerebellar allele-specific methylation signatures that may underlie DAB1 pathogenic dysregulation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Stroke-associated pneumonia according to mCDC criteria, impact on prognosis and antibiotic therapy

  • Rabaneda-Lombarte, Neus
  • Faura, Júlia|||0000-0002-8436-1377
  • Ezcurra Diaz, Garbiñe|||0000-0002-9511-3117
  • Olivé-Gadea, Marta|||0000-0003-4637-1598
  • Álvarez-Larruy, Marta|||0000-0003-0119-5607
  • Vidal-de Francisco, Diana
  • Domínguez-Mayoral, Ana
  • Avellaneda-Gómez, Carla|||0000-0003-4851-1224
  • Freijo, Mari Mar
  • Zapata-Arriaza, Elena|||0000-0002-1730-1999
  • Serrano-Heras, Gemma|||0000-0001-9368-4832
  • Alcahut-Rodríguez, Cristian
  • Fernandez-Perez, Isabel|||0000-0002-9949-1393
  • Moniche, Francisco|||0000-0001-8613-2909
  • Pérez-Sánchez, Soledad|||0000-0002-8940-9763
  • Millán Torné, Mònica|||0000-0002-4692-5936
  • Rubiera, Marta
  • Dorado Bouix, Laura|||0000-0003-1095-6797
  • Maisterra Santos, Olga
  • Montaner, Joan|||0000-0003-4845-2279
  • Bustamante, Alejandro|||0000-0003-4390-8900
Objective: The modified Centers for Disease Control and Prevention (mCDC) criteria have been proposed for diagnosing and managing stroke-associated pneumonia (SAP). The objective was to investigate the impact of SAP on stroke outcome depending on whether or not it conforms to mCDC criteria. Our secondary objective was to identify the responsible factors for antibiotic initiation in stroke patients. Methods: We conducted a prospective, multicenter, observational study of ischemic stroke patients with moderate to severe stroke (NIHSS≥4) admitted within 24 h. For 7 days, mCDC criteria were assessed daily, and infections and antibiotics were recorded. Pneumonias were divided into those fulfilling mCDC criteria (mCDC-SAP) or not (other pneumonias, OPn). The effect of each type of pneumonia on 3-month outcome was evaluated in separated logistic regression models. Factors associated with antibiotic initiation were explored using a random forest analysis. Results: Of the 342 patients studied, infections were diagnosed in 72 (21.6%), including 39 (11.7%) cases of pneumonia. Of them, 25 (7.5%) fulfilled mCDC criteria. Antibiotics were used in 92% of mCDC-SAP and 64.3% of OPn. In logistic regression analysis, mCDC-SAP, but not OPn, was an independent predictor of poor outcome [OR, 4.939 (1.022-23.868)]. The random forest analysis revealed that fever had the highest importance for antibiotic initiation. Interpretation: The mCDC criteria might be useful for detecting clinically relevant SAP, which is associated with poor outcomes. Isolated signs of infection were more important for antibiotic initiation than compliance with pre-defined criteria. Therefore, adherence to mCDC criteria might result in antibiotic saving without compromising clinical outcome.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Metabolic profile of N-ethylhexedrone, N-ethylpentedrone, and 4-chloromethcathinone in urine samples by UHPLC-QTOF-HRMS

  • Massano, Marta
  • Nuñez-Montero, Melani
  • Papaseit, Esther|||0000-0003-2620-4274
  • Hladun, Olga|||0000-0002-6230-5876
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Ventura, Mireia|||0000-0003-1133-6872
  • Marchei, Emilia|||0000-0002-7158-6032
  • Alladio, Eugenio
  • Gerace, Enrico
  • Pichini, Simona
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Salomone, Alberto
Forensic laboratories are constantly required to identify new drugs and their metabolites. N-ethylhexedrone (NEH, HEXEN), N-Ethylpentedrone (NEP), and 4-Chloromethcathinone (4-CMC, clephedrone) are synthetic substances structurally related to natural cathinone, alkaloid present in the leaves of the Catha edulis (Khat) plant. These synthetic cathinones (SC) are members of the heterogenous family of new psychoactive substances (NPS) that raised major concerns in scientific and forensic communities over the past years due to their widespread consumption. In this context, we investigated their metabolic profile using of UHPLC-QTOF-HRMS to elucidate the distribution of the parent drug and its metabolites in urine samples over time. Initially, both male and female volunteers were divided into three groups and eight subjects of each group were administered intranasally or orally with one SC (20-40 mg of NEH or NEP intranasal, 100-150 mg of 4-CMC oral). Urine samples were collected at 0-2 and 2-4 or 2-5 h. Urine (50 μL) was diluted 1:2 with acetonitrile/methanol (95:5) and injected into the UHPLC-QTOF-HRMS. Phase-I and phase-II metabolites were identified on the basis of fragmentation patterns and exact masses. Several phase-I and glucuronide-phase-II metabolites were identified in urine samples. Keto group reduction, hydroxylation and dealkylation were the common metabolic pathways identified for all cathinones and the presence of NEH-glucuronide, NEP-glucuronide and 4-CMC-glucuronide was also relevant. Significant is the slower metabolite formation for 4-CMC, which was detected at high concentrations in its original form even 5 h after administration, due to its long half-life and low intrinsic clearance compared to the other SCs. UHPLC-QTOF-HRMS demonstrated a considerable capability to semi-quantify the three synthetic cathinones and identify the target metabolites with high reliability. The introduction of new target compounds improves the efficiency of toxicological screening analysis on real samples and extends the window of detection of the SCs in biological matrices.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Interleukin-16 is increased in obesity and alters adipogenesis and inflammation in vitro

  • Reyes-Farias, Marjorie|||0000-0001-9179-7251
  • Fernández-García, Pablo|||0000-0001-8018-5954
  • Corrales, Patricia|||0000-0002-9817-8389
  • González, Lorena
  • Soria-Gondek, Andrea|||0000-0002-7210-0073
  • Martínez, Ester
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Tarascó, Jordi
  • Moreno Santabarbara, Pablo|||0000-0002-6652-120X
  • Sumoy, Lauro|||0000-0003-0005-4618
  • Medina-Gómez, Gema|||0000-0001-8169-681X
  • Sánchez-Infantes, David|||0000-0001-6086-7501
  • Herrero, Laura|||0000-0003-4244-4673
Introduction: Obesity is a chronic condition associated with low-grade inflammation mainly due to immune cell infiltration of white adipose tissue (WAT). WAT is distributed into two main depots: subcutaneous WAT (sWAT) and visceral WAT (vWAT), each with different biochemical features and metabolic roles. Proinflammatory cytokines including interleukin (IL)-16 are secreted by both adipocytes and infiltrated immune cells to upregulate inflammation. IL-16 has been widely studied in the peripheral proinflammatory immune response; however, little is known about its role in adipocytes in the context of obesity. Aim & Methods: We aimed to study the levels of IL-16 in WAT derived from sWAT and vWAT depots of humans with obesity and the role of this cytokine in palmitate-exposed 3T3-L1 adipocytes. Results: The results demonstrated that IL-16 expression was higher in vWAT compared with sWAT in individuals with obesity. In addition, IL-16 serum levels were higher in patients with obesity compared with normal-weight individuals, increased at 6 months after bariatric surgery, and at 12 months after surgery decreased to levels similar to before the intervention. Our in vitro models showed that IL-16 could modulate markers of adipogenesis (Pref1), lipid metabolism (Plin1, Cd36, and Glut4), fibrosis (Hif1a, Col4a, Col6a, and Vegf), and inflammatory signaling (IL6) during adipogenesis and in mature adipocytes. In addition, lipid accumulation and glycerol release assays suggested lipolysis alteration. Discussion: Our results suggest a potential role of IL-16 in adipogenesis, lipid and glucose homeostasis, fibrosis, and inflammation in an obesity context.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Electrophysiological and histological characterization of atrial scarring in a model of isolated atrial myocardial infarction

  • Amorós Figueras, Gerard|||0000-0002-2109-5550
  • Casabella Ramón, Sergi|||0000-0001-7597-350X
  • Company-Se, Georgina|||0000-0002-0473-4955
  • Arzamendi, Dabit|||0000-0001-7543-5867
  • Jorge, Esther|||0000-0002-2777-0000
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Macías, Y.
  • Sanchez-Quintana, Damian
  • Rosell Ferrer, Javier|||0000-0002-9691-328X
  • Guerra Ramos, José María|||0000-0001-5397-9177
  • Cinca, Juan|||0000-0003-4819-4265
Characterization of atrial myocardial infarction is hampered by the frequent concurrence of ventricular infarction. Theoretically, atrial infarct scarring could be recognized by multifrequency tissue impedance, like in ventricular infarction, but this remains to be proven. Objective: This study aimed at developing a model of atrial infarction to assess the potential of multifrequency impedance to recognize areas of atrial infarct scar. Seven anesthetized pigs were submitted to transcatheter occlusion of atrial coronary branches arising from the left coronary circumflex artery. Six weeks later the animals were anesthetized and underwent atrial voltage mapping and multifrequency impedance recordings. The hearts were thereafter extracted for anatomopathological study. Two additional pigs not submitted to atrial branch occlusion were used as controls. Selective occlusion of the atrial branches induced areas of healed infarction in the left atrium in 6 of the 7 cases. Endocardial mapping of the left atrium showed reduced multi-frequency impedance (Phase angle at 307 kHz: from -17.1° ± 5.0° to -8.9° ± 2.6°, p <.01) and low-voltage of bipolar electrograms (.2 ± 0.1 mV vs. 1.9 ± 1.5 mV vs., p <.01) in areas affected by the infarction. Data variability of the impedance phase angle was lower than that of bipolar voltage (coefficient of variability of phase angle at307 kHz vs. bipolar voltage:.30 vs.77). Histological analysis excluded the presence of ventricular infarction. Selective occlusion of atrial coronary branches permits to set up a model of selective atrial infarction. Atrial multifrequency impedance mapping allowed recognition of atrial infarct scarring with lesser data variability than local bipolar voltage mapping. Our model may have potential applicability on the study of atrial arrhythmia mechanisms.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Possible role for rare TRPM7 variants in patients with hypomagnesaemia with secondary hypocalcaemia

  • Vargas-Poussou, Rosa|||0000-0002-4169-0680
  • Claverie-Martin, F.
  • Prot-Bertoye, C.
  • Carotti, V.
  • Van Der Wijst, J.
  • Perdomo-Ramirez, A.
  • Fraga Rodriguez, Gloria Maria|||0000-0002-7682-1396
  • Hureaux, M.
  • Bos, C.|||0000-0001-5016-9435
  • Latta, F.
  • Houillier, Pascal
  • Hoenderop, J.G.J.|||0000-0002-1816-8544
  • De Baaij, J.H.F.|||0000-0003-2372-8486
Hypomagnesaemia with secondary hypocalcaemia (HSH) is a rare autosomal recessive disorder caused by pathogenic variants in TRPM6, encoding the channel-kinase transient receptor potential melastatin type 6. Patients have very low serum magnesium (Mg2+) levels and suffer from muscle cramps and seizures. Despite genetic testing, a subgroup of HSH patients remains without a diagnosis. In this study, two families with an HSH phenotype but negative for TRPM6 pathogenic variants were subjected to whole exome sequencing. Using a complementary combination of biochemical and functional analyses in overexpression systems and patient-derived fibroblasts, the effect of the TRPM7-identified variants on Mg2+ transport was examined. For the first time, variants in TRPM7 were identified in two families as a potential cause for hereditary HSH. Patients suffer from seizures and muscle cramps due to magnesium deficiency and episodes of hypocalcaemia. In the first family, a splice site variant caused the incorporation of intron 1 sequences into the TRPM7 messenger RNA and generated a premature stop codon. As a consequence, patient-derived fibroblasts exhibit decreased cell growth. In the second family, a heterozygous missense variant in the pore domain resulted in decreased TRPM7 channel activity. We establish TRPM7 as a prime candidate gene for autosomal dominant hypomagnesaemia and secondary hypocalcaemia. Screening of unresolved patients with hypocalcaemia and secondary hypocalcaemia may further establish TRPM7 pathogenic variants as a novel Mendelian disorder.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study

  • García-Escobar, Eva|||0000-0002-0134-3473
  • Valdés, Sergio|||0000-0001-8623-4331
  • Soriguer, Federico|||0000-0002-1992-5666
  • Vendrell, Joan|||0000-0002-6994-6115
  • Urrutia Etxebarria, Inés M.|||0000-0001-5386-8776
  • Maldonado-Araque, Cristina
  • Ortega, Emilio|||0000-0002-2217-8905
  • Ocón, Pilar|||0000-0001-9257-2687
  • Montanya, Eduard|||0000-0003-2518-9076
  • Menéndez Torre, Edelmiro|||0000-0002-9548-7821
  • Lago-Sampedro, Ana Maria
  • González-Frutos, Teba
  • Gomis, Ramon|||0000-0002-7285-1328
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • García-Serrano, Sara
  • Galán-García, José Luis|||0000-0002-8773-6998
  • Castell, Conxa|||0000-0003-2558-1959
  • Bordiú, Elena
  • Badía-Guillén, Rocío
  • Aguilera-Venegas, Gabriel|||0000-0002-5813-6184
  • Girbés, Juan|||0000-0002-1665-4549
  • Gaztambide, Sonia|||0000-0003-3569-2265
  • Delgado, Elias|||0000-0001-6114-9712
  • Chaves, Felilpe Javier|||0000-0001-8009-3689
  • Castaño, Luis|||0000-0003-0437-9401
  • Calle-Pascual, Alfonso
  • Rojo-Martínez, G.|||0000-0003-2179-2134
  • Franch-Nadal, Josep|||0000-0002-5175-1555
Our aim was to evaluate whether fatty liver index (FLI) is associated with the risk of type 2 diabetes (T2DM) development within the Spanish adult population and according to their prediabetes status; additionally, to examine its incremental predictive value regarding traditional risk factors. A total of 2260 subjects (Prediabetes: 641 subjects, normoglycemia: 1619 subjects) from the Di@bet.es cohort study were studied. Socio-demographic, anthropometric, clinical data and survey on habits were recorded. An oral glucose tolerance test was performed and fasting determinations of glucose, lipids and insulin were made. FLI was calculated and classified into three categories: Low (< 30), intermediate (30-60) and high (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Human gut microbiota composition associated with international travels

  • Henares Bonilla, Desiree|||0000-0003-2631-2718
  • Monsálvez, Víctor|||0009-0003-0126-3224
  • Brotons de los Reyes, Pedro|||0000-0002-2399-7320
  • Machado, María Luisa|||0000-0001-8997-4917
  • Capilla, Silvia|||0000-0002-7274-2973
  • Gomila, Aina|||0000-0001-6979-9269
  • Bierge, Paula|||0000-0003-0917-3445
  • Cubero, Meritxell
  • Pich, Oscar Q.|||0000-0003-3561-630X
  • Requena-Méndez, Ana|||0000-0002-4422-241X
  • Muñoz-Almagro, Carmen|||0000-0001-5586-404X
  • Gasch, Oriol|||0000-0001-8518-458X
Objective: The objective of this study was to evaluate whether long stays in non-European countries influence the composition, diversity, and dynamics of gut microbiota, considering the potential impact of travelling, close contact with new people, and consumption of water and food. Methods: Two prospective cohorts were analyzed: (i) A longitudinal cohort comprising long-term travellers who provided fecal samples before and after their travels. (ii) A cohort consisting of long-term travellers and recently arrived migrants from non-European countries, which was compared with non-traveller controls. Each participant self-collected fecal samples and provided demographic and epidemiological data. Microbiota was characterized through 16 S rRNA gene sequencing. Results: The longitudinal cohort comprised 17 subjects. A trend toward higher bacterial diversity was observed after travelling (Shannon index 3.12vs3.26). When comparing 84 travellers/migrants with 97 non-travellers, a confirmed association of higher diversity levels with travelling was observed (Phylogenetic diversity: 22.1vs20.9). Specific genera enriched in travellers' gut microbiota were identified, including Escherichia/Shigella, Bacteroides, and Parabacteroides. The analysis revealed three major clusters with profound differences in their bacterial composition, which exhibited differential distribution between travellers and non-travellers (Adonis P < 0.001; R2 = 30.6 %). Two clusters were more frequently observed in travellers: The first cluster, characterized by dominance of Escherichia/Shigella, exhibited the lowest levels of richness and diversity. The second cluster, dominated by Faecalibacterium and Bacteroides, displayed the highest richness and diversity patterns. Conclusion: These findings highlight the diverse impact of international travel on gut microbiota composition and underscore the importance of considering microbiota resilience and diversity in understanding the health implications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia, Post hoc analysis of trial

  • Ricart, Marta|||0000-0003-0099-6525
  • Bonacina, Erika|||0000-0002-8042-8247
  • García Manau, Pablo|||0000-0002-2415-1626
  • López, Monica
  • Caamiña Álvarez, Sara|||0000-0001-9178-3132
  • Vives, Àngels|||0000-0001-9712-6379
  • Lopez-Quesada, Eva|||0000-0002-4477-3246
  • Maroto, Anna|||0000-0003-3225-9095
  • de Mingo, Laura
  • Pintado, Elena
  • Ferrer Costa, Roser|||0000-0002-8925-3172
  • Martin, Lourdes|||0000-0003-1781-5305
  • Rodriguez-Zurita, Alicia|||0000-0003-4177-4726
  • Garcia Cancela, Esperanza|||0000-0001-8924-9096
  • Pallarols Badia, Mar
  • Pratcorona Alicart, Laia|||0000-0002-3805-1589
  • Teixidor, Mireia|||0000-0001-8548-1648
  • Orizales Lago, Carmen María|||0000-0001-7184-2799
  • Ocaña, Vanesa|||0000-0003-2547-5646
  • del Barco, Ester|||0000-0002-1484-9027
  • Carreras Moratonas, Elena|||0000-0003-3471-7248
  • Suy, Anna|||0000-0003-2987-6105
  • Mendoza, Manel|||0000-0002-3030-3833
This study aims to evaluate the safety of discontinuing aspirin treatment at 24-28 weeks in women at high risk after first-trimester combined screening for preeclampsia (PE) and normal placental growth factor (PlGF) levels at 24-28 weeks of gestation. This is a post hoc analysis of the StopPRE trial, conducted at nine Spanish maternity hospitals from September 2019 to September 2021. In the StopPRE trial, all high-risk single pregnancies identified during first-trimester screening for PE were treated with 150 mg of daily aspirin. Out of 1604 eligible women with a soluble fms-like tyrosine kinase-1 to PlGF ratio (sFlt-1/PlGF) ≤38 at 24-28 weeks, 968 were randomly assigned in a 1:1 ratio to either continue aspirin until 36 weeks (control group) or discontinue it (intervention group). In this secondary analysis, only women with PlGF ≥100 pg/mL at 24-28 weeks were included. As in the StopPRE trial, the non-inferiority margin was set at a 1.9% difference in preterm PE incidence between the groups. Among the 13 983 screened pregnant women, 1984 (14.2%) were deemed high-risk for preterm PE, of which 397 (20.0%) were ineligible, 636 declined participation, and 32 were excluded. Ultimately, 919 women with PlGF.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

High-resolution versus conventional manometry for the diagnosis of small bowel motor dysfunction

  • Alcalá González, Luis Gerardo|||0000-0003-3247-1539
  • Nieto Ruiz, Adoración|||0000-0002-3421-2840
  • Accarino, Ana María|||0000-0002-5829-1811
  • Azpiroz Vidaur, Fernando|||0000-0002-7327-960X
  • Malagelada Prats, Carolina|||0000-0001-7097-1492
Background: The diagnosis of small bowel motility disorders is performed by manometric evaluation of the contractile patterns of the small intestine. Conventional intestinal manometry systems include few pressure sensors at relatively long intervals. We have recently shown that high-resolution jejunal manometry, with multiple closely spaced recording sites, allows the analysis of propagation patterns of intestinal motility in healthy subjects that cannot be detected with conventional manometry. The objective of this pilot study was to explore the feasibility and diagnostic value of high-resolution intestinal manometry in patients with suspected small bowel dysmotility. Methods: Prospective pilot study evaluating intestinal motility patterns in 16 consecutive patients (16-61 years; 11 women) with severe, chronic digestive symptoms referred for the evaluation of intestinal motility and in 18 healthy controls (21-38 years; 8 women). A 36-channel high-resolution manometry catheter was orally placed under radiological guidance in the jejunum. Intestinal motility was continuously recorded for 3 h fasting and 2 h after a 450 kcal meal. The manometric recordings were analyzed in two formats: (a) with the high-resolution data from 34 channels and (b) showing only the recordings from 5 channels separated by 7 cm intervals, mimicking a conventional manometry recording. Key Results: In the analysis mimicking conventional manometry, abnormal motility criteria were detected in six patients and in no healthy subject [bursts (n = 3), postprandial minute rhythm (n = 1) and myopathic pattern (n = 2)]. These classical dysmotility criteria were also detected by high-resolution manometry. High-resolution analysis detected one or more abnormal findings in seven additional patients that were not observed in any healthy subject, specifically: (a) abnormal propagation of Phase III (n = 3); (b) reduced propagated activity during Fasting Phase II (n = 4); (c) increased propagated activity during Fasting Phase II and postprandial phase (n = 1). Conclusions and Inferences: This pilot study suggests that high-resolution intestinal manometry may improve the sensitivity of conventional manometry in the detection of intestinal motor dysfunction.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Geometric, Biomechanic and Haemodynamic Aortic Abnormalities Assessed by 4D Flow Cardiovascular Magnetic Resonance in Patients Treated by TEVAR Following Blunt Traumatic Thoracic Aortic Injury

  • Gil-Sala, Daniel|||0000-0003-4885-5836
  • Guala, Andrea|||0000-0002-5006-8164
  • Garcia Reyes, Marvin
  • Azancot, María A.|||0000-0002-8447-1373
  • Dux-Santoy, Lydia|||0000-0001-8736-2095
  • Allegue Allegue, Nicolas
  • Teixido-Tura, Gisela|||0000-0003-4714-2420
  • Goncalves Martins, Gabriela
  • Ruiz Muñoz, Aroa|||0000-0002-1138-8528
  • Constenla Garcia, Ivan|||0000-0002-7107-2277
  • Evangelista Masip, Arturo|||0000-0001-8182-1174
  • Tello Díaz, Cristina
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Rodríguez Palomares, José F.|||0000-0002-7229-9780
  • Bellmunt Montoya, Sergi|||0000-0002-2851-720X
Objective: Thoracic endovascular aortic repair (TEVAR) is widely used for the treatment of patients with blunt traumatic thoracic aortic injury (BTAI). However, aortic haemodynamic and biomechanical implications of this intervention are poorly investigated. This study aimed to assess whether patients treated by TEVAR following BTAI have thoracic aortic abnormalities in geometry, stiffness, and haemodynamics. Methods: Patients with BTAI treated by TEVAR at Vall d'Hebron Hospital between 1999 and 2019 were compared with propensity score matched healthy volunteers (HVs). All subjects underwent cardiovascular magnetic resonance (CMR) comprising a 4D flow CMR sequence. Spatially resolved aortic diameter, length, volume, and curvature were assessed. Pulse wave velocity, distensibility, and longitudinal strain (all measurements of aortic stiffness) were determined regionally. Moreover, advanced haemodynamic descriptors were quantified: systolic flow reversal ratio (SFRR), quantifying backward flow during systole, and in plane rotational flow (IRF), measuring in plane strength of helical flow. Results: Twenty-six BTAI patients treated by TEVAR were included and matched with 26 HVs. They did not differ in terms of age, sex, and body surface area. Patients with TEVAR had a larger and longer ascending aorta (AAo) and marked abnormalities in local curvature. Aortic stiffness was greater in the aortic segments proximal and distal to TEVAR compared with controls. Moreover, TEVAR patients presented strongly altered flow dynamics compared with controls: a reduced IRF from the distal AAo to the proximal descending aorta and an increased SFRR in the whole thoracic aorta. These differences persisted adjusting for cardiovascular risk factors and were independent of time elapsed since TEVAR implantation. Conclusion: At long term follow up, previously healthy patients who underwent TEVAR implantation following BTAI had increased diameter, length and volume of the ascending aorta, and increased aortic stiffness and abnormal flow patterns in the whole thoracic aorta compared with matched controls. Further studies should address whether these alterations have clinical implications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Individual blood concentrations of persistent organic pollutants and chemical elements, and COVID-19, A prospective cohort study in Barcelona

  • Porta, Miquel|||0000-0003-1684-7428
  • Pumarega, José Antonio|||0000-0001-6950-6702
  • Gasull, Magda|||0000-0003-4546-3650
  • Aguilar, Ruth|||0000-0003-3277-3107
  • Henríquez-Hernández, Luis A.
  • Basagaña, X.|||0000-0002-8457-1489
  • Zumbado, Manuel
  • Villar Garcia, Judit|||0000-0002-6767-3424
  • Rius i Gibert, Maria Cristina|||0000-0001-5189-6503
  • Mehta, Sneha
  • Vidal, Marta
  • Jimenez, Alfons
  • Campi, Laura
  • Lop Gros, Joan|||0000-0002-9442-5688
  • P. Luzardo, Octavio|||0000-0002-4153-3028
  • Dobaño Lazaro, Carlota|||0000-0002-6751-4060
  • Moncunill, Gemma|||0000-0001-5105-9836
Background: There is wide, largely unexplained heterogeneity in immunological and clinical responses to SARS-CoV-2 infection. Numerous environmental chemicals, such as persistent organic pollutants (POPs) and chemical elements (including some metals, essential trace elements, rare earth elements, and minority elements), are immunomodulatory and cause a range of adverse clinical events. There are no prospective studies on the effects of such substances on the incidence of SARS-CoV-2 infection and COVID-19. Objective: To investigate the influence of blood concentrations of POPs and elements measured several years before the pandemic on the development of SARS-CoV-2 infection and COVID-19 in individuals from the general population. Methods: We conducted a prospective cohort study in 154 individuals from the general population of Barcelona. POPs and elements were measured in blood samples collected in 2016-2017. SARS-CoV-2 infection was detected by rRT-PCR in nasopharyngeal swabs and/or by antibody serology using eighteen isotype-antigen combinations measured in blood samples collected in 2020-2021. We analyzed the associations between concentrations of the contaminants and SARS-CoV-2 infection and development of COVID-19, taking into account personal habits and living conditions during the pandemic. Results: Several historically prevalent POPs, as well as arsenic, cadmium, mercury, and zinc, were not associated with COVID-19, nor with SARS-CoV-2 infection. However, DDE (adjusted OR = 5.0 [95% CI: 1.2-21]), lead (3.9 [1.0-15]), thallium (3.4 [1.0-11]), and ruthenium (5.0 [1.8-14]) were associated with COVID-19, as were tantalum, benzo(b)fluoranthene, DDD, and manganese. Thallium (3.8 [1.6-8.9]), and ruthenium (2.9 [1.3-6.7]) were associated with SARS-CoV-2 infection, and so were lead, gold, and (protectively) iron and selenium. We identified mixtures of up to five substances from several chemical groups, with all substances independently associated to the outcomes. Conclusions: Our results provide the first prospective and population-based evidence of an association between individual concentrations of some contaminants and COVID-19 and SARS-CoV-2 infection. POPs and elements may contribute to explain the heterogeneity in the development of SARS-CoV-2 infection and COVID-19 in the general population. If the associations are confirmed as causal, means are available to mitigate the corresponding risks.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease

  • Fortea, Juan|||0000-0002-1340-638X
  • García-Arcelay, Elena
  • Terrancle, Ángeles
  • Gálvez, Blanca
  • Díez-Carreras, Verónica
  • Rebollo, Pablo|||0000-0002-7517-6540
  • Maurino, Jorge|||0000-0001-9858-3555
  • García-Ribas, Guillermo
Alzheimer's disease (AD) biomarkers reflect key elements of pathophysiology and improve the diagnostic process. However, their use in routine clinical practice is still limited. We aimed to assess neurologists' barriers and enablers to early AD diagnosis using core AD biomarkers. We conducted an online study in collaboration with the Spanish Society of Neurology. Neurologists answered a survey exploring their attitudes towards AD diagnosis using biomarkers in mild cognitive impairment (MCI) or mild AD dementia. Multivariate logistic regression analyses were conducted to determine the association between neurologists' characteristics and diagnostic attitudes. We included 188 neurologists with a mean age (SD) of 40.6 (11.3) years, 52.7% male. Most participants had access to AD biomarkers, mainly in cerebrospinal fluid (CSF) (89.9%,#x0025;, n = 169). The majority of participants (95.2%,#x0025;, n = 179) considered CSF biomarkers useful for an etiological diagnosis in MCI. However, 85.6% of respondents (n = 161) used them in less than 60% of their MCI patients in routine clinical practice. Facilitating patients and their families to plan for the future was the most frequent enabler for the use of biomarkers. Short consultation time and practicalities associated with the programming of a lumbar puncture were the most common barriers. A younger neurologist age (p = 0.010) and a higher number of patients managed weekly (p = 0.036) were positively associated with the use of biomarkers. Most neurologists had a favorable attitude to the use of biomarkers, especially in MCI patients. Improvements in resources and consultation time may increase their use in routine clinical practice.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Falls Predict Acute Hospitalization in Parkinson's Disease

  • Santos García, Diego|||0000-0002-3126-5111
  • de Deus Fonticoba, Teresa
  • Cores, Carlos
  • Suarez Castro, Ester
  • Hernández-Vara, Jorge|||0000-0002-9129-5224
  • Jesús Maestre, Silvia|||0000-0002-1874-4628
  • Mir, Pablo|||0000-0003-1656-302X
  • Cosgaya, Marina
  • Martí Domenech, Maria Josep|||0000-0002-9872-7835
  • Pastor, Pau|||0000-0002-7493-8777
  • Cabo-Lopez, Iria|||0000-0003-2436-6499
  • Seijo, Manuel
  • Legarda, Inés
  • Vives, Bárbara
  • Caballol, Nuria|||0000-0003-3363-3077
  • Ruiz Martinez, Javier
  • Croitoru, Ioana
  • Cubo, Esther|||0000-0003-0018-1182
  • Miranda, Javier
  • Alonso Losada, Maria Gema
  • Labandeira, Carmen
  • Lopez Ariztegui, Nuria
  • Morales-Casado, Mabel
  • Gonzalez-Aramburu, Isabel|||0000-0002-3696-4093
  • Infante, Jon|||0000-0003-4025-4606
  • Escalante, Sonia|||0000-0001-8931-1400
  • Bernardo, Noemí
  • Blázquez Estrada, Marta|||0000-0003-3348-9992
  • Menéndez González, Manuel
  • Garcia Caldentey, Juan
  • Borrue, Carmen
  • Vela, Lydia|||0000-0001-6663-395X
  • Catalán Alonso, Maria José
  • Gomez Mayordomo, Víctor
  • Kurtis, Mónica|||0000-0003-3037-9712
  • Prieto, Cristina|||0000-0002-0812-8100
  • Ordás Bandera, Carlos Manuel|||0000-0003-3551-8769
  • Nogueira, Víctor
  • Lopez Manzanares, Lydia
  • Ávila Rivera, Maria Asunción
  • Puente, Victor
  • García Moreno, José Manuel
  • Solano Vila, Berta|||0009-0007-8945-0487
  • Álvarez Sauco, María
  • Carrillo Padilla, Francisco
  • Martínez-Castrillo, Juan Carlos|||0000-0001-7744-6850
  • Sánchez Alonso, Pilar|||0000-0003-0496-4707
  • Gaston, Itziar
  • Kulisevsky, Jaime|||0000-0003-4870-1431
  • Valero, Caridad
  • Fàbregues-Boixar i Nebot, Oriol de|||0000-0002-3518-5338
  • González Ardura, Jessica
  • Lopez Diaz, Luis Manuel
  • Martínez Martín, Pablo|||0000-0003-0837-5280
There is a need for identifying risk factors for hospitalization in Parkinson's disease (PD) and also interventions to reduce acute hospital admission. Objective: To analyze the frequency, causes, and predictors of acute hospitalization (AH) in PD patients from a Spanish cohort. PD patients recruited from 35 centers of Spain from the COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015) cohort from January 2016 to November 2017, were included in the study. In order to identify predictors of AH, Kaplan-Meier estimates of factors considered as potential predictors were obtained and Cox regression performed on time to hospital encounter 1-year after the baseline visit. Thirty-five out of 605 (5.8%) PD patients (62.5±8.9 years old; 59.8% males) presented an AH during the 1-year follow-up after the baseline visit. Traumatic falls represented the most frequent cause of admission, being 23.7% of all acute hospitalizations. To suffer from motor fluctuations (HR [hazard ratio] 2.461; 95% CI, 1.065-5.678; p = 0.035), a very severe non-motor symptoms burden (HR [hazard ratio] 2.828; 95% CI, 1.319-6.063; p = 0.008), falls (HR 3.966; 95% CI 1.757-8.470; p = 0.001), and dysphagia (HR 2.356; 95% CI 1.124-4.941; p = 0.023) was associated with AH after adjustment to age, gender, disease duration, levodopa equivalent daily dose, total number of non-antiparkinsonian drugs, and UPDRS-IIIOFF. Of the previous variables, only falls (HR 2.998; 95% CI 1.080-8.322; p = 0.035) was an independent predictor of AH. Falls is an independent predictor of AH in PD patients.
Dipòsit Digital de Documents de la UAB
Publicación

Changes in glucagon-like peptide 1 and 2 levels in people with obesity after a diet-induced weight-loss intervention are related to a specific microbiota signature, A prospective cohort study

  • Rodríguez-Peña, M-Mar
  • Astiarraga, Brenno|||0000-0003-2216-8974
  • Seco, Jesus|||0000-0002-4049-8873
  • Ceperuelo Mallafré, Victòria|||0000-0002-4460-9761
  • Caballé Mestres, Adrià|||0000-0002-2388-4713
  • Pérez-Brocal Vicente|||0000-0002-1927-9676
  • Attolini, Camille Stephan-Otto
  • Moya, Andrés|||0000-0002-2867-1119
  • Llauradó, Gemma|||0000-0002-3237-6366
  • Megía, Ana|||0000-0002-5101-9452
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Vilarrasa, Nuria|||0000-0003-3188-1990
  • Fernández-Veledo, Sonia|||0000-0003-2906-3788
  • Vendrell, Joan|||0000-0002-6994-6115
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Lipidome Profiling in Childhood Obesity Compared to Adults, A Pilot Study

  • Soria-Gondek, Andrea|||0000-0002-7210-0073
  • Fernández-García, Pablo|||0000-0001-8018-5954
  • González, Lorena
  • Reyes-Farias, Marjorie|||0000-0001-9179-7251
  • Murillo-Vallés, Marta|||0000-0002-3208-2982
  • Valls, Aina|||0000-0002-0751-5029
  • Real, Nativitat
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Tarascó, Jordi
  • Jenkins, Benjamin|||0000-0003-0038-9709
  • Galán, María|||0000-0002-4758-8388
  • Villarroya, Francesc|||0000-0003-1266-9142
  • Koulman, Albert|||0000-0001-9998-051X
  • Corrales, Patricia|||0000-0002-9817-8389
  • Vidal-Puig, Antonio
  • Cereijo, Rubén|||0000-0002-1108-230X
  • Sánchez-Infantes, David|||0000-0001-6086-7501
The objective is to assess the circulating lipidome of children with obesity before and after lifestyle intervention and to compare the data to the circulating lipidome of adults with obesity before and after bariatric surgery. Ten pediatric (PE) and thirty adult (AD) patients with obesity were prospectively recruited at a referral single center. The PE cohort received lifestyle recommendations. The AD cohort underwent bariatric surgery. Clinical parameters and lipidome were analyzed in serum before and after six months of metabolic intervention. The abundance of phosphatidylinositols in the PE cohort and phosphatidylcholines in the AD significantly increased, while O-phosphatidylserines in the PE cohort and diacyl/triacylglycerols in the AD decreased. Fifteen lipid species were coincident in both groups after lifestyle intervention and bariatric surgery. Five species of phosphatidylinositols, sphingomyelins, and cholesteryl esters were upregulated. Eight species of diacylglycerols, glycerophosphoglycerols, glycerophosphoethanolamines, and phosphatidylcholines were downregulated. Most matching species were regulated in the same direction except for two phosphatidylinositols: PI(O-36:2) and PI(O-34:0). A specific set of lipid species regulated after bariatric surgery in adult individuals was also modulated in children undergoing lifestyle intervention, suggesting they may constitute a core circulating lipid profile signature indicative of early development of obesity and improvement after clinical interventions regardless of individual age.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prepandemic personal concentrations of per- and polyfluoroalkyl substances (PFAS) and other pollutants, Specific and combined effects on the incidence of COVID-19 disease and SARS-CoV-2 infection

  • Pumarega, José Antonio|||0000-0001-6950-6702
  • Gasull, Magda|||0000-0003-4546-3650
  • Koponen, Jani
  • Campi, Laura
  • Rantakokko, Panu|||0000-0002-8624-1387
  • Henríquez-Hernández, Luis A.
  • Aguilar, Ruth|||0000-0003-3277-3107
  • Donat-Vargas, Carolina
  • Zumbado, Manuel
  • Villar Garcia, Judit|||0000-0002-6767-3424
  • Rius i Gibert, Maria Cristina|||0000-0001-5189-6503
  • Santiago Díaz, Pablo|||0000-0003-2219-7687
  • Vidal, Marta
  • Jimenez, Alfons
  • Iglesias, Mar|||0000-0002-2274-4671
  • Dobaño Lazaro, Carlota|||0000-0002-6751-4060
  • Moncunill, Gemma|||0000-0001-5105-9836
  • Porta, Miquel|||0000-0003-1684-7428
Objective: To investigate the specific and combined effects of personal concentrations of some per- and polyfluoroalkyl substances (PFAS), other persistent organic pollutants (POPs), and chemical elements -measured in individuals' blood several years before the pandemic- on the development of SARS-CoV-2 infection and COVID-19 disease in the general population. Methods: We conducted a prospective cohort study in 240 individuals from the general population of Barcelona. PFAS, other POPs, and chemical elements were measured in plasma, serum, and whole blood samples, respectively, collected in 2016-2017. PFAS were analyzed by liquid chromatography-triple quadrupole mass spectrometry. SARS-CoV-2 infection was detected by rRT-PCR in nasopharyngeal swabs and/or antibody serology in blood samples collected in 2020-2021. Results: No individual PFAS nor their mixtures were significantly associated with SARS-CoV-2 seropositivity or COVID-19 disease. Previously identified mixtures of POPs and elements (Porta et al., 2023) remained significantly associated with seropositivity and COVID-19 when adjusted for PFAS (all OR.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Supporting legislative action, Urinary levels of phthalates and phenols among influencers in the 'Plastics in the spotlight' advocacy initiative

  • Pumarega, José Antonio|||0000-0001-6950-6702
  • Buscà, Oriol
  • Gasull, Magda|||0000-0003-4546-3650
  • Porta, Miquel|||0000-0003-1684-7428
Background: Society-wide initiatives to prevent human exposure to plastic residues include laws and policies. Such measures require citizens' support, which can be increased by honest advocacy and pedagogic projects. These efforts must have a scientific basis. Objective: To assist the 'Plastics in the spotlight' advocacy initiative raise awareness among the general public of the presence of plastic residues in the human body, and to increase citizens' support for legislation on plastic control in the European Union. Methods: Spot urine samples of 69 volunteers with cultural and political influence from Spain, Portugal, Latvia, Slovenia, Belgium, and Bulgaria were collected. Concentrations of 30 phthalate metabolites and phenols were determined through a high-performance liquid chromatography with tandem mass spectrometry and ultra-high-performance liquid chromatography with tandem mass spectrometry, respectively. Results: At least 18 compounds were detected in all urine samples. The maximum number of compounds detected per participant was 23, and the mean, 20.5. Phthalates were detected more frequently than phenols. Median concentrations were highest for monoethyl phthalate (41.6 ng/mL, adjusted for specific gravity), and maximum concentrations were highest for mono-iso-butyl phthalate (1345.1 ng/mL), oxybenzone (1915.1 ng/mL), and triclosan (949.6 ng/mL). Most reference values were not exceeded. Women had higher concentrations of the 14 phthalate metabolites and oxybenzone than men. Urinary concentrations were not correlated with age. Discussion: The study had three main limitations: method of subject selection (volunteers), small sample size, and limited data on determinants of exposure. Studies on volunteers do not pretend to be representative of the general population and are no substitute for biomonitoring studies in representative samples of the populations of interest. Studies as ours can only illustrate the existence and some aspects of the problem, and can raise awareness among citizens concerned by the evidence that the studies provide in a group of subjects who are humanly appealing. Conclusions: The results illustrate that human exposure to phthalates and phenols is widespread. All countries appeared to be similarly exposed to these contaminants, with higher levels in females. Most concentrations did not exceed reference values. The effects of this study on the objectives of the 'Plastics in the spotlight' advocacy initiative deserve a specific analysis from policy science.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Estimating the prevalence of chronic infections among asymptomatic migrants, results of a screening programme in Catalonia, Spain

  • Cruz, Angeline
  • Martínez-Perez, Angela
  • Almuedo-Riera, Alex
  • Roca Saumell, Carme
  • Gigante Lopez, Marina
  • Gasch, Oriol|||0000-0001-8518-458X
  • Falcó, Gemma
  • Jiménez-Lozano, Ana
  • Sanchez-Collado, Consol
  • Alonso Padilla, Julio|||0000-0003-4466-7969
  • Hurtado, Juan Carlos
  • Álvarez-Martínez, Miriam J.
  • Casellas, Aina|||0000-0003-4939-8411
  • Requena-Méndez, Ana|||0000-0002-4422-241X
Migrants are disproportionately affected by several infectious diseases differing the risk within migrant groups. This study aimed to estimate the prevalence of six chronic infections in asymptomatic migrants attended at primary care or specialized units where health assessments are offered. A multicentric cross-sectional study was conducted to estimate the prevalence of human immunodeficiency virus (HIV), hepatitis B and C virus, Strongyloides stercoralis, Schistosoma spp., and Trypanosoma cruzi infections in the migrant population who participated in a screening programme implemented at six primary health care centres, and two infectious diseases outpatient clinics in Catalonia, Spain. Of the 314 recruited migrants, 284 (90.4 %) were tested for at least one infection. The prevalence of the infections was as follows: 1.8 % for HIV, 1.8 % for chronic hepatitis B virus, 14.1 % for previous exposure to a hepatitis B virus infection, 0.4 % for hepatitis C virus infection, 2.6 % for S.stercoralis infection, and 7.0 % for T.cruzi infection. No cases infected with Schistosoma spp. were reported. A higher prevalence of HIV, hepatitis B and C virus was observed in Sub-Saharan Africans, whereas a higher prevalence of S.stercoralis and T.cruzi infections was reported in migrants from Latin-America and the Caribbean. Findings suggest a high burden of the studied infections, including parasitic infections, in the migrant population with variations within migrant groups based on areas of birth.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Molecular screening of transitional B cells as a prognostic marker of improved graft outcome and reduced rejection risk in kidney transplant

  • Perezpayá, Inés
  • Garcia, Sergio G.|||0000-0001-7698-3734
  • Clos Sansalvador, Marta|||0000-0001-8522-7818
  • Sanroque-Muñoz, Marta|||0009-0004-5197-7708
  • Font-Morón, Miriam|||0000-0002-4714-252X
  • Rodríguez-Martínez, Paula|||0000-0002-9001-2501
  • Vila-Santandreu, Anna
  • Bover, Jordi|||0000-0003-3577-2273
  • Borràs i Serres, Francesc Enric|||0000-0003-4038-1912
  • Cañas, Laura
  • Franquesa, Marcella|||0000-0002-1287-8908
Understanding immune cell dynamics in kidney transplantation may provide insight into the mechanisms of rejection and improve patient management. B cells have gained interest with a special relevance of the "regulatory" subsets and their graft outcome prognostic value. In this study, we aimed to prove that the direct immunophenotyping and target gene expression analysis of kidney transplant patients' fresh whole blood will help to identify graft rejection risk and assist in the monitoring of kidney transplanted patients. We employed flow cytometry and qPCR techniques to characterize B and T cell subsets within fresh whole blood samples, with particular emphasis on transitional B cells (TrB) identified as CD19 + CD24 hi CD38 hi. TrB are a relevant population in the context of kidney transplantation and are closely associated with regulatory B cells (Bregs) in humans. Patients were monitored, tracking pertinent clinical parameters and kidney-related events, including alterations in graft function and episodes of biopsy proven rejection. Higher percentages of TrB cells at 3 months after transplantation were positively associated with better graft outcomes and lower biopsy-proven acute rejection risk. Furthermore, a novel panel of B cell regulatory associated genes was validated at 3 months post-transplantation by qPCR analysis of peripheral blood mononuclear cell (PBMC) mRNA, showing high predictive power of graft events and prognostic value. These findings suggest that monitoring TrB may provide interesting patient management information, improve transplant outcomes, and allow for personalized drug regimens to minimize clinical complications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Multicentre randomised trial of screening with sFlt1/PlGF and planned delivery to prevent pre-eclampsia at term, protocol of the PE37 study

  • Llurba, Elisa|||0000-0003-4048-6407
  • Crispi, Fatima|||0000-0002-7422-5240
  • Crovetto, Francesca|||0000-0003-0140-7411
  • Youssef, Lina|||0000-0002-0554-5507
  • Delgado, Juan Luis
  • Puig, Isabel
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • Krofta, Ladislav
  • Mackova, Katerina
  • Martinez-Varea, Alicia
  • Tubau Navarra, Albert|||0000-0001-5460-0763
  • Ruiz, Aina
  • Paya, Antoni
  • Prat Grau, Maria|||0000-0002-3811-9205
  • Chantraine, Frederic
  • Comas, Carmina|||0000-0001-6631-0165
  • Kajdy, Anna
  • Lopez-Tinajero, Maria Fernanda|||0000-0002-3999-2620
  • Figueras, Francesc|||0000-0003-4403-1274
  • Gratacós, Eduard|||0000-0002-7405-7224
  • Castillo, Heidi
  • Casas, Irene
  • Campos, Rafael José
  • Timmermans, Marie
  • Parriego, Vanessa
  • Sys, Dorota
  • Modzelewski, Jan
Pre-eclampsia affects ~5%-7% of pregnancies. Although improved obstetric care has significantly diminished its associated maternal mortality, it remains a leading cause of maternal morbidity and mortality in the world. Term pre-eclampsia accounts for 70% of all cases and a large proportion of maternal-fetal morbidity related to this condition. Unlike in preterm pre-eclampsia, the prediction and prevention of term pre-eclampsia remain unsolved. Previously proposed approaches are based on combined third-trimester screening and/or prophylactic drugs, but these policies are unlikely to be widely implementable in many world settings. Recent evidence shows that the soluble fms-like tyrosine kinase-1 (s-Flt-1) to placental growth factor (PlGF) ratio measured at 35-37 weeks' gestation predicts term pre-eclampsia with an 80% detection rate. Likewise, recent studies demonstrate that induction of labour beyond 37 weeks is safe and well accepted by women. We hypothesise that a single-step universal screening for term pre-eclampsia based on sFlt1/PlGF ratio at 35-37 weeks followed by planned delivery beyond 37 weeks reduces the prevalence of term pre-eclampsia without increasing the caesarean section rates or worsening the neonatal outcomes. We propose an open-label randomised clinical trial to evaluate the impact of a screening of term pre-eclampsia with the sFlt-1/PlGF ratio followed by planned delivery in asymptomatic nulliparous women at 35-37 weeks. Women will be assigned 1:1 to revealed (sFlt-1/PlGF known to clinicians) versus concealed (unknown) arms. A cut-off of.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Factors associated with the discrepancy between objective and subjective cognitive impairment in bipolar disorder

  • Bonnin, Caterina del Mar|||0000-0002-1197-1596
  • Sánchez-Moreno, Jose|||0000-0003-1520-093X
  • Lima, Flávia M.|||0000-0002-9066-768X
  • Roca, Xavier
  • Segú, Xavier|||0000-0003-4376-9680
  • Montejo, Laura|||0000-0003-4407-9454
  • Solé, Brisa|||0000-0003-1673-8248
  • Hidalgo-Mazzei, Diego|||0000-0002-2693-6849
  • Martin-Parra, Sara
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • Vieta, Eduard|||0000-0002-0548-0053
  • Torrent, Carla|||0000-0003-0335-582X
  • Rosa, Adriane|||0000-0001-8629-4625
The aim of this study is to evaluate the discrepancy between objective cognitive measures and cognitive subjective complaints in a sample of euthymic patients with bipolar disorder (BD). Methods: One hundred and sixteen participants (83 euthymic patients with BD and 33 healthy controls) were enrolled for this study. Patients were assessed with a comprehensive neuropsychological battery and they also reported their subjective cognitive complaints with the Cognitive Complaints in Bipolar Disorder Rating Scale (COBRA). The discrepancy between objective and subjective data was calculated using a novel methodology proposed in a previous study (Miskowiak, 2016). Statistical analyses included Pearson correlations and multiple linear regression. Results: Higher number of previous depressive episodes was identified as one variable associated with the global sensitivity composite score (Beta = 0.25; t = 2.1; p = 0.04) and with the verbal learning and memory sensitivity score (Beta = 0.26; t = 2.16; p = 0.03). That is, patients with more previous depressive episodes tend to over-report cognitive complaints. In contrast, higher number of previous hospitalizations was associated with stoicism in the global total score (Beta = -0.27; t = -2.24: p = 0.029) and in the domain of attention/processing speed (Beta = -0.34; t = -2.52; p = 0.016), indicating patients with more hospitalizations tend to report less cognitive complaints. Discussion: Our study identified some factors that might help to explain the discrepancy between objective and subjective cognitive measures in BD, including number of previous depressive episodes and number of previous hospitalizations. This highlights the need of the combined use of both types of cognitive measures to make an accurate assessment of cognitive dysfunctions and their effective treatment.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Methodological Assessment of ExoGAG for Isolation of Cerebrospinal Fluid Extracellular Vesicles as a Source of Biomarkers

  • Salvat-Rovira, Nil|||0009-0005-8515-3819
  • Vázquez-Oliver, Anna|||0000-0002-9842-7656
  • Rivas Asensio, Elisa|||0009-0006-1645-0059
  • Herrero-Lorenzo, Marina|||0000-0003-2693-0700
  • Gámez-Valero, Ana|||0000-0002-9530-2751
  • Pérez Pérez, Jesús|||0000-0002-9835-0484
  • Izquierdo, Cristina
  • Campolongo, Antonia|||0000-0002-7962-3264
  • Martí, Eulàlia|||0000-0002-1030-3158
  • Kulisevsky, Jaime|||0000-0003-4870-1431
  • Pérez-González, Rocío|||0000-0002-0641-2001
Extracellular vesicles (EVs) in cerebrospinal fluid (CSF) represent a valuable source of biomarkers for central nervous system (CNS) diseases, offering new pathways for diagnosis and monitoring. However, existing methods for isolating EVs from CSF often prove to be labor-intensive and reliant on specialized equipment, hindering their clinical application. In this study, we present a novel, clinically compatible method for isolating EVs from CSF. We optimized the use of ExoGAG, a commercially available reagent that has been tested in plasma, urine and semen, and compared it directly with differential ultracentrifugation using Western blotting, protein quantification, nanoparticle tracking analysis, and cryogenic electron microscopy. Additionally, we analyzed the presence of specific microRNAs (miRNAs) known to be present in CSF-derived EVs. Our data demonstrate that ExoGAG is an effective method for isolating EVs from CSF, yielding a higher amount of EVs compared to traditional ultracentrifugation methods, and with comparable levels of specific miRNAs. In conclusion, the use of ExoGAG in a clinical setting may facilitate the testing of biomarkers essential for tracking brain pathology in CNS diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

In Vitro Activity of Ampicillin Plus Ceftriaxone Against Non-faecalis and Non-faecium Enterococcal Isolates With/Without VanC Phenotype, Clinical Implications for Infective Endocarditis

  • García-González, Javier
  • Cañas, María Alexandra|||0000-0002-0521-7204
  • Cuervo, Guillermo|||0000-0002-7075-943X
  • Hernández Meneses, Marta|||0000-0001-9991-1127
  • Verdejo, Miguel Ángel|||0000-0001-7870-0515
  • Bodro, Marta|||0000-0002-0520-8279
  • Díez de los Ríos, Javier
  • Gasch, Oriol|||0000-0001-8518-458X
  • Ribera Sánchez, Albert|||0000-0002-7120-4276
  • Falces, Carles|||0000-0002-3483-3786
  • Perissinotti, Andrés|||0000-0003-4190-2425
  • Vidal, Bárbara
  • Quintana, Eduard|||0000-0002-5386-7463
  • Moreno Camacho, Asunción|||0000-0001-6382-0039
  • Piquet, Maria
  • Roca, Ignasi|||0000-0002-1800-1576
  • Fernandez-Pittol, Mariana|||0000-0002-1685-7127
  • San José-Villar, Sol M.
  • García de la Mària, Cristina|||0000-0002-0585-9469
  • Miró, José M.|||0000-0001-8057-7755
(1) Background: Alternative antibiotics are needed to treat infective endocarditis (IE) caused by non-faecalis/non-faecium enterococci; we aimed to assess the in vitro activity of ampicillin plus ceftriaxone (AMP + CTR) against these enterococci and to describe its clinical efficacy in IE cases. (2) Methods: Time-kill curves with standard (ISI) and high (IHI) inocula were performed to test VanC isolates [3 E. casseliflavus (ECAS) and 1 E. gallinarum (EGALL)] and non-VanC isolates [1 E. durans (EDUR), 1 E. hirae (EHIR) and 1 E. raffinosus (ERAF)]. The narrative literature review of IE cases treated with AMP + CTR was analyzed alongside three study cases. Clinical outcomes were relapse and death. (3) Results: Ampicillin plus gentamicin (AMP + GEN) showed synergistic and bactericidal activity against most isolates. AMP + CTR was synergistic at ISI for EGALL, EDUR, and EHIR and bactericidal against EHIR. At IHI, indifferent activity was observed for all isolates. In IE cases treated with AMP + CTR, it was only effective for EDUR and EHIR. Clinical information for EGALL IE is lacking. For IE caused by ECAS and ERAF, AMP + CTR seems suboptimal or ineffective, respectively. (4) AMP + CTR cannot be recommended for treating IE due to ECAS/ERAF. In contrast, this combination was effective in IE caused by EDUR/EHIR and could be recommended.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exploring the association between metabolic syndrome, its components and subsequent cancer incidence, A cohort study in Catalonia

  • López Jiménez, Tomàs|||0000-0001-8255-4936
  • Plana Ripoll, Oleguer|||0000-0002-6470-7465
  • Duarte Salles, Talita|||0000-0002-8274-0357
  • Recalde, Martina|||0000-0003-2256-618X
  • Bennett, Matthew|||0000-0002-8309-8191
  • Cos Claramunt, Francesc Xavier|||0000-0003-3943-479X
  • Puente, Diana|||0000-0003-4725-537X
Background: Metabolic syndrome (MS) has emerged as a significant global health concern. The relationship between MS and the risk of cancer doesn't seem clear, whether examining by components or in combination. The objective of this study is to examine the relationship between MS, its components, and the overall risk of cancer, including the risk of 13 specific cancer types. Methods: We included 3,918,781 individuals aged 40 years or older sourced from the SIDIAP database between 2008 and 2017. Cox models were employed with MS components and their combinations. A subsample was created using a matched cohort (by age and sex). Incidence curves were computed to determine the time elapsed between the date of having 1-5 MS components and cancer incidence, compared to matched participants with no MS components, which showed that individuals who had one MS component experienced a greater incidence of cancer over 5 and 10 years than individuals with no MS, and the incidence rose with an increase in the number of MS components. Results: Individuals exposed to MS components were diagnosed with cancer earlier than those who were not exposed to them. In the Cox model, HDL (HR 1.46, 95% CI: 1.41-1.52) and Glycemia (HR 1.40, 95% CI: 1.37-1.44) were the individual combinations with the highest risk of overall cancer. In combinations with two components, the highest HR was HDL+Glycemia (HR 1.52, 95% CI: 1.45-1.59) and Glycemia+HBP (HR 1.48, 95% CI: 1.45-1.50). In combinations with three components, the highest HR was HDL+Glycemia+HBP (HR 1.58, 95% CI: 1.55-1.62). Conclusion: In summary, having one or more MS components raises the risk of developing at least 11 cancer types and these risk differ according to type of component included. Some sex differences are also observed. Our findings suggest that implementing prevention measures aimed at specific MS components may lower the risk of various cancer types.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

RET Fusion Testing in Patients With NSCLC, The RETING Study

  • Conde, Esther
  • Hernandez, Susana
  • Rodriguez Carrillo, Jose Luis
  • Martinez, Rebeca
  • Alonso, Marta
  • Curto, Daniel
  • Jimenez, Beatriz
  • Caminoa, Alejandra
  • Benito, Amparo
  • Garrido, Pilar|||0000-0002-5899-6125
  • Clavé, Sergi|||0000-0002-9435-8454
  • Arriola, Edurne|||0000-0001-8960-7519
  • Esteban Rodríguez, Isabel|||0000-0003-1576-7215
  • Castro, Javier de|||0000-0002-3622-6306
  • Sansano, Irene|||0000-0003-0188-5210
  • Felip, Enriqueta|||0000-0002-7620-0098
  • Rojo, Federico|||0000-0001-9989-0290
  • Dómine Gómez, Manuel|||0000-0003-1634-9832
  • Abdulkader, Ihab
  • Garcia-Gonzalez, Jorge
  • Teixidó, Cristina|||0000-0002-7226-6567
  • Reguart, Noemi|||0000-0001-8190-499X
  • Compañ, Desamparados
  • Insa, Amelia|||0000-0002-3438-6170
  • Mancheño, Nuria
  • Palanca, Sarai
  • Juan, Óscar|||0000-0002-7772-9030
  • Baixeras, Nuria|||0000-0001-6127-0475
  • Nadal, Ernest|||0000-0002-9674-5554
  • Cebollero, Maria
  • Calles, Antonio
  • Martin, Paloma
  • Salas, Clara
  • Provencio Pulla, Mariano|||0000-0001-6315-7919
  • Aranda, Ignacio
  • Massuti, Bartomeu|||0000-0002-6247-4493
  • López Vilaró, Laura|||0000-0002-5428-8017
  • Majem Tarruella, Margarita|||0000-0002-9919-7485
  • Paz-Ares, Luis|||0000-0002-3327-3246
  • Lopez-Rios, Fernando
RET inhibitors with impressive overall response rates are now available for patients with NSCLC, yet the identification of RET fusions remains a difficult challenge. Most guidelines encourage the upfront use of next-generation sequencing (NGS), or alternatively, fluorescence in situ hybridization (FISH) or reverse transcriptase-polymerase chain reaction (RT-PCR) when NGS is not possible or available. Taken together, the suboptimal performance of single-analyte assays to detect RET fusions, although consistent with the notion of encouraging universal NGS, is currently widening some of the clinical practice gaps in the implementation of predictive biomarkers in patients with advanced NSCLC. This situation prompted us to evaluate several RET assays in a large multicenter cohort of RET fusion-positive NSCLC (n = 38) to obtain real-world data. In addition to RNA-based NGS (the criterion standard method), all positive specimens underwent break-apart RET FISH with two different assays and were also tested by an RT-PCR assay. The most common RET partners were KIF5B (78.9%), followed by CCDC6 (15.8%). The two RET NGS-positive but FISH-negative samples contained a KIF5B(15)-RET(12) fusion. The three RET fusions not identified with RT-PCR were AKAP13(35)-RET(12), KIF5B(24)-RET(9) and KIF5B(24)-RET(11). All three false-negative RT-PCR cases were FISH-positive, exhibited a typical break-apart pattern, and contained a very high number of positive tumor cells with both FISH assays. Signet ring cells, psammoma bodies, and pleomorphic features were frequently observed (in 34.2%, 39.5%, and 39.5% of tumors, respectively). In-depth knowledge of the advantages and disadvantages of the different RET testing methodologies could help clinical and molecular tumor boards implement and maintain sensible algorithms for the rapid and effective detection of RET fusions in patients with NSCLC. The likelihood of RET false-negative results with both FISH and RT-PCR reinforces the need for upfront NGS in patients with NSCLC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The effect between metabolic syndrome and life expectancy after cancer diagnosis: Catalan cohort study

  • López Jiménez, Tomàs|||0000-0001-8255-4936
  • Plana Ripoll, Oleguer|||0000-0002-6470-7465
  • Duarte Salles, Talita|||0000-0002-8274-0357
  • Palomar-Cros, Anna|||0000-0001-8151-9290
  • Puente, Diana|||0000-0003-4725-537X
This study examines remaining life expectancy (RLE) after a cancer diagnosis, focusing on age, sex, cancer type, and metabolic syndrome (MS) components, using data from the SIDIAP database in Catalonia (2006-2017). RLE was analyzed for 13 cancer types, stratified by sex and MS components. The cohort study includes 183,364 individuals followed from diagnosis until death, transfer, or study end (December 2017). RLE at age 68 (median diagnosis age) was calculated based on MS components (0, 1, 2, and ≥ 3). Men aged 68 with 0 MS components had an RLE of 13.2 years, compared to 8.9 years for those with ≥ 3 MS. Women had an RLE of 15.9 years with 0 MS components versus 11.4 years with ≥ 3 MS. RLE varied by cancer type, with the highest RLE in men seen in prostate cancer and in women in non-Hodgkin lymphoma. The lowest RLE for both sexes was in pancreatic cancer. The largest differences between 0 and ≥ 3 MS components were observed in non-Hodgkin lymphoma and the smallest in pancreatic cancer. Increased MS components were associated with reduced RLE in at least 8 cancer types for men and 9 for women. Prevention strategies targeting MS components could increase RLE in cancer patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impact of valve-sparing aortic root replacement on aortic fluid dynamics and biomechanics in patients with syndromic heritable thoracic aortic disease

  • Dux-Santoy, Lydia|||0000-0001-8736-2095
  • Ruiz Muñoz, Aroa|||0000-0002-1138-8528
  • Guala, Andrea|||0000-0002-5006-8164
  • Galian-Gay, Laura|||0000-0001-6828-5928
  • Fernandez-Galera, Rubén
  • Valente, Filipa|||0000-0002-5569-3292
  • Casas, Guillem|||0000-0001-7122-320X
  • Oliveró, Ruperto|||0000-0002-0888-8572
  • Ferrer-Cornet, Marta
  • Bragulat-Arévalo, Mireia
  • Carrasco-Poves, Alejandro
  • Garrido-Oliver, Juan|||0000-0002-5806-2031
  • Morales-Galán, Alberto
  • Johnson, Kevin M.
  • Wieben, Oliver
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
  • Evangelista Masip, Arturo|||0000-0001-8182-1174
  • Rodriguez-Palomares, José F
  • Teixido-Tura, Gisela|||0000-0003-4714-2420
Patients with syndromic heritable thoracic aortic diseases (sHTAD) who underwent prophylactic aortic root replacement are at high risk of distal aortic events, but the underlying mechanisms remain unclear. This prospective, longitudinal study evaluates the impact of valve-sparing aortic root replacement (VSARR) on aortic fluid dynamics and biomechanics in these patients. Sixteen patients with Marfan or Loeys-Dietz syndrome underwent two time-resolved three-dimensional phase-contrast cardiovascular magnetic resonance (4D flow CMR) studies before (sHTAD-preSx) and after VSARR (sHTAD-postSx). Two matched cohorts of 40 healthy volunteers (HV) and 16 sHTAD patients without indication for aortic root replacement (sHTAD-NSx) with available 4D flow CMR were included for comparison. In-plane rotational flow (IRF), systolic flow reversal ratio (SFRR), wall shear stress (WSS), pulse wave velocity (PWV), and aortic strain were analyzed in the ascending (AscAo) and descending aorta (DescAo). All patients with sHTAD presented altered hemodynamics and increased stiffness (p < 0.05) compared to HV, both in the AscAo (median PWV 7.4 in sHTAD-NSx; 6.8 in sHTAD-preSx; 4.9 m/s in HV) and DescAo (median PWV 9.1 in sHTAD-NSx; 8.1 in sHTAD-preSx; 6.3 m/s in HV). Patients awaiting VSARR had markedly reduced in-plane (median IRF -2.2 vs 10.4 cm 2 /s in HV, p = 0.001), but increased through-plane flow rotation (median SFRR 7.8 vs 3.8% in HV, p = 0.002), and decreased WSS (0.36 vs 0.47 N/m 2 in HV, p = 0.004) in the proximal DescAo. After VSARR, proximal DescAo IRF (p = 0.010) and circumferential WSS increased (p = 0.011), no longer differing from HV, but SFRR, axial WSS and stiffness remained altered. Patients in which aortic tortuosity was reduced after surgery showed greater post-surgical increase in IRF compared to those in which tortuosity increased (median IRF increase 18.1 vs 3.3 cm 2 /s, p = 0.047). Most AscAo flow alterations were restored to physiological values after VSARR. In patients with sHTAD, VSARR partially restores downstream fluid dynamics to physiological levels. However, some flow disturbances and increased stiffness persist in the proximal DescAo. Further longitudinal studies are needed to evaluate whether persistent alterations contribute to post-surgical risk.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Increased grey matter volumes in the temporal lobe and its relationship with cognitive functioning in euthymic patients with bipolar disorder

  • Porta-Casteràs, Daniel|||0000-0002-3921-3607
  • Vicent Gil, Muriel|||0000-0001-7534-5095
  • Serra Blasco, Maria|||0000-0001-5793-9906
  • Navarra-Ventura, Guillem|||0000-0001-9839-7357
  • Solé, Brisa|||0000-0003-1673-8248
  • Montejo, Laura|||0000-0003-4407-9454
  • Torrent, Carla|||0000-0003-0335-582X
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • De la Peña-Arteaga, Víctor|||0000-0001-8627-2653
  • Palao, Diego|||0000-0002-3323-6568
  • Vieta, Eduard|||0000-0002-0548-0053
  • Cardoner, Narcís|||0000-0001-9633-0888
  • Cano, Marta|||0000-0003-0675-9483
Bipolar disorder (BD) is characterized by episodic mood dysregulation, although a significant portion of patients suffer persistent cognitive impairment during euthymia. Previous magnetic resonance imaging (MRI) research suggests BD patients may have accelerated brain aging, observed as lower grey matter volumes. How these neurostructural alterations are related to the cognitive profile of BD is unclear. We aim to explore this relationship in euthymic BD patients with multimodal structural neuroimaging. A sample of 27 euthymic BD patients and 24 healthy controls (HC) underwent structural grey matter MRI and diffusion-weighted imaging (DWI). BD patient's cognition was also assessed. FreeSurfer algorithms were used to obtain estimations of regional grey matter volumes. White matter pathways were reconstructed using TRACULA, and four diffusion metrics were extracted. ANCOVA models were performed to compare BD patients and HC values of regional grey matter volume and diffusion metrics. Global brain measures were also compared. Bivariate Pearson correlations were explored between significant brain results and five cognitive domains. Euthymic BD patients showed higher ventricular volume (F(1, 46) = 6.04; p = 0.018) and regional grey matter volumes in the left fusiform (F(1, 46) = 15.03; pFDR = 0.015) and bilateral parahippocampal gyri compared to HC (L: F(1, 46) = 12.79, pFDR = 0.025/ R: F(1, 46) = 15.25, pFDR = 0.015). Higher grey matter volumes were correlated with greater executive function (r = 0.53, p = 0.008). We evaluated a modest sample size with concurrent pharmacological treatment. Higher medial temporal volumes in euthymic BD patients may be a potential signature of brain resilience and cognitive adaptation to a putative illness neuroprogression. This knowledge should be integrated into further efforts to implement imaging into BD clinical management.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Link between Abdominal Obesity Indices and the Progression of Liver Fibrosis, Insights from a Population-Based Study

  • Julián, María Teresa|||0000-0003-2524-1823
  • Arteaga, Ingrid
  • Torán-Monserrat, Pere|||0000-0002-9865-7427
  • Pera, Guillem|||0000-0003-3188-7268
  • Pérez-Montes de Oca, Alejandra|||0000-0001-8807-1935
  • Ruiz-Rojano, Irene
  • Casademunt-Gras, Elena
  • Chacón, Carla|||0000-0001-8524-6189
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
There is currently no available information on the correlation between abdominal obesity indices and the risk of liver fibrosis progression. We aimed to investigate the relationship between the body mass index (BMI), waist circumference (WC), and the visceral adiposity index (VAI) with the progression of liver fibrosis. The study also evaluated the association between these indices and the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and liver fibrosis. A total of 1403 subjects participated in the cross-sectional and longitudinal population-based study. Liver stiffness was assessed via transient elastography, at baseline and follow-up (median: 4.2 years). The subgroup with dysglycemia was also analyzed. In the cross-sectional study, the highest quartile of VAI, BMI ≥ 30 kg/m 2, and abdominal obesity showed significant associations with the prevalence of MASLD and liver fibrosis, as well as with fibrosis progression. However, VAI showed no association with MASLD incidence. Among the dysglycemic subjects, there was no observed association between VAI and the incidence of MASLD or the progression of fibrosis. In conclusion, the BMI, WC, and the VAI are associated with an increased risk of progression to moderate-to-advanced liver fibrosis in the general population. However, the VAI does not perform better than the BMI and WC measurement.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Diagnostic performance of plasma pTau 217, pTau 181, Aβ 1-42 and Aβ 1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease

  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Zhu, Nuole|||0000-0002-0015-9455
  • Rubio Guerra, Sara|||0000-0001-7652-8029
  • Rodríguez-Baz, Íñigo|||0000-0003-3039-9115
  • Ferrer Pérez, Rosa|||0009-0004-9477-699X
  • Carmona Iragui, Maria|||0000-0001-6914-2339
  • Barroeta, Isabel|||0000-0003-2764-7923
  • Illán-Gala, Ignacio|||0000-0002-5418-2052
  • Santos Santos, Miguel Ángel|||0000-0003-1567-617X
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Alcolea, Daniel|||0000-0002-3819-3245
Recently developed blood markers for Alzheimer's disease (AD) detection have high accuracy but usually require ultra-sensitive analytic tools not commonly available in clinical laboratories, and their performance in clinical practice is unknown. We analyzed plasma samples from 290 consecutive participants that underwent lumbar puncture in routine clinical practice in a specialized memory clinic (66 cognitively unimpaired, 130 participants with mild cognitive impairment, and 94 with dementia). Participants were classified as amyloid positive (A+) or negative (A-) according to CSF Aβ/Aβ ratio. Plasma pTau, pTau, Aβ and Aβ were measured in the fully-automated LUMIPULSE platform. We used linear regression to compare plasma biomarkers concentrations between A + and A- groups, evaluated Spearman's correlation between plasma and CSF and performed ROC analyses to assess their diagnostic accuracy to detect brain amyloidosis as determined by CSF Aβ/Aβ ratio. We analyzed the potential of pTau to predict amyloidosis in CSF. Plasma pTau and pTau concentration were higher in A + than A- while the plasma Aβ/Aβ ratio was lower in A + compared to A-. pTau and the Aβ/Aβ ratio showed moderate correlation between plasma and CSF (Rho = 0.66 and 0.69, respectively). The areas under the ROC curve to discriminate A + from A- participants were 0.94 (95% CI 0.92-0.97) for pTau, and 0.88 (95% CI 0.84-0.92) for both pTau and Aβ/Aβ. Chronic kidney disease (CKD) was related to increased plasma biomarker concentrations, but ratios were less affected. Plasma pTau had the highest fold change (x4.2) and showed high predictive capability in discriminating A + from A-, having 4-7% misclassification rate. The global accuracy of plasma pTau using a two-threshold approach was robust in symptomatic groups, exceeding 90%. The evaluation of blood biomarkers on an automated platform exhibited high diagnostic accuracy for AD pathophysiology, and pTau showed excellent diagnostic accuracy to identify participants with AD in a consecutive sample representing the routine clinical practice in a specialized memory unit.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice

  • Verberk, I.M.W.
  • Jutte, J.
  • Kingma, M.Y.
  • Vigneswaran, S.
  • Gouda, M.M.T.E.E.
  • van Engelen, M.P.
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Chevalier, C.
  • Marizzoni, M.
  • van de Giessen, E.M.
  • Lemstra, A.W.
  • Pijnenburg, Y.A.L.
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • den Braber, A.
  • Wilson, D.
  • Schut, M.C.
  • van Harten, A.C.
  • Teunissen, C.E.
INTRODUCTION: We developed a multimarker blood test result interpretation tool for the clinical dementia practice, including phosphorylated (P-)tau181, amyloid-beta (Abeta)42/40, glial fibrillary acidic protein (GFAP), and neurofilament light (NfL). METHODS: We measured the plasma biomarkers with Simoa (n = 1199), applied LASSO regression for biomarker selection and receiver operating characteristics (ROC) analyses to determine diagnostic accuracy. We validated our findings in two independent cohorts and constructed a visualization approach. RESULTS: P-tau181, GFAP, and NfL were selected. This combination had area under the curve (AUC) = 83% to identify amyloid positivity in pre-dementia stages, AUC = 87%-89% to differentiate Alzheimer's or controls from frontotemporal dementia, AUC = 74%-76% to differentiate Alzheimer's or controls from dementia with Lewy bodies. Highly reproducible AUCs were obtained in independent cohorts. The resulting visualization tool includes UpSet plots to visualize the stand-alone biomarker results and density plots to visualize the biomarker results combined. DISCUSSION: Our multimarker blood test interpretation tool is ready for testing in real-world clinical dementia settings. Highlights: We developed a multimarker blood test interpretation tool for clinical dementia practice. Our interpretation tool includes plasma biomarkers P-tau, GFAP, and NfL. Our tool is particularly useful for Alzheimer's and frontotemporal dementia diagnosis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL), GELLC-7 trial from the Spanish group of CLL (GELLC)

  • Abrisqueta, Pau|||0000-0001-9625-7422
  • González Barca, Eva|||0000-0002-1323-1508
  • Ferrá, Christelle|||0000-0003-4571-5125
  • Ríos-Herranz, Eduardo
  • Fernández de la Mata, Margarita
  • Delgado, Julio|||0000-0002-5157-4376
  • Andreu, Rafael|||0000-0002-9220-3352
  • Hernández-Rivas, José Ángel
  • Terol, María José
  • Navarro, Almudena
  • Vidriales, M. Belén
  • Baltasar, Patricia
  • De La Serna, Javier|||0000-0003-3904-1101
  • Ramírez, Á.ngel
  • Ballester, C.
  • Moreno, Carol|||0000-0003-3275-0271
  • García-Marco, J.A.|||0000-0002-8993-5982
  • Córdoba, Raúl|||0000-0002-7654-8836
  • Yáñez, Lucrecia|||0000-0001-9925-3048
  • Casado, Luis Felipe
  • González, Marcos
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
BTK inhibitors have been concurrently administered with anti-CD20 monoclonal antibodies (mAbs) in chronic lymphocytic leukemia (CLL). However, the optimal regimen for combining these two drugs remains pending. Methods: This multi-center phase 2 study aimed to analyze whether consolidation with ofatumumab improved the response in patients with CLL receiving front-line treatment with ibrutinib. Patients received 12 cycles of ibrutinib monotherapy. Those who achieved CR after this induction were maintained on ibrutinib. Conversely, those who did not attain CR continued with ibrutinib in addition to a consolidation, which involved 7 doses of ofatumumab. The primary objective was the complete response (CR) rate at cycle 20. This study is registered within the EU Clinical Trials Register (EudraCT 2016-004937-26). Findings: Between September 8, 2017, and May 21, 2018, 84 patients (median age, 69 years) were included. After completion of 12 cycles of ibrutinib (n = 80), 4 patients (5%) were in CR, 67 (84%) in partial response (PR), and 6 patients (7%) had a PR with lymphocytosis (PRL). After consolidation with ofatumumab, 20 patients improved the response from PR to CR and 6 patients with PRL obtained a PR. Seventy-one patients (85%) completed 20 cycles of treatment, with a CR rate of 24/71 (34%). According to the intention-to-treat analysis at cycle 20, the ORR was 69/84 (82.2%), with a CRR of 24/84 (28.6%). Progression-free survival and overall survival at 48-months were 89.9% (CI: 82.4-95.5) and 92.2% (CI: 85.3-97.1), respectively. Interpretation: These findings underscore the potential for a consolidation strategy in CLL, wherein the addition of a mAb in patients with low tumor burden might enhance the quality of the response. Funding: The study was funded by Janssen that also supplied ibrutinib, whereas ofatumumab was supplied by Novartis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic

  • Cano, Amanda|||0000-0001-9567-4283
  • Capdevila, María
  • Puerta, Raquel|||0000-0002-1191-5893
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • De Rojas, Itziar|||0000-0002-2148-381X
  • García-González, Pablo|||0000-0003-0125-5403
  • Olivé Roig, Clàudia|||0000-0002-9438-5639
  • García-Gutiérrez, Fernando
  • Sotolongo Grau, Oscar|||0000-0002-9679-0670
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Aguilera, Nuria
  • Ramis, Maribel
  • Rosende-Roca, Maite
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
  • Tartari, Juan Pablo
  • Lafuente, Asunción
  • Vargas, Liliana|||0000-0001-5685-5903
  • Pérez-Cordón, Alba|||0000-0002-6028-0791
  • Muñoz, Nathalia
  • Sanabria, Ángela|||0000-0002-7501-9895
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Morató, Xavier|||0000-0002-3012-2864
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Fernández, Victoria
  • Marquié, Marta|||0000-0002-0660-0950
  • Valero, Sergi|||0000-0002-6599-948X
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Boada, Mercè|||0000-0003-2617-3009
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
The identification of patients with an elevated risk of developing Alzheimer's disease (AD) dementia and eligible for the disease-modifying treatments (DMTs) in the earliest stages is one of the greatest challenges in the clinical practice. Plasma biomarkers has the potential to predict these issues, but further research is still needed to translate them to clinical practice. Here we evaluated the clinical applicability of plasma pTau181 as a predictive marker of AD pathology in a large real-world cohort of a memory clinic. Methods: Three independent cohorts (modelling [n = 991, 59.7% female], testing [n = 642, 56.2% female] and validation [n = 441, 55.1% female]) of real-world patients with subjective cognitive decline (SCD), mild cognitive impairment (MCI), AD dementia, and other dementias were included. Paired cerebrospinal fluid (CSF) and plasma samples were used to measure AT(N) CSF biomarkers and plasma pTau181. CSF and plasma pTau181 showed correlation in all phenotypes except in SCD and other dementias. Age significantly influenced the biomarker's performance. The general Aβ(+) vs Aβ(-) ROC curve showed an AUC = 0.77 [0.74-0.80], whereas the specific ROC curve of MCI due to AD vs non-AD MCI showed an AUC = 0.89 [0.85-0.93]. A cut-off value of 1.30 pg/ml of plasma pTau181 exhibited a sensitivity of 93.57% [88.72-96.52], specificity of 72.38% [62.51-79.01], VPP of 77.85% [70.61-83.54], and 8.30% false negatives in the subjects with MCI of the testing cohort. The HR of cox regression showed that patients with MCI up to this cut-off value exhibited a HR = 1.84 [1.05-3.22] higher risk to convert to AD dementia than patients with MCI below the cut-off value. Plasma pTau181 has the potential to be used in the memory clinics as a screening biomarker of AD pathology in subjects with MCI, presenting a valuable prognostic utility in predicting the MCI conversion to AD dementia. In the context of a real-world population, a confirmatory test employing gold-standard procedures is still advisable. This study has been mainly funded by Ace Alzheimer Center Barcelona, Instituto de Salud Carlos III (ISCIII), Biomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Spanish Ministry of Science and Innovation, Fundación ADEY, Fundación Echevarne and Grífols S.A.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Quantification of rare somatic single nucleotide variants by droplet digital PCR using SuperSelective primers

  • Pablo-Fontecha, Verónica|||0000-0001-9084-4597
  • Hernández-Illán, Eva
  • Reparaz, Andrea
  • Asensio, Elena
  • Morata, Jordi|||0000-0002-6146-4322
  • Tonda, Raúl
  • Lahoz, Sara|||0000-0002-4491-9911
  • Parra, Carolina
  • Lozano, Juan José
  • García-Heredia, Anabel
  • Martínez-Roca, Alejandro
  • Beltran i Agulló, Sergi|||0000-0002-2810-3445
  • Balaguer, Francesc|||0000-0002-0206-0539
  • Jover, Rodrigo
  • Castells, Antoni|||0000-0001-8431-2033
  • Trullàs, Ramon
  • Podlesniy, Petar
  • Camps, Jordi|||0000-0003-2929-4228
Somatic single-nucleotide variants (SNVs) occur every time a cell divides, appearing even in healthy tissues at low frequencies. These mutations may accumulate as neutral variants during aging, or eventually, promote the development of neoplasia. Here, we present the SP-ddPCR, a droplet digital PCR (ddPCR) based approach that utilizes customized SuperSelective primers aiming at quantifying the proportion of rare SNVs. For that purpose, we selected five potentially pathogenic variants identified by whole-exome sequencing (WES) occurring at low variant allele frequency (VAF) in at-risk colon healthy mucosa of patients diagnosed with colorectal cancer or advanced adenoma. Additionally, two APC SNVs detected in two cancer lesions were added to the study for WES-VAF validation. SuperSelective primers were designed to quantify SNVs at low VAFs both in silico and in clinical samples. In addition to the two APC SNVs in colonic lesions, SP-ddPCR confirmed the presence of three out of five selected SNVs in the normal colonic mucosa with allelic frequencies ≤ 5%. Moreover, SP-ddPCR showed the presence of two potentially pathogenic variants in the distal normal mucosa of patients with colorectal carcinoma. In summary, SP-ddPCR offers a rapid and feasible methodology to validate next-generation sequencing data and accurately quantify rare SNVs, thus providing a potential tool for diagnosis and stratification of at-risk patients based on their mutational profiling.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis

  • Fondelli, Federico|||0000-0002-6875-4744
  • Willemyns, Jana|||0000-0001-6325-9309
  • Domenech-Garcia, Roger|||0009-0002-5742-566X
  • Mansilla, Maria José
  • Godoy-Tena, Gerard|||0000-0003-3832-5794
  • Ferreté-Bonastre, Anna G.|||0000-0003-3327-6129
  • Agúndez-Moreno, Alex|||0009-0000-9524-235X
  • Presas Rodríguez, Sílvia|||0000-0001-8545-2476
  • Ramo-Tello, Cristina|||0000-0001-8643-5053
  • Ballestar, Esteban|||0000-0002-1400-2440
  • Martínez Cáceres, Eva María|||0000-0002-6762-8025
Multiple sclerosis (MS) is a chronic disease characterized by dysregulated self-reactive immune responses that damage the neurons' myelin sheath, leading to progressive disability. The primary therapeutic option, immunosuppressants, inhibits pathogenic anti-myelin responses but depresses the immune system. Antigen-specific monocyte-derived autologous tolerogenic dendritic cells (tolDCs) offer alternative therapeutic approaches to restore tolerance to autoantigens without causing generalized immunosuppression. However, immune dysregulation in MS could impact the properties of the monocytes used as starting material for this cell therapy. Here, we characterized CD14+ monocytes, mature dendritic cells, and vitamin D3-tolDCs (VitD3-tolDCs) from active, treatment-naive MS patients and healthy donors (HDs). Using multiomics, we identified a switch in these cell types toward proinflammatory features characterized by alterations in the aryl hydrocarbon receptor (AhR) and NF-κB pathways. MS patient-derived VitD3-tolDCs showed reduced tolerogenic properties compared with those from HDs, which were fully restored through direct AhR agonism and by use of in vivo or in vitro dimethyl fumarate (DMF) supplementation. Additionally, in the experimental autoimmune encephalomyelitis mouse model, combined therapy of DMF and VitD3-tolDCs was more efficient than monotherapies in reducing the clinical score of mice. We propose that a combined therapy with DMF and VitD3-tolDCs offers enhanced therapeutic potential in treating MS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Amyloid deposition in adults with drug-resistant temporal lobe epilepsy

  • Fonseca, Elena|||0000-0002-3895-1237
  • Lallana, Sofía|||0000-0002-5999-9889
  • Ortega, Gemma
  • Cano, Amanda|||0000-0001-9567-4283
  • Sarria Estrada, Silvana|||0000-0003-0083-362X
  • Pareto, Deborah|||0000-0001-7356-3769
  • Quintana, Manuel|||0000-0003-0288-9088
  • Lorenzo Bosquet, Carles|||0000-0002-8824-4602
  • López Maza, Samuel|||0000-0003-3660-2604
  • Gifreu, Ariadna
  • Campos Fernández, Daniel|||0000-0003-4795-5309
  • Abraira del Fresno, Laura|||0000-0002-5119-7929
  • Santamarina Perez, Estevo|||0000-0003-1915-0335
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • Puerta, Raquel|||0000-0002-1191-5893
  • Aguilera, Núria
  • Ramis, Maribel
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Tárraga, Lluís|||0000-0002-8423-946X
  • Rovira, Alex|||0000-0002-2132-6750
  • Marquié, Marta|||0000-0002-0660-0950
  • Boada, Mercè|||0000-0003-2617-3009
  • Toledo, Manuel|||0000-0003-1550-3316
Objective: Pathological amyloid-β (Aβ) accumulation and hyperphosphorylated tau proteins have been described in resected temporal lobe specimens of epilepsy patients. We aimed to determine cerebrospinal fluid (CSF) Aβ1-42 and p181-tau levels and cerebral Aβ deposits on positron emission tomography (Aβ PET) and correlate these findings with cognitive performance in adults with drug-resistant temporal lobe epilepsy (TLE). Methods: In this cross-sectional study, we enrolled individuals with drug-resistant TLE who were 25-55 years old. Each participant underwent F-flutemetamol PET, determination of CSF Aβ1-42, p181-tau, and total tau, and a comprehensive neuropsychological assessment. We evaluated normalized standard uptake value ratios (SUVRs) for different brain regions on Aβ PET. Results: Thirty patients (mean age = 41.9 ± SD 8.1 years, 57% men) were included. The median disease duration was 9.5 (interquartile range = 4-24) years. Twenty-six patients (87%) had a clinically significant cognitive impairment on neuropsychological evaluation, 18 (69%) of the amnesic type. On Aβ PET, high uptake was observed in both mesial temporal regions (ipsilateral: SUVR z-score =.90, 95% confidence interval [CI] =.60-1.20; contralateral: SUVR z-score =.92, 95% CI =.57-1.27; p <.001), which was higher when compared to SUVR z-scores in all the remaining regions (p <.001) and in the ipsilateral anterior cingulate (SUVR z-score =.27, 95% CI =.04-.49, p =.020). No significant deposition was observed in other regions. Seven patients (23%) had low Aβ1-42 levels, and two (7%) had elevated p181-tau levels in CSF. Higher p181-tau levels correlated with poorer verbal fluency (R = -.427, p =.044). Significance: Our findings reveal a considerable Aβ deposition in mesial temporal regions and ipsilateral anterior cingulate among adults with drug-resistant TLE. Additionally, abnormal CSF Aβ1-42 levels were observed in a significant proportion of patients, and p181-tau levels were associated with verbal fluency. These results suggest that markers of neuronal damage can be observed in adults with TLE, warranting further investigation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Identification of novel NUP98 fusion partners and comutations in acute myeloid leukemia, an adult cohort study

  • Heald, James S.
  • Méndez, Aleix|||0009-0002-0659-763X
  • Pato, Miguel L.|||0000-0001-8840-7259
  • Ruiz-Xivillé, Neus
  • Cabezón, Marta|||0000-0001-5122-7481
  • Zamora, Lurdes|||0000-0003-1713-7110
  • Vives, Susana
  • Coll, Rosa|||0000-0003-0560-1254
  • Maluquer, Clara
  • Granada, Isabel|||0000-0002-4275-0104
  • Sole, F|||0000-0002-3251-2161
  • Esteller, M|||0000-0003-4490-6093
  • Berdasco, Maria|||0000-0002-6750-0400
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

JAK-STAT Pathway, A Novel Target to Tackle Viral Infections

  • Ezeonwumelu, I.J.|||0000-0003-4007-2212
  • García Vidal, Edurne|||0000-0003-0698-8710
  • Ballana, Ester|||0000-0002-5215-7363
Modulation of the antiviral innate immune response has been proposed as a putative cellular target for the development of novel pan-viral therapeutic strategies. The Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway is especially relevant due to its essential role in the regulation of local and systemic inflammation in response to viral infections, being, therefore, a putative therapeutic target. Here, we review the extraordinary diversity of strategies that viruses have evolved to interfere with JAK-STAT signaling, stressing the relevance of this pathway as a putative antiviral target. Moreover, due to the recent remarkable progress on the development of novel JAK inhibitors (JAKi), the current knowledge on its efficacy against distinct viral infections is also discussed. JAKi have a proven efficacy against a broad spectrum of disorders and exhibit safety profiles comparable to biologics, therefore representing good candidates for drug repurposing strategies, including viral infections.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis

  • Quirant, Bibiana|||0000-0002-3875-8074
  • Mansilla Lopez, Maria Jose|||0000-0002-5044-6313
  • Navarro-Barriuso, Juan|||0000-0003-2884-4961
  • Presas Rodríguez, Sílvia|||0000-0001-8545-2476
  • Teniente Serra, Aina|||0000-0003-3440-804X
  • Fondelli, Federico|||0000-0002-6875-4744
  • Ramo-Tello, Cristina|||0000-0001-8643-5053
  • Martínez Cáceres, Eva María|||0000-0002-6762-8025
Autologous antigen-specific therapies based on tolerogenic dendritic cells (tolDC) offer the possibility to treat autoimmune diseases by restoring homeostasis and targeting specifically autoreactive responses. Here, we explore the hypothesis that systemic inflammation occurring in autoimmune diseases, such as multiple sclerosis (MS), can generate a disease-specific environment able to alter the functionality of tolDC. In this context in fact, a combined therapy of tolDC with an immunomodulatory treatment could potentiate the beneficial effect of this antigen-specific cell therapy. For this purpose, we analyzed the efficacy of a combined therapy based on the use of vitamin D3 (VitD3)-tolDC plus interferon beta (IFN-beta) in MS. VitD3-tolDC were generated from healthy donors and MS patients and co-cultured with allogeneic peripheral blood mononuclear cells, in the presence or absence of IFN-beta. In vitro, VitD3-tolDC treatment reduced the percentage of activated T cells and allogeneic proliferation, whereas VitD3-tolDC+IFN-beta treatment enhanced the suppressive ability of VitD3-tolDC and, additionally, induced a shift towards a Th2 profile. To determine the clinical benefit of the combined therapy, C57BL/6-experimental autoimmune encephalomyelitis (EAE)-induced mice were treated with antigen-specific VitD3-tolDC and/or IFN-beta. Treatment of EAE mice with combined therapy ameliorated the disease course compared to each monotherapy. These results suggest that a combined therapy based on antigen-specific VitD3-tolDC and IFN-beta may represent a promising strategy for MS patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Tracking temporal response dynamics in the ventral striatum during social feedback in anorexia nervosa, A functional magnetic resonance imaging exploratory study

  • Membrives, Sonia|||0000-0002-0439-7936
  • López-Solà, Marina|||0000-0002-5517-2665
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
  • Sánchez Díaz, Isabel María|||0000-0001-5874-8204
  • Martínez-Zalacaín, Ignacio|||0000-0002-4036-0284
  • Palao, Diego|||0000-0002-3323-6568
  • Pujol Nuez, Jesús|||0000-0002-9946-4547
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Davey, Chris G.
  • Harrison, Ben J.
  • Keating, Charlotte
  • Rossell, Susan L.
  • Oliva, Joan Carles|||0000-0003-1273-2746
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Cardoner, Narcís|||0000-0001-9633-0888
  • Via, Esther|||0000-0002-2331-3232
Objective: Research suggests abnormalities in reward-based processes in anorexia nervosa (AN). However, few studies have explored if such alterations might be associated with different temporal activation patterns. This study aims to characterize alterations in time-dependent processes in the ventral striatum (VS) during social feedback in AN using functional magnetic resonance imaging (fMRI). Method: Twenty women with restrictive-subtype AN and 20 age-matched healthy controls (HC) underwent a social judgment experimental fMRI task. Temporal VS hemodynamic responses were extracted in SPM for each participant and each social condition (acceptance/rejection). Results: Compared with age-matched HC, patients with AN showed a significant time by group interaction of peak VS response throughout the task, with a progressive blunting of peak activation responses, accompanied by a progressive increase in baseline activity levels over time. Discussion: The results suggest an attenuated response pattern to repetitive social rejection in the VS in patients with AN, together with a difficulty in returning to baseline. The information obtained from this study will guide future, design-specific studies to further explore alterations temporal dynamics.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Vedolizumab and ART in recent HIV-1 infection unveil the role of α4β7 in reservoir size

  • Jimenez-Leon, Maria Reyes|||0000-0003-2723-319X
  • Gasca-Capote, Carmen|||0000-0002-7211-8599
  • Roca-Oporto, Cristina|||0000-0003-0079-5491
  • Espinosa, Nuria|||0000-0003-2249-2352
  • Sobrino, Salvador
  • Fontillon-Alberdi, Maria|||0000-0003-4031-8067
  • Gao, Ce
  • Roseto, Isabelle
  • Gladkov, Gregory
  • Rivas-Jeremias, Inmaculada
  • Neukam, Karin
  • Sánchez Hernández, José Germán
  • Rigo Bonnin, Raül|||0000-0001-5511-074X
  • Cervera-Barajas, Antonio J.
  • Mesones, Rosario
  • García, Federico
  • Alvarez-Rios, Ana Isabel
  • Bachiller, Sara
  • Vitalle, Joana
  • Perez-Gomez, Alberto
  • Camacho-Sojo, María Inés
  • Gallego, Isabel
  • Brander, Christian|||0000-0002-0548-5778
  • McGowan, Ian
  • Mothe, Beatriz|||0000-0001-9975-407X
  • Viciana, Pompeyo|||0000-0001-5606-0166
  • Yu, Xu
  • Lichterfeld, Mathias
  • López Cortés, Luis Fernando|||0000-0002-3804-3458
  • Ruiz-Mateos, Ezequiel|||0000-0001-6747-7813
BACKGROUND. We evaluated the safety and viral rebound, after analytical treatment interruption (ATI), of vedolizumab and ART in recent HIV-1 infection. We used this model to analyze the effect of α4β7 on the HIV-1 reservoir size. METHODS. Participants started ART with monthly vedolizumab infusions, and ATI was performed at week 24. Biopsies were obtained from ileum and cecum at baseline and week 24. Vedolizumab levels, HIV-1 reservoir, flow cytometry, and cell-sorting and antibody competition experiments were assayed. RESULTS. Vedolizumab was safe and well tolerated. No participant achieved undetectable viremia off ART 24 weeks after ATI. Only a modest effect on the time to achieve more than 1,000 HIV-1 RNA copies/mL and the proportion of participants off ART was observed, being higher in the vedolizumab group compared with historical controls. Just before ATI, α4β7 expression was associated with HIV-1 DNA and RNA in peripheral blood and with PD1 and TIGIT levels. Importantly, a complete blocking of α4β7 was observed on peripheral CD4 T cells but not in gut (ileum and cecum), where α4β7 blockade and vedolizumab levels were inversely associated with HIV-1 DNA. CONCLUSION. Our findings support α4β7 as an important determinant in HIV-1 reservoir size, suggesting the complete α4β7 blockade in tissue as a promising tool for HIV-cure combination strategies. TRIAL REGISTRATION. ClinicalTrials.gov NCT03577782. FUNDING. This work was supported by the Instituto de Salud Carlos III (Fondo Europeo de Desarrollo Regional, "a way to make Europe," research contracts FI17/00186 and FI19/00083 and research projects PI18/01532, PI19/01127, PI22/01796), Conserjería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía (research projects P20/00906), the Red Temática de Investigación Cooperativa en SIDA (RD16/0025/0020), and the Spanish National Research Council.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effect of Mediterranean diet or mindfulness-based stress reduction during pregnancy on placental volume and perfusion, A subanalysis of the IMPACT BCN randomized clinical trial

  • Nakaki, Ayako|||0000-0002-4395-3878
  • Denaro, Eugenio
  • Crimella, Maddalena
  • Castellani, Roberta
  • Vellvé, Kilian|||0000-0002-2376-7664
  • Izquierdo, Nora
  • Basso, Annachiara
  • Paules, Cristina|||0000-0001-6795-0367
  • Casas, Rosa|||0000-0002-0211-9166
  • Benitez, Leticia|||0000-0002-4950-036X
  • Casas, Irene
  • Larroya, Marta|||0000-0001-7929-6630
  • Genero, Mariona
  • Castro Barquero, Sara|||0000-0002-6876-5443
  • Gomez-Gomez, A|||0000-0001-8172-1827
  • Pozo, Oscar J|||0000-0002-1735-9728
  • Vieta, Eduard|||0000-0002-0548-0053
  • Estruch, Ramón|||0000-0003-1260-4445
  • Nadal, Alfons
  • Gratacós, Eduard|||0000-0002-7405-7224
  • Crovetto, Francesca|||0000-0003-0140-7411
  • Crispi, Fatima|||0000-0002-7422-5240
  • Youssef, Lina|||0000-0002-0554-5507
Introduction: The IMPACT BCN trial-a parallel-group randomized clinical trial where 1221 pregnant women at high risk for small-for-gestational age (SGA) newborns were randomly allocated at 19- to 23-week gestation into three groups: Mediterranean diet, Mindfulness-based Stress reduction or non-intervention-has demonstrated a positive effect of Mediterranean diet and Stress reduction in the prevention of SGA. However, the mechanism of action of these interventions remains still unclear. The aim of this study is to investigate the effect of Mediterranean diet and Stress reduction on placental volume and perfusion. Material and Methods: Participants in the Mediterranean diet group received monthly individual and group educational sessions, and free provision of extra-virgin olive oil and walnuts. Women in the Stress reduction group underwent an 8-week Stress reduction program adapted for pregnancy, consisting of weekly 2.5-h and one full-day sessions. Non-intervention group was based on usual care. Placental volume and perfusion were assessed in a subgroup of randomly selected women (n = 165) using magnetic resonance (MR) at 36-week gestation. Small placental volume was defined as MR estimated volume <10th centile. Perfusion was assessed by intravoxel incoherent motion. Results: While mean MR placental volume was similar among the study groups, both interventions were associated with a lower prevalence of small placental volume (3.9% Mediterranean diet and 5% stress reduction vs. 17% non-intervention; p = 0.03 and p = 0.04, respectively). Logistic regression showed that small placental volume was significantly associated with higher risk of SGA in both study groups (OR 7.48 [1.99-28.09] in Mediterranean diet and 20.44 [5.13-81.4] in Stress reduction). Mediation analysis showed that the effect of Mediterranean diet on SGA can be decomposed by a direct effect and an indirect effect (56.6%) mediated by a small placental volume. Similarly, the effect of Stress reduction on SGA is partially mediated (45.3%) by a small placental volume. Results on placental intravoxel incoherent motion perfusion fraction and diffusion coefficient were similar among the study groups. Conclusions: Structured interventions during pregnancy based on Mediterranean diet or Stress reduction are associated with a lower proportion of small placentas, which is consistent with the previously observed beneficial effects of these interventions on fetal growth.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction, The modifying role of obesity

  • Palau, Palau
  • Núñez, Gonzalo
  • De la Espriella, Rafael|||0000-0002-8720-3999
  • Miñana, Gema|||0000-0001-8777-2588
  • Domínguez, Eloy
  • Lorenzo, Miguel|||0000-0001-9182-4459
  • López, Laura
  • Flor, Cristina
  • Marín, Paloma
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Sanchis, Juan|||0000-0003-0797-8709
  • Núñez, Julio|||0000-0003-1672-7119
This study investigates the association between maximal functional capacity (peakVO) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in 133 ambulatory patients with heart failure with preserved ejection fraction (HFpEF), focusing on patients with obesity. Across all participants, NT-proBNP inversely correlated with peakVO. However, this association varied based on obesity status. In patients without obesity, there was an inverse relationship between NT-proBNP and peakVO, while no significant correlation was observed in patients with obesity. These findings suggest that in stable ambulatory HFpEF, NT-proBNP did not predict peakVO in patients with obesity.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Challenges encountered in the enantioselective analysis of new psychoactive substances exemplified by clephedrone (4-CMC)

  • Jorbenadze, Saba
  • Khatiashvili, Tamar
  • Giunashvili, Lasha
  • Tchelidze, Aluda
  • Lo Faro, Alfredo Fabrizio|||0000-0002-0240-5277
  • Pichini, Simona
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Papaseit, Ester
  • Nuñez-Montero, Melani
  • Carlier, Jeremy
  • Farkas, Tivadar
  • Busardo, Francesco Paolo|||0000-0002-3082-4532
  • Chankvetadze, Bezhan
In this study we report on efforts to develop an enantioselective method for the detection of the drug of abuse clephedrone (1-(4-chlorophenyl)-2-(methylamino)-1-propanone (4-chloromethcathinone, also known as 4-CMC or para-chloro-methcathinone)) and its phase-1 metabolites in human biological fluids. The major goal is not to only report results, but primarily to emphasize the various challenges encountered when developing a reliable analytical method for the detection and quantification of novel psychoactive substances (NPS) and their metabolites in the matrix of interest. Such challenges start with the lack of chemical stability of some NPS in biological matrices. Additionally, most often metabolites are unavailable in pure form to serve as analytical standards, just as deuterated standards for native drugs and metabolites are frequently not commercially available. Furthermore, if the NPS is chiral, enantiomerically pure standards with known absolute stereochemistry are required, as well as a stereochemical stability of a drug and its metabolites becomes an issue. In addition, the chirality of a NPS significantly increases the number of species to be detected in the sample and thus challenges the development of an adequate separation method. These issues are shortly addressed, and some solutions offered in this manuscript.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Network analysis of influential risk factors in adolescent suicide attempters

  • Fernandez-Fernandez, Jennifer
  • Jiménez-Treviño, Luis|||0000-0002-9551-8587
  • Andreo Jover, Jorge|||0000-0002-6703-8017
  • Ayad-Ahmed, Wala|||0000-0002-0786-0076
  • Bobes-Bascarán, Maria T.|||0000-0002-5279-504X
  • Canal-Rivero, Manuel|||0000-0002-5818-5103
  • Cebrià, Ana Isabel|||0000-0002-2632-8130
  • Crespo-Facorro, Benedicto|||0000-0003-0033-7132
  • Torre-Luque, Alejandro de la|||0000-0003-0595-6127
  • Díaz-Marsá, Marina|||0000-0003-1364-3163
  • González-Pinto, Ana|||0000-0002-2568-5179
  • Gómez Vallejo, Sandra|||0000-0003-0963-6585
  • Grande, Iria|||0000-0002-0137-0666
  • Iglesias, Noelia
  • Ortin, Francisco
  • March, Katya B.
  • Palao Tarrero, Ángela|||0000-0003-2717-5807
  • Pérez-Díez, Iván|||0000-0002-9972-2825
  • Pérez-Guerra, Carla
  • Ruiz-Veguilla, Miguel|||0000-0002-5790-7346
  • Vieta, Eduard|||0000-0002-0548-0053
  • Pérez Solà, Víctor|||0000-0002-5825-2337
  • Sáiz, Pilar A.|||0000-0002-5705-4523
Objective: This study aims to investigate the interrelationship of risk factors for suicidal behaviour and their influence on attempt severity in a sample of adolescents who have recently attempted suicide. For it a network analyse was performed. Method: Data from a sample of adolescents from 12 to 17 years of age with documented suicide attempts were collected and analysed in the context of a larger study conducted in Spain called SURVIVE. Several factors were examined including age, sex, depression, trauma, impulsivity, and substance abuse. Graph analysis was performed to identify relationships and centrality measures among these factors. Results: A total of 267 participants were enrolled: 233 females and 34 males with a mean age of 15.00 years (SD = 1.52). The results indicate that age and sex do not have a notable relationship with attempt severity in adolescents. Emotional and behavioural difficulties, measured by the Strengths and Difficulties Questionnaire (SDQ), have the greatest influence on other variables. Depression and childhood trauma show varying degrees of association with suicidal behaviour, as does motor impulsivity. Substance use does not appear to be strongly related to suicide attempt severity. The number of suicide attempts is strongly correlated with emotional and behavioural difficulties, depression, and childhood trauma. Lethality of suicide attempts and intensity of suicidal ideation do not show significant associations with the other variables. Conclusion: This study identifies significant risk factors for adolescent suicide. Emotional and behavioural symptoms, depression, and childhood trauma are strongly linked to suicidal behaviour. However, age, sex, and substance abuse show minimal correlation. Assessing emotional difficulties and depressive symptoms using specific questionnaires could be crucial in evaluating suicidal behaviour in adolescents.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Stability of cytokine and immunoglobulin concentrations in the general population: prepandemic basal concentrations and intraindividual changes until the COVID-19 pandemic

  • Gasull, Magda|||0000-0003-4546-3650
  • Pumarega, José Antonio|||0000-0001-6950-6702
  • Aguilar, Ruth|||0000-0003-3277-3107
  • Campi, Laura
  • Prieto-Merino, David
  • Villar Garcia, Judit|||0000-0002-6767-3424
  • Rius i Gibert, Maria Cristina|||0000-0001-5189-6503
  • Bolúmar, Francisco
  • Trasande, Leonardo|||0000-0002-1928-597X
  • Dobaño Lazaro, Carlota|||0000-0002-6751-4060
  • Moncunill, Gemma|||0000-0001-5105-9836
  • Porta, Miquel|||0000-0003-1684-7428
Background: While there is wide evidence on concentrations of cytokines in patients attending health care facilities, evidence is scant on physiological, basal concentrations of cytokines in the general population and across sociodemographic groups, as well as on their potential stability over time. Furthermore, from a public health perspective it is remarkable that no studies have analyzed intraindividual changes in such concentrations from before the COVID-19 pandemic until its outbreak. Objectives: To investigate: (a) prepandemic concentrations of cytokines and immunoglobulins to viral exposures in a general, non-institutionalized population, and their associated sociodemographic variables; (b) the intraindividual change in such concentrations between a prepandemic period (2016-17) and the initial pandemic period (2020-21); and (c) whether such change was similar in participants who in 2020-21 were SARS-CoV-2 seronegative and seropositive, and between participants who did and did not develop COVID-19. Methods: We conducted a prospective cohort study in 240 individuals from the general population of Barcelona, Spain. Thirty cytokines and 31 immunoglobulins were measured in paired serum samples collected in 2016-17 and 2020-21 in the same individuals. Results: The median value of the relative intraindividual change in cytokine concentrations between 2016 and 2020 was <15% for 29 of the 30 cytokines. A substantial number of participants had an intraindividual increase or decrease ≥15% in some cytokines. No major differences in intraindividual changes of cytokine and immunoglobulin levels between 2016 and 2020 were observed between participants who did and did not develop COVID-19. Conclusion: We provide novel information on physiological, basal ex-vivo concentrations of cytokines and immunoglobulins in a general population, which should be relevant for clinical practice and public health. Intraindividual changes in cytokines and immunoglobulins during the 4 years from 2016-17 to 2020-21 were moderate, and they did not differ between participants who in 2020-21 were SARS-CoV-2 seropositive and seronegative, nor between participants who did and did not develop COVID-19 disease. These findings are also novel and relevant for medicine and public health. In particular, the stability in the biomarkers is relevant to assess the role of the immunological and inflammatory state (measured through baseline levels of cytokines and immunoglobulins) in the development of SARS-CoV-2 seropositivity and COVID-19 disease, as well as in the susceptibility to other infections and pathologies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Choroidal thickness as predictor of subclinical carotid atherosclerosis in adults with type 1 diabetes

  • Castelblanco, Esmeralda|||0000-0002-2061-6270
  • Salvador-Miras, Ignacio
  • Carbonell Puig, Marc
  • Gratacòs, Mònica|||0000-0001-7304-7289
  • Traveset, Alicia|||0000-0003-2703-326X
  • Correig Fraga, Eudald|||0000-0001-8556-0469
  • Hernández García, Marta|||0000-0003-1237-298X
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Franch-Nadal, Josep|||0000-0002-5175-1555
  • Mauricio, Didac|||0000-0002-2868-0250
Patients with Type 1 Diabetes (T1DM) have a higher risk of cardiovascular disease. This study used carotid ultrasound to identify subclinical carotid plaques and Optical Coherence Tomography (OCT) to evaluate ophthalmological markers as predictors of carotid plaque presence in 242 adults with T1DM, employing machine learning models for early risk assessment. Individuals with carotid plaques (N=67) did not show significant differences in retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL) and inner plexiform layer (IPL) complex compared to those without (N=175). However, subfoveal and temporal choroidal area thickness significantly decreased in individuals with plaques (P≤0.01). Machine learning identified age, hypertension, dyslipidemia, smoking, and diabetic retinopathy as key predictors for plaque presence, while ophthalmological measures made a modest contribution. Choroidal thickness exhibited an inverse relationship with plaque risk. Despite robust accuracy and high specificity (82-85% and 92-98%, respectively), the models were overly conservative in predicting positive instances (balanced accuracy of 0.60 for the left eye and 0.71 for the right eye). If further validated, choroidal thickness could complement traditional risk factors as an early marker of CV risk in T1DM patients. Integrating this measure in specialized clinical settings could help identify individuals who may need additional cardiovascular assessments.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group

  • Oñate, Guadalupe|||0000-0003-2180-2371
  • Garrido Diaz, Ana|||0000-0002-5297-8946
  • Arnan, Montserrat
  • Pomares, Helena
  • Alonso, Ester
  • Tormo, Mar|||0000-0001-9622-1649
  • Díaz-Beyá, Marina|||0000-0001-9624-2597
  • Vives Polo, Susana|||0000-0003-2217-5285
  • Zamora, Lurdes|||0000-0003-1713-7110
  • Sampol, Antonia|||0000-0001-7465-6203
  • Coll, Rosa|||0000-0003-0560-1254
  • Salamero, Olga|||0000-0003-3237-0025
  • Cervera, Marta
  • Garcia-Guiñon, Antonio|||0000-0003-0006-4162
  • Vall-Llovera, Ferran|||0000-0002-0718-5955
  • Garcia-Avila, Sara|||0000-0002-9293-2029
  • Bargay, Joan|||0000-0002-6739-3916
  • Ortin, Xavier
  • Iranzo, Eva
  • Guijarro, Francesca|||0000-0001-6376-0929
  • Pratcorona, Marta|||0000-0001-6375-596X
  • Nomdedeu Guinot, Jose Francisco|||0000-0003-3399-346X
  • Esteve Reyner, Jordi|||0000-0002-8056-648X
  • Sierra, Jorge|||0000-0002-7966-0356
Given the heterogeneity of acute myeloid leukemia patients, it is necessary to identify patients considered fit for intensive therapy but who will perform poorly, and in whom alternative approaches deserve investigation. We analyzed 1034 fit adults ≤70 years intensively treated between 2012 and 2022 in the CETLAM group. Young adults ( ≤ 60 years) presented higher remission rates and improved survival than older adults above that age (CR 79% vs. 73%; p = 0.03 and 4-yr OS 53% vs. 33%; p < 0.001). Remission and survival outcomes varied among different genetic subsets. An especially adverse genetic group included complex, monosomal karyotype, TP53 alterations (deleted/mutated), and MECOMr. Transplant feasibility in this very adverse risk group was low, and OS and EFS at 4 years were 14% and 12%, in contrast to 70% and 57% in the favorable group and 38% and 32% in all other patients. We integrated clinical and genetic data into the Intensive Chemotherapy Score for AML (ICSA) with 6-risk categories with significantly different remission rates and OS, validated in another cohort of 581 AML patients from a previous CETLAM protocol. In summary, we identified groups of fit patients that benefit differently from an intensive approach which may be helpful in future treatment decisions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Round-robin testing for LMO2 and MYC as immunohistochemical markers to screen MYC rearrangements in aggressive large B-cell lymphoma

  • Papaleo, Natalia|||0000-0001-6943-3494
  • Climent, Fina|||0000-0002-4360-8388
  • Tapia, Gustavo|||0000-0003-1882-0368
  • Luizaga Velasco, Luis|||0000-0001-9314-5783
  • Azcarate, Juan
  • Bosch-Schips, Jan|||0009-0009-7888-6810
  • Muñoz-Mármol, Ana Maria|||0000-0003-1008-7763
  • Salido, Marta|||0000-0001-9988-5977
  • Lome-Maldonado, Carmen|||0000-0001-8973-3275
  • Vázquez, Ivonne|||0000-0002-5305-1560
  • Colomo, Luis|||0000-0001-5236-5085
Aggressive large B-cell lymphomas (aLBCL) include a heterogeneous group of lymphomas with diverse biological features. One of the approaches to the diagnosis of aLBCL is based on the identification of MYC rearrangements (MYC-R), in addition to BCL2 and BCL6 rearrangements by genetic techniques, mainly fluorescent in situ hybridization (FISH). Because of the low incidence of MYC-R, the identification of useful immunohistochemistry markers to select cases for MYC FISH testing may be useful in daily practice. In a previous work, we identified a strong association between the profile CD10 positive/LMO2 negative expression and the presence of MYC-R in aLBCL and obtained good intralaboratory reproducibility. In this study, we wanted to evaluate external reproducibility. To evaluate whether LMO2 can be a reproducible marker between observers 50 aLBCL cases were circulated among 7 hematopathologists of 5 hospitals. Fleiss' kappa index for LMO2 and MYC were 0.87 and 0.70, respectively, indicating high agreement between observers. In addition, during 2021-2022, the enrolled centers included LMO2 in their diagnostic panels to evaluate prospectively the utility of the marker, and 213 cases were analyzed. Comparing LMO2 with MYC, the group of CD10 positive cases showed higher specificity (86% vs 79%), positive predictive value (66% vs 58%), likelihood positive value (5.47 vs 3.78), and accuracy (83% vs 79%), whereas the negative predictive values remained similar (90% vs 91%). These findings place LMO2 as a useful and reproducible marker to screen MYC-R in aLBCL.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prepandemic levels of cytokines and immunoglobulins and risk of SARS-CoV-2 infection and COVID-19 in the general population of Barcelona

  • Porta, Miquel|||0000-0003-1684-7428
  • Pumarega, José Antonio|||0000-0001-6950-6702
  • Aguilar, Ruth|||0000-0003-3277-3107
  • Prieto-Merino, David
  • Campi, Laura
  • Rius i Gibert, Maria Cristina|||0000-0001-5189-6503
  • Villar Garcia, Judit|||0000-0002-6767-3424
  • Vidal, Marta
  • Jimenez, Alfons
  • Peña, Antonio
  • Muñoz, Miguel-Angel|||0000-0002-4083-3248
  • Trasande, Leonardo|||0000-0002-1928-597X
  • Bolúmar, Francisco
  • Moncunill, Gemma|||0000-0001-5105-9836
  • Gasull, Magda|||0000-0003-4546-3650
  • Dobaño Lazaro, Carlota|||0000-0002-6751-4060
Background: From a public health perspective it is remarkable that there are yet no longitudinal studies in the general population investigating the influence of the basal immune state, measured before the pandemic, on the risk of SARS-CoV-2 infection and COVID-19. Objective: To investigate the specific and combined effects of personal levels of cytokines and immunoglobulins-measured in individuals' blood 4 years before the pandemic-on the risk of SARS-CoV-2 infection and COVID-19 in a general population. Methods: We conducted a prospective cohort study in 240 individuals from the general population of Barcelona. Thirty cytokines and 31 immunoglobulins were quantified in prepandemic serum samples (collected in 2016-17) by high-throughput multiplex quantitative suspension array technology. Results: Higher concentrations in 2016-17 of IL-8 and TNF-α significantly decreased the risk of SARS-CoV-2 seropositivity in 2020-21, whereas higher concentrations of MIP-1α were a risk factor for seropositivity. Most cytokines in mixtures with IL-8, MIP-1α, TNF-α or G-CSF were associated with SARS-CoV-2 seropositivity (all OR ≥2.0 or OR≤0.4 and p < 0.05). The five individual isotype-antigen pairs more clearly associated with seropositivity were: protectively, IgG to CMV pp150, IgG to CMV pp65, and IgG to N OC43; and, increasing risk of seropositivity, IgM to CMV pp65 and IgM to EBV EA-D. The four cytokines most consistently associated with the risk of COVID-19 were also G-CSF, IL-8, TNF-α, and MIP-1α. The four isotype-antigen pairs more strongly associated with risk of COVID-19 (all protective) were IgA to CMV pp65 and N 229E, and IgG to EBV EAD and VCAp18. Conclusion: The unique longitudinal design of this study, with measurements before and during the pandemic in a general population, provides novel knowledge on the protective and detrimental effects of specific individual cytokines and immunoglobulins, and their mixtures, on the risk of SARS-CoV-2 seropositivity and COVID-19. If confirmed, findings would be significantly relevant for medicine and public health.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Midbrain and pons MRI shape analysis and its clinical and CSF correlates in degenerative parkinsonisms, a pilot study

  • Painous, Cèlia|||0000-0002-7027-3093
  • Pascual-Diaz, Saül|||0000-0001-5871-5867
  • Muñoz-Moreno, E.
  • Sánchez, V.
  • Pariente, JC.
  • Prats-Galino, Alberto|||0000-0002-2710-6433
  • Soto, M.
  • Fernández, Manel
  • Pérez-Soriano, A.
  • Cámara, Ana|||0000-0002-8005-9461
  • Muñoz, Estela|||0000-0002-6693-4987
  • Valldeoriola, F.
  • Caballol, Nuria|||0000-0003-3363-3077
  • Pont-Sunyer, C.
  • Martin, N.
  • Basora, Misericordia|||0000-0002-1892-5330
  • Tio, M.
  • Ríos, José|||0000-0002-0716-8784
  • Martí Domenech, Maria Josep|||0000-0002-9872-7835
  • Bargalló, Núria|||0000-0001-6284-5402
  • Compta, Yaroslau|||0000-0001-6443-0104
To conduct brainstem MRI shape analysis across neurodegenerative parkinsonisms and control subjects (CS), along with its association with clinical and cerebrospinal fluid (CSF) correlates. We collected demographic and clinical variables, performed planimetric and shape MRI analyses, and determined CSF neurofilament-light chain (NfL) levels in 84 participants: 11 CS, 12 with Parkinson's disease (PD), 26 with multiple system atrophy (MSA), 21 with progressive supranuclear palsy (PSP), and 14 with corticobasal degeneration (CBD). MSA featured the most extensive and significant brainstem shape narrowing (that is, atrophy), mostly in the pons. CBD presented local atrophy in several small areas in the pons and midbrain compared to PD and CS. PSP presented local atrophy in small areas in the posterior and upper midbrain as well as the rostral pons compared to MSA. Our findings of planimetric MRI measurements and CSF NfL levels replicated those from previous literature. Brainstem shape atrophy correlated with worse motor state in all parkinsonisms and with higher NfL levels in MSA, PSP, and PD. Atypical parkinsonisms present different brainstem shape patterns which correlate with clinical severity and neuronal degeneration. In MSA, shape analysis could be further explored as a potential diagnostic biomarker. By contrast, shape analysis appears to have a rather limited discriminant value in PSP. • Atypical parkinsonisms present different brainstem shape patterns. • Shape patterns correlate with clinical severity and neuronal degeneration. • In MSA, shape analysis could be further explored as a potential diagnostic biomarker. The online version contains supplementary material available at 10.1007/s00330-023-09435-0.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Acute pharmacological effects of α-PVP in humans, a naturalistic observational study

  • Rosa, Georgina de la
  • Papaseit, Esther|||0000-0003-2620-4274
  • Hladun, Olga|||0000-0002-6230-5876
  • Poyatos, Lourdes|||0000-0002-4641-8600
  • Caicedo, Dolly Andrea
  • Argote Oramas, Martha Catalina
  • Martín, Soraya|||0009-0008-3761-9217
  • Ventura, Mireia|||0000-0003-1133-6872
  • La Maida, Nunzia|||0000-0003-0127-4225
  • Di Trana, Annagiulia|||0000-0002-8456-0827
  • Graziano, Silvia|||0000-0002-5609-0872
  • Pichini, Simona
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
Alpha-pyrrolidinopentiophenone (α-PVP) is a commonly consumed analogue of pyrovalerone, a synthetic cathinone with psychostimulant properties similar to those of 3,4-Methylenedioxypyrovalerone (MDPV) and cocaine. Since the pharmacology of α-PVP remains scarcely studied, we aimed to evaluate the acute pharmacological effects and its abuse potential in humans after intranasal administration. We carried out a non-controlled observational study in a naturalistic environment in nine participants (3 women and six men) with a previous history of psychostimulant use. Participants self-administered a single intranasal dose of 10mg or 20mg of α-PVP. The outcomes included physiological effects (systolic and diastolic blood pressure, heart rate, and temperature) and subjective effects (Evaluation of Subjective Effects of Substances with Abuse Potential questionnaire_VESSPA-SSE, the short form of the Addiction Research Center Inventory questionnaire_ARCI and visual analog scales_VASs) and were measured at different time points (0, 20 and 40 minutes and 1, 1.5, 2, 2.5, 3, 4 and 5 hours). An acute increase in blood pressure and heart rate was observed that peaked 40 minutes after administration. Subjective effects also showed a rapid onset and disappeared 3 to 5 hours after administration. α-PVP showed psychostimulant properties similar to those displayed by cocaine and empathogenic effects commonly associated with MDMA and other cathinones (eg. methylone) consumption.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Food addiction and impaired executive functions in women with obesity

  • Steward, Trevor|||0000-0003-3116-8175
  • Mestre-Bach, Gemma|||0000-0001-5345-0484
  • Vintró Alcaraz, Cristina|||0000-0001-9453-8810
  • Lozano Madrid, María|||0000-0003-3833-317X
  • Agüera, Zaida|||0000-0003-4453-4939
  • Fernandez Formoso, Jose Antonio|||0000-0001-5310-1655
  • Granero, Roser|||0000-0001-6308-3198
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Vilarrasa, Nuria|||0000-0003-3188-1990
  • García Ruiz de Gordejuela, Amador|||0000-0002-0485-8536
  • Veciana de las Heras, Misericordia|||0000-0002-1878-8663
  • Custal, Nuria
  • Virgili, Nuria
  • López-Urdiales, Rafael|||0000-0002-2355-3041
  • Gearhardt, Ashley N.|||0000-0003-3843-5731
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Soriano-Mas, Carles|||0000-0003-4574-6597
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Background: Individuals with obesity (OB) often report suffering from addiction-like symptoms. As in addictions, deficits in executive function domains, such as decision-making and sustained attention, are found in OB. No study to date has examined the associations between food addiction, OB, and neuropsychological performance. Method: Thirty-three adult women with OB and 36 healthy weight controls completed the Yale Food Addiction Scale Version 2.0, a validated instrument used to assess food-related addictive behaviours. Additionally, participants completed computerized versions of the Iowa Gambling Task (IGT) and Conners' Continuous Performance Test, second edition (CPT-II) to examine decision-making and attentional control, respectively. Results: Food addiction criteria were met in 24.2% of the participants with OB and in 2.8% of the control group. In the OB group, food addiction severity levels were negatively correlated with overall scores on the IGT. Participants with OB meeting criteria for food addiction committed more omissions and perseveration errors on the CPT-II compared with those without food addiction. Conclusions: Our results point to an association between food addiction severity levels and impairments in decision-making and attentional capacity in individuals with OB. Given the heterogeneity found in OB, it stands to reason that this subset of patients with food addiction could potentially benefit from interventions targeting neuropsychological deficits.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Associations of food addiction and non suicidal self-injury among women with an eating disorder, a common strategy for regulation emotions?

  • Carlson, Lily
  • Steward, Trevor|||0000-0003-3116-8175
  • Agüera, Zaida|||0000-0003-4453-4939
  • Mestre-Bach, Gemma|||0000-0001-5345-0484
  • Magaña, Pablo|||0000-0003-2005-4172
  • Granero, Roser|||0000-0001-6308-3198
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Claes, Laureance
  • Gearhardt, Ashley N.|||0000-0003-3843-5731
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Food addiction and preoperative weight loss achievement in patients seeking bariatric surgery

  • Guerrero Pérez, Fernando
  • Sánchez González, Jéssica|||0000-0002-9327-0100
  • Sánchez Díaz, Isabel María|||0000-0001-5874-8204
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Granero, Roser|||0000-0001-6308-3198
  • Simó-Servat, Andreu|||0000-0002-1092-1327
  • Ruiz Serrano, Ana
  • Virgili, Nuria
  • López-Urdiales, Rafael|||0000-0002-2355-3041
  • Montserrat-Gil de Bernabé, Monica
  • Garrido, Pilar|||0000-0002-5899-6125
  • Monseny, Rosa
  • García Ruiz de Gordejuela, Amador|||0000-0002-0485-8536
  • Pujol-Gebelli, Jordi
  • Monasterio, Carmen
  • Salord, Neus
  • Gearhardt, Ashley N.|||0000-0003-3843-5731
  • Carlson, Lily
  • Menchón Magriñá, José Manuel|||0000-0002-6231-6524
  • Vilarrasa, Nuria|||0000-0003-3188-1990
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
Introduction: Evidence suggests that food addiction (FA) is prevalent among individuals with obesity seeking bariatric surgery (BS), but there is no evidence about whether FA is a predictor of weight loss (WL). We aimed to analyse the prevalence of FA in patients with obesity seeking BS and to examine whether FA could predict WL following dietary intervention before surgery. Method: The study included 110 patients with obesity who underwent a dietetic intervention. Assessment included endocrinological variables, a semistructured interview to rule out mental disorders, and Yale Food Addiction Scale version 2.0 (YFAS 2.0). Results: In our sample, the prevalence of FA was 26.4%. Those who met YFAS 2.0 criteria showed less WL after dietetic intervention and regain weight during dietary intervention. Conclusions: FA appears to be prevalent in obesity. Our findings confirmed a lower WL throughout dietary intervention before surgery in patients who fulfilled baseline criteria for FA. Future interventions should include multidisciplinary intervention to maximize WL before and after BS.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Association of Epicardial Adipose Tissue with Novel Inflammation and Heart Failure Biomarkers in Type 2 Diabetes Patients, Effect of Metabolic Control

  • Gil, Pedro|||0000-0003-3707-7450
  • Rives Jimenez, Jose|||0009-0001-5725-9270
  • Viladés Medel, David|||0000-0002-3638-9703
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Genua, Idoia|||0000-0001-6834-561X
  • Miñambres, Inka|||0000-0002-0899-3938
  • Grau-Agramunt, Margarida
  • Gich, Ignasi|||0000-0003-3975-6588
  • Camacho, Mercedes|||0000-0001-5970-3294
  • Benitez, Sonia|||0000-0003-3565-0743
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
  • Pérez, Antonio|||0000-0001-5528-1143
Background : Type 2 diabetes (T2D patients) have a 74% increased risk of heart failure (HF), but traditional HF biomarkers lack sensitivity in early disease detection. Increased epicardial adipose tissue volume (EATv) is associated with cardiovascular risk in T2D, and novel biomarkers such as growth differentiation factor 15 (GDF15), Galectin-3, and soluble suppression of tumorigenicity 2 (sST2) are inflammation biomarkers linked to HF. Methods : We investigated associations between EATv, inflammation biomarkers, and the effect of metabolic control in 14 healthy controls (HCs) and 36 newly diagnosed T2D patients both before (poor glycemic control, PGC) and after 12 months of glycemic optimization (good glycemic control, GGC). EATv indexed to body surface area (iEATv) was quantified by multidetector computed tomography, and biomarker levels were measured by immunoassays. Results : PGC patients had higher iEATv (59.53 ± 21.67 vs. 36.84 ± 16.57 cm 3 /m 2, p = 0.0017) and elevated GDF15, Galectin-3, and sST2 levels (all p < 0.05) than HC subjects. The glycemic optimization reduced iEATv (p = 0.0232) and sST2 (p = 0.048), while GDF15 and Galectin-3 remained unchanged. Multivariable analysis confirmed independent associations between iEATv, GDF15 (β = 0.27, p = 0.027) and sST2 (β = 0.29, p = 0.02). Conclusions : These results support the link between systemic inflammation, EAT expansion, and cardiac dysfunction, and they point to the role of epicardial fat in early HF risk of T2D patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Low-Density Lipoprotein Subfraction Phenotype Is Associated with Epicardial Adipose Tissue Volume in Type 2 Diabetes

  • Rives Jimenez, Jose|||0009-0001-5725-9270
  • Gil, Pedro|||0000-0003-3707-7450
  • Viladés Medel, David|||0000-0002-3638-9703
  • García Osuna, Álvaro|||0000-0002-6682-0226
  • Genua, Idoia|||0000-0001-6834-561X
  • Miñambres, Inka|||0000-0002-0899-3938
  • Grau-Agramunt, Margarida
  • Gich, Ignasi|||0000-0003-3975-6588
  • Puig Grifol, Núria|||0000-0002-4699-3162
  • Benitez, Sonia|||0000-0003-3565-0743
  • Julve i Gil, Josep|||0000-0002-6531-2246
  • Pérez, Antonio|||0000-0001-5528-1143
  • Sánchez Quesada, José Luis|||0000-0003-0224-591X
Background : Increased epicardial adipose tissue (EAT) volume is a common feature in type 2 diabetes (T2DM) which is directly associated with heart failure and advanced atherosclerosis. We aimed to evaluate lipoprotein-related biomarkers of EAT volume in T2DM patients before and after glycemic control. Methods : This study included 36 T2DM patients before and after optimization of glycemic control and on 14 healthy controls (HCs). EAT volume was measured using computed tomography imaging indexed to the body surface area (iEAT). Biochemical and lipid profiles were determined using commercial methods. Lipoproteins were isolated by ultracentrifugation, and variables of lipoprotein function were assessed. Multivariable regression analysis was used to find variables independently associated with iEAT. Results : iEAT was higher in T2DM than in controls and decreased with glycemic optimization. HDLs from T2DM had less apoA-I and cholesterol and more apoC-III and triglycerides. LDLs from T2DM had more triglycerides and apoB and smaller sizes than those from HCs. Significant correlations were found between iEAT and age, BMI, HbA1c, GGT, VLDLc, triglycerides, LDL size, apoA-I in HDL, and apoC-III in HDL. In the multivariable regression analysis, age, LDL size, and GGT associations remained statistically significant, and predicted 50% of the variability in EAT volume. ROC analysis using these variables showed an AUC of 0.835. Conclusions : Qualitative characteristics of lipoproteins were altered in T2DM. Multivariable analysis showed that LDL size and GGT plasma levels were independently associated with iEAT volume, suggesting that these variables might be useful biomarkers for stratifying T2DM patients with increased EAT volume.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A specific gut microbiota signature is associated with an enhanced GLP-1 and GLP-2 secretion and improved metabolic control in patients with type 2 diabetes after metabolic Roux-en-Y gastric bypass

  • Hernández-Montoliu, Laura
  • Rodríguez-Peña, M.Mar
  • Puig, Rocío
  • Astiarraga, Brenno|||0000-0003-2216-8974
  • Guerrero-Pérez, Fernando
  • Virgili, Nuria
  • López-Urdiales, Rafael|||0000-0002-2355-3041
  • Osorio, Javier|||0000-0002-0889-4585
  • Monseny, Rosa
  • Lazzara, Claudia
  • Sobrino, Lucía
  • Pérez-Maraver, Manuel|||0000-0003-4427-7581
  • Pérez-Prieto, María
  • Pellitero, Silvia|||0000-0002-9510-7251
  • Fernández-Veledo, Sonia|||0000-0003-2906-3788
  • Vendrell, Joan|||0000-0002-6994-6115
  • Vilarrasa, Nuria|||0000-0003-3188-1990
Objective: To determine changes in incretins, systemic inflammation, intestinal permeability and microbiome modifications 12 months after metabolic RYGB (mRYGB) in patients with type 2 diabetes (T2D) and their relationship with metabolic improvement. Materials and methods: Prospective single-center non-randomized controlled study, including patients with class II-III obesity and T2D undergoing mRYGB. At baseline and one year after surgery we performed body composition measurements, biochemical analysis, a meal tolerance test (MTT) and lipid test (LT) with determination of the area under the curve (AUC) for insulin, C-peptide, GLP-1, GLP-2, and fasting determinations of succinate, zonulin, IL-6 and study of gut microbiota. Results: Thirteen patients aged 52.6 ± 6.5 years, BMI 39.3 ± 1.4 kg/m, HbA 7.62 ± 1.5% were evaluated. After mRYGB, zonulin decreased and an increase in AUC after MTT was observed for GLP-1 (pre 9371 ± 5973 vs post 15788 ± 8021 pM, P<0.05), GLP-2 (pre 732 ± 182 vs post 1190 ± 447 ng/ml, P<0.001) and C- peptide, as well as after LT. Species belonging to Streptococaceae, Akkermansiacea, Rickenellaceae, Sutterellaceae, Enterobacteriaceae, Oscillospiraceae, Veillonellaceae, Enterobacterales_uc, and Fusobacteriaceae families increased after intervention and correlated positively with AUC of GLP-1 and GLP-2, and negatively with glucose, HbA, triglycerides and adiposity markers. Clostridium perfringens and Roseburia sp. 40_7 behaved similarly. In contrast, some species belonging to Lachnospiraceae, Erysipelotricaceae, and Rumnicocaceae families decreased and showed opposite correlations. Higher initial C-peptide was the only predictor for T2D remission, which was achieved in 69% of patients. Conclusions: Patients with obesity and T2D submitted to mRYGB show an enhanced incretin response, a reduced gut permeability and a metabolic improvement, associated with a specific microbiota signature.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Association Between the Mediterranean Diet and Fatty Acids in Red Blood Cells of Spanish Adolescents

  • Ayala-Aldana, Nicolas|||0000-0002-3530-6734
  • Lafuente, David
  • Lázaro, Iolanda|||0000-0002-6172-9845
  • Pinar-Martí, Ariadna|||0000-0002-2602-3396
  • Manidis, Alexios
  • Bernardo-Castro, Sara|||0000-0001-8809-5101
  • Fernández-Barrés, Sílvia|||0000-0002-9977-2291
  • Healy, Darren|||0000-0002-0084-2289
  • Vrijheid, Martine|||0000-0002-7090-1758
  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
  • Sala-Vila, Aleix|||0000-0002-5038-2794
  • Júlvez, Jordi|||0000-0003-0818-4003
Objective: The Mediterranean diet (MedDiet) is characterized by its emphasis on plant-based foods, olive oil, and fish products, and has been associated with providing relevant fatty acids (FAs) for adolescent physiology. This study aims to investigate the relationship between adherence to the MedDiet and the FA composition of red blood cell (RBC) membranes in an adolescent population. Methods: The current research examines the relationship between MedDiet adherence, assessed using the KIDMED questionnaire, and the composition of RBC membranes, specifically measuring 22 FAs in a cross-sectional analysis of adolescents from two cohorts (mean age = 14.55). Baseline data from 552 participants with complete dietary adherence and FA information were analyzed using multivariable regression models and principal component analysis (PCA) as confirmatory analysis. All regression models were adjusted by age, sex, body mass index, physical activity, maternal education and cohort enrollment. Results: Main results shown that "Good adherence" to the MedDiet was positively associated with omega-3 FAs, including eicosapentaenoic acid (β = 0.34; 95% CI: 0.17, 0.52; p -value < 0.001) and docosahexaenoic acid (β = 0.29; 95% CI: 0.11, 0.46; p -value = 0.001), and inversely associated with specific omega-6 FAs, such as arachidonic acid (β = -0.28; 95% CI: -0.46, -0.11; p -value = 0.002) and adrenic acid (β = -0.19; 95% CI: -0.30, -0.08; p -value < 0.001). PCA identified distinct FA patterns, with "Good adherence" to the MedDiet being associated with an increase in the omega-3 FAs pattern (β = 0.32; 95% CI: 0.14, 0.49; p -value < 0.001). These findings remained robust after multiple test comparisons. Conclusions: This study underscores the potential of the MedDiet to promote optimal RBC FA composition in healthy adolescents, characterized by high levels of omega-3 FAs and reduced levels of arachidonic acid and adrenic acid in RBC membranes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sex differences in psychosocial functioning and neurocognition in bipolar disorder, a systematic review and meta-analysis

  • Serra-Navarro, Maria|||0000-0002-9736-4630
  • Clougher, Derek|||0000-0001-7631-3845
  • Oliva, Vincenzo|||0000-0002-5961-6032
  • Valenzuela-Pascual, Clàudia
  • De Prisco, Michele|||0000-0002-2032-1181
  • Forte, Maria Florencia|||0000-0001-5930-5501
  • Garriga, Marina|||0000-0001-7312-4969
  • Solé, Brisa|||0000-0003-1673-8248
  • Sánchez-Moreno, Jose|||0000-0003-1520-093X
  • Verdolini, Norma|||0000-0001-9488-2881
  • Tortorella, Alfonso|||0000-0002-8095-2305
  • Bernardo, Miquel|||0000-0001-8748-6717
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Martínez-Àran, Anabel|||0000-0002-0623-6263
  • Vieta, Eduard|||0000-0002-0548-0053
  • Amoretti, Silvia|||0000-0001-6017-2734
  • Torrent, Carla|||0000-0003-0335-582X
Impairment in both psychosocial functioning and neurocognition (NC) performance is present in bipolar disorder (BD) yet the role of sex differences in these deficits remains unclear. The present systematic review and meta-analysis examined whether males and females with BD demonstrate differences in psychosocial functioning and NC performance. The Cochrane Library, EMBASE, PsycINFO, PubMed, Scopus, and Web of Science databases were systematically searched from inception until November 20, 2023. Twenty studies published between 2005 and 2023 with a total sample size of 2286 patients with BD were included. A random effects meta-analysis revealed a statistically significant result with a small effect (SMD = 0.313) for sex differences in verbal learning and memory as well as visual learning and memory (SMD = 0.263). Females outperformed males in both domains. No significant sex differences were observed for any other NC outcome or psychosocial functioning. High heterogeneity and differences in assessment scales used should be considered when interpreting these findings, given their potential impact on results. Future research should adopt a more homogenous, standardized approach using longitudinal designs to gain a clearer insight into sex differences in this population. This approach so may increase the use of preventative therapeutic options to address the difficult clinical challenge of reaching cognitive and functional recovery.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The OSCAR-MP Consensus Criteria for Quality Assessment of Retinal Optical Coherence Tomography Angiography

  • Wicklein, Rebecca|||0000-0002-6661-6081
  • Yam, Charmaine
  • Noll, Christina
  • Aly, Lilian|||0000-0002-7051-124X
  • Banze, Nicolas
  • Romahn, Eva Feodora
  • Wolf, Elisabeth
  • Hemmer, Bernhard|||0000-0001-5985-6784
  • Oertel, Frederike Cosima|||0000-0003-4906-5983
  • Zimmermann, Hanna G.|||0000-0002-0276-8051
  • Albrecht, Philipp|||0000-0001-7987-658X
  • Ringelstein, Marius|||0000-0003-3618-8407
  • Baumann, Carmen
  • Feucht, Nikolaus
  • Penkava, Josef
  • Havla, Joachim|||0000-0002-4386-1340
  • Gernert, Jonathan A.
  • Mardin, Christian
  • Vasileiou, Eleni S.|||0000-0002-8639-8405
  • van der Walt, Anneke|||0000-0002-4278-7003
  • Al-Louzi, Omar|||0000-0003-2260-5660
  • Cabello, Sergio
  • Vidal-Jordana, Angela|||0000-0002-7270-5507
  • Krämer, Julia
  • Wiendl, Heinz|||0000-0003-4310-3432
  • Preiningerova, Jana Lizrova|||0000-0003-0337-3462
  • Ciccarelli, Olga|||0000-0001-7485-1367
  • Garcia-Martin, Elena|||0000-0001-6258-2489
  • Kana, Veronika
  • Calabresi, Peter A.|||0000-0002-7776-6472
  • Paul, Friedemann|||0000-0002-6378-0070
  • Saidha, Shiv|||0000-0001-6387-0714
  • Petzold, Axel|||0000-0002-0344-9749
  • Toosy, Ahmed T.|||0000-0002-4441-3750
  • Knier, Benjamin|||0000-0003-4187-9472
Optical coherence tomography angiography (OCTA) is a noninvasive high-resolution imaging technique for assessing the retinal vasculature and is increasingly used in various ophthalmologic, neuro-ophthalmologic, and neurologic diseases. To date, there are no validated consensus criteria for quality control (QC) of OCTA. Our study aimed to develop criteria for OCTA quality assessment. To establish criteria through (1) extensive literature review on OCTA artifacts and image quality to generate standardized and easy-to-apply OCTA QC criteria, (2) application of OCTA QC criteria to evaluate interrater agreement, (3) identification of reasons for interrater disagreement, revision of OCTA QC criteria, development of OCTA QC scoring guide and training set, and (4) validation of QC criteria in an international, interdisciplinary multicenter study. We identified 7 major aspects that affect OCTA quality: (O) obvious problems, (S) signal strength, (C) centration, (A) algorithm failure, (R) retinal pathology, (M) motion artifacts, and (P) projection artifacts. Seven independent raters applied the OSCAR-MP criteria to a set of 40 OCTA scans from people with MS, Sjogren syndrome, and uveitis and healthy individuals. The interrater kappa was substantial (κ 0.67). Projection artifacts were the main reason for interrater disagreement. Because artifacts can affect only parts of OCTA images, we agreed that prior definition of a specific region of interest (ROI) is crucial for subsequent OCTA quality assessment. To enhance artifact recognition and interrater agreement on reduced image quality, we designed a scoring guide and OCTA training set. Using these educational tools, 23 raters from 14 different centers reached an almost perfect agreement (κ 0.92) for the rejection of poor-quality OCTA images using the OSCAR-MP criteria. We propose a 3-step approach for standardized quality control: (1) To define a specific ROI, (2) to assess the occurrence of OCTA artifacts according to the OSCAR-MP criteria, and (3) to evaluate OCTA quality based on the occurrence of different artifacts within the ROI. OSCAR-MP OCTA QC criteria achieved high interrater agreement in an international multicenter study and is a promising QC protocol for application in the context of future clinical trials and studies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment

  • Bolsewig, K.
  • Willemse, E.A.J.
  • Sánchez-Juan, Pascual|||0000-0002-6081-8037
  • Rábano, Alberto|||0000-0001-9320-6566
  • Martínez, Minerva|||0000-0002-9036-2595
  • Doecke, J.D.|||0000-0003-2863-0293
  • Bellomo, Giovanni|||0000-0003-0456-5650
  • Vermunt, L.
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Halbgebauer, S.
  • in 't Veld, S.
  • Mattsson-Carlgren, N.
  • Veverova, K.
  • Fowler, C.J.
  • Boonkamp, L.
  • Koel-Simmelink, M.
  • Hussainali, Z.
  • Ruiters, D.N.
  • Gaetani, L.
  • Toja, A.
  • Fortea, Juan|||0000-0002-1340-638X
  • Pijnenburg, Y.
  • Lemstra, A.W.
  • van der Flier, Wiesje M.|||0000-0001-8766-6224
  • Hort, J.
  • Otto, M.|||0000-0003-4273-4267
  • Hansson, Oskar|||0000-0001-8467-7286
  • Parnetti, Lucilla|||0000-0001-5722-3967
  • Masters, C.L.
  • Lleó, Alberto|||0000-0002-2568-5478
  • Teunissen, C.E.
  • Campo Milán, Marta del|||0000-0003-2808-3699
DOPA Decarboxylase (DDC) has been proposed as a cerebrospinal fluid (CSF) biomarker with increased concentrations in Lewy body disorders (LBDs) and highest levels in patients receiving dopaminergic treatment. Here we evaluate plasma DDC, measured by proximity extension assay, and the effect of dopaminergic treatment in three independent LBD (with a focus on dementia with Lewy bodies (DLB) and Parkinson's disease (PD)) cohorts: an autopsy-confirmed cohort (n = 71), a large multicenter, cross-dementia cohort (n = 1498) and a longitudinal cohort with detailed treatment information (n = 66, median follow-up time[IQR] = 4[4, 4] years). Plasma DDC was not altered between different LBDs and other disease groups or controls in absence of treatment. DDC levels increased over time in PD, being significantly associated to higher dosages of dopaminergic treatment. This emphasizes the need to consider treatment effect when analyzing plasma DDC, and suggests that plasma DDC, in contrast to CSF DDC, is of limited use as a diagnostic biomarker for LBD, but could be valuable for treatment monitoring.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Catatonia in first-episode psychosis, prevalence and psychopathological association

  • Cuevas-Esteban, Jorge|||0000-0002-6172-4331
  • Serrat, Francesc|||0000-0002-8503-5848
  • Iglesias-González, Maria|||0000-0002-7794-1533
  • Motta, Nicole
  • Jimenez-Fernandez, Beltran
  • Vila-Badia, Regina|||0000-0001-8819-3991
  • Colomer-Salvans, Alicia
  • Serra-Arumí, Clara
  • Del Cacho, Núria
  • Corbella-Sotil, Ariadna
  • Butjosa, Anna
  • Pardo, Marta
  • Usall, Judith|||0000-0002-1746-7737
Background First-episode psychosis (FEP) is a critical phase in psychotic disorders where early intervention significantly influences long-term outcomes. Catatonia, characterised by motor, behavioural, and psychological abnormalities, is an under-recognised aspect of FEP. Aims This study examines catatonia prevalence in affective and non-affective FEP, its role as a severity indicator across psychopathological domains, its correlations with other symptoms and its association with clinical syndromes. Method A cross-sectional study was conducted with 58 FEP patients (38 females, 20 males) aged 15-55 years. Of those, 40 were antipsychotic-naive, and 18 had minimal prior antipsychotic exposure. Participants were recruited from acute psychiatric units. Catatonia was assessed using the Bush Francis Catatonia Rating Scale (BFCRS), while psychopathology was evaluated with the Positive and Negative Symptom Scale (PANSS), Calgary Depression Scale (CDS) and Young Mania Rating Scale (YMRS). Data analysis included descriptive statistics, t-tests, χ tests, and multivariable regression using SPSS version 25 for Windows. Results Catatonic signs were identified in 22.4% of cases based on the Bush Francis Catatonia Screening Instrument (BFCSI) criteria (BFCSI-positive group, defined as ≥2 signs present for over 24 h), indicating potential catatonia. Prevalence varied by criteria: 13.8% (DSM-IV), 10.3% (Fink and Taylor), 10.38% (ICD-11) and 8.6% (DSM-5). Catatonic patients had more years of education and significantly higher PANSS totals, Emsley negative, disorganised, excited, and anxiety scores. Catatonic signs moderately correlated with Emsley disorganised scores. Regression analysis identified PANSS total and Emsley domain scores as significant predictors of catatonia severity. Conclusions Catatonia is notably prevalent in FEP and associated with severe psychopathology, particularly in negative and disorganised domains. These findings underscore the importance of improving recognition of catatonia in early psychosis. Larger longitudinal studies are needed to confirm these findings and explore treatment implications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Aspirin Discontinuation at 24-28 Weeks and Placental Biomarker Trajectories, Post Hoc Analysis of a Randomised Trial

  • Bonacina, Erika|||0000-0002-8042-8247
  • Armengol-Alsina, Mireia|||0000-0002-2087-5176
  • García Manau, Pablo|||0000-0002-2415-1626
  • Lopez Rodriguez, Monica|||0000-0002-3125-9870
  • Rodriguez-Zurita, Alicia|||0000-0003-4177-4726
  • Vives, Àngels|||0000-0001-9712-6379
  • Lopez-Quesada, Eva|||0000-0002-4477-3246
  • Ricart, Marta|||0000-0003-0099-6525
  • Maroto, Anna|||0000-0003-3225-9095
  • de Mingo, Laura
  • Pintado, Elena
  • Arias-Garcia, Andrea
  • Martin, Lourdes|||0000-0003-1781-5305
  • Chulilla Perez, Carolina|||0000-0002-3860-5377
  • Garcia Cancela, Esperanza|||0000-0001-8924-9096
  • Pallarols, Mar
  • Vidal-Sagnier, Laia
  • Teixidor, Mireia|||0000-0001-8548-1648
  • Orizales Lago, Carmen María|||0000-0001-7184-2799
  • Pérez-Gomez, Adela
  • Ocaña, Vanesa|||0000-0003-2547-5646
  • Puerto Tamayo, Linda Grace|||0000-0001-5539-6397
  • Millán, Pilar
  • Diaz, Sonia
  • del Barco, Ester|||0000-0002-1484-9027
  • Dalmau, Marta
  • Rolle, Valeria|||0000-0002-1793-7049
  • Carreras Moratonas, Elena|||0000-0003-3471-7248
  • Suy, Anna|||0000-0003-2987-6105
  • Mendoza, Manel|||0000-0002-3030-3833
Objective: To compare the trajectories of placental biomarkers throughout pregnancy after aspirin discontinuation at 24-28 weeks with those of a cohort treated until 36 weeks of gestation. Design: A longitudinal secondary analysis of the StopPRE trial, using repeated measures of soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF), and their ratio. Setting: Nine maternity hospitals across Spain. Population: The original StopPRE trial included 936 women at high risk for preterm preeclampsia based on first-trimester screening. All participants received aspirin 150 mg daily until randomisation at 24-28 weeks. At that point, 463 women were assigned to continue aspirin until 36 weeks, while 473 were assigned to discontinue it. Methods: sFlt-1, PlGF, sFlt-1/PlGF were measured at baseline (24-28 weeks) and during follow-up visits at 28-32, 32-36, and after 36 weeks of gestation. Linear mixed-effects models (LMM) with treatment-by-gestational age interaction were used to analyze biomarker trajectories over time. Main Outcome Measures: Differences in trajectories of raw values and multiples of the median for sFlt-1, PlGF, sFlt-1/PlGF between groups. Results: Among 463 participants in the aspirin continuation group and 473 in the discontinuation group, 3483 measurements of each biomarker were analysed. There were no significant differences in the trajectories of sFlt-1, PlGF, or sFlt-1/PlGF between groups (p-values for raw analysis: 0.662, 0.728 and 0.979, respectively). Conclusions: In women at high risk of preterm preeclampsia, discontinuing aspirin at 24-28 weeks did not alter the trajectories of placental biomarkers. This may explain why stopping aspirin did not increase preterm PE risk in the StopPRE trial.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The link between ultra-processed food consumption, fecal microbiota, and metabolomic profiles in older mediterranean adults at high cardiovascular risk

  • Atzeni, Alessandro
  • Hernández-Cacho, Adrián
  • Khoury, Nadine
  • Babio, Nancy|||0000-0003-3527-5277
  • Belzer, Clara
  • Vioque, Jesús|||0000-0002-2284-148X
  • Corella, Dolores|||0000-0002-2366-4104
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Clish, Clary|||0000-0001-8259-9245
  • Vidal, Josep|||0000-0002-4564-4518
  • Konstanti, Prokopis
  • Gonzales-Palacios, Sandra
  • Coltell, Oscar
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Moreno Indias, Isabel
  • Carlos Chillerón, Silvia
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Hu, Frank B.
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
Ultra-processed food (UPF) consumption has been linked to adverse metabolic outcomes, potentially mediated by alterations in gut microbiota and metabolite production. This study aims to explore the cross-sectional and longitudinal associations between NOVA-classified UPF consumption, fecal microbiota, and fecal metabolome in a population of Mediterranean older adults at high cardiovascular risk. A total of 385 individuals, aged between 55 and 75 years, were included in the study. Dietary and lifestyle information, anthropometric measurements, and stool samples were collected at baseline and after 1-year follow-up. Fecal microbiota and metabolome were assessed using 16 S rRNA sequencing and liquid chromatography-tandem mass spectrometry, respectively. At baseline, higher UPF consumption was associated with lower abundance of Ruminococcaceae incertae sedis (β = - 0.275, P = 0.047) and lower concentrations of the metabolites propionylcarnitine (β = - 0.0003, P = 0.013) and pipecolic acid (β = - 0.0003, P = 0.040) in feces. Longitudinally, increased UPF consumption was linked to reduced abundance of Parabacteroides spp. after a 1-year follow-up (β = - 0.278, P = 0.002). High UPF consumption was associated with less favorable gut microbiota and metabolite profiles, suggesting a possible link to reduced short-chain fatty acid (SCFA) production, altered mitochondrial energy metabolism, and impaired amino acid metabolism. These findings support the reduction of UPF consumption and the promotion of dietary patterns rich in fiber for better gut health. Further research is needed to confirm these associations and clarify the underlying mechanisms. : ISRCTN89898870 (10.1186/ISRCTN89898870). The online version contains supplementary material available at 10.1186/s12937-025-01125-5.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementia

  • Delaby, Constance|||0000-0002-8606-6814
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Busto, G.
  • Gabelle, A.
  • Ayrignac, X.
  • Bennys, K.
  • Muiño, Elena|||0000-0001-5839-7328
  • Villatoro-González, Paula|||0009-0001-0287-4073
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Pradeilles, N.
  • Bounasri, Shaima El
  • Torres Alcalá, Soraya|||0000-0002-7054-2046
  • Hirtz, C.
  • Zetterberg, Henrik|||0000-0003-3930-4354
  • Lleó, Alberto|||0000-0002-2568-5478
  • Fortea, Juan|||0000-0002-1340-638X
  • Lehmann, Sylvain|||0000-0001-6117-562X
Background: Blood-based assays are expected to be integrated into clinical routines across various contexts, including Alzheimer's disease (AD). Vascular dementia (VaD), which is the second most common cause leading to dementia after AD, could also significantly benefit from this advancement. However, no informative fluid biomarker has been identified for VaD. Given the disruption of iron homeostasis in both AD and VaD, this study aims to characterize the potential of the iron-related hormone Hepcidin as a biomarker for these two conditions. We will compare its added value to established AT(N) blood biomarkers. Methods: Blood biomarkers (amyloid-composite, p-Tau, Neurofilament Light Chain [NfL] and Hepcidin) levels in blood were analyzed in two independent cohorts and compared between AD patients and non-AD individuals. Additionally, blood Hepcidin and NfL were evaluated in the contexts of VaD and CADASIL, with their relative diagnostic value assessed. Results: Blood Hepcidin and NfL do not significantly increase the AUC obtained with both p-Tau and amyloid composite in the context of AD. In contrast, AUC for VaD diagnosis is significantly higher when combining these two blood biomarkers compared to NfL alone. Hepcidin was not significantly modified in CADASIL patients compared to control subjects. Conclusion: Blood Hepcidin and NfL have limited interest in the clinical context of AD but determination of these biomarkers shows to be highly informative for the diagnosis of VaD. This result could have important implications for diagnosis and implementation of clinical trials.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

NOTCH3 Variant Position Affects the Phenotype at the Pluripotent Stem Cell Level in CADASIL

  • Bugallo-Casal, A.
  • Muiño, Elena|||0000-0001-5839-7328
  • Bravo, S.B.
  • Hervella, P.
  • Arias-Rivas, S.
  • Rodríguez-Yáñez, M.
  • Vara-León, E.
  • Quintas-Rey, R.
  • Pérez-Gayol, L.
  • Maisterra-Santos, Olga
  • Pizarro Gonzálvez, Jesús|||0000-0002-5808-9293
  • Martorell-Riera, M.R.
  • Vives-Bauzá, C.
  • Fernández Cadenas, Israel|||0000-0003-4821-2363
  • Castillo, J.
  • Campos, Francisco|||0000-0001-8665-1039
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common genetic form of stroke. It is caused by a cysteine-altering variant in one of the 34 epidermal growth factor-like repeat (EGFr) domains of Notch3. NOTCH3 pathogenic variants in EGFr 1-6 are associated with high disease severity, whereas those in EGFr 7-34 are associated with late stroke onset and increased survival. However, whether and how the position of the NOTCH3 variant directly affects the disease severity remains unclear. In this study, we aimed to generate human-induced pluripotent stem cells (hiPSCs) from patients with CADASIL with EGFr 1-6 and 7-34 pathogenic variants to evaluate whether the NOTCH3 position affects the cell phenotype and protein profile of the generated hiPSCs lines. Six hiPSCs lines were generated: two from patients with CADASIL with EGFr 1-6 pathogenic variants, two from patients with EGFr 7-34 variants, and two from controls. Notch3 aggregation and protein profiles were tested in the established six hiPSCs lines. Cell analysis revealed that the NOTCH3 variants did not limit the cell reprogramming efficiency. However, EGFr 1-6 variant position was associated with increased accumulation of Notch3 protein in pluripotent stem cells and proteomic changes related with cytoplasmic reorganization mechanisms. In conclusion, our analysis of hiPSCs derived from patients with CADASIL support the clinical association between the NOTCH3 variant position and severity of CADASIL.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Blood concentrations of metals, essential trace elements, rare earth elements and other chemicals in the general adult population of Barcelona, Distribution and associated sociodemographic factors

  • Gasull, Magda|||0000-0003-4546-3650
  • Camargo Sanromà, Judit|||0000-0003-3716-3287
  • Pumarega, José Antonio|||0000-0001-6950-6702
  • Henríquez-Hernández, Luis ALberto|||0000-0003-3237-0316
  • Campi, Laura
  • Zumbado, Manuel
  • Contreras-Llanes, Manuel
  • Oliveras, Laura|||0000-0003-0033-7829
  • González-Marín, Patricia|||0000-0003-1175-7589
  • Luzardo, Octavio P.
  • Gómez-Gutiérrez, Anna|||0000-0003-0401-8497
  • Alguacil, Juan|||0000-0003-2703-9725
  • Porta, Miquel|||0000-0003-1684-7428
Background: Very little information is available on the population distribution and on sociodemographic predictors of body concentrations of rare earth elements (REE) and other chemicals used in the manufacturing of high-tech devices. Objectives: To analyze the distribution and associated sociodemographic factors of blood concentrations of chemical elements (including some metals, essential trace elements, rare earth elements and other minority elements) in a representative sample of the general population of Barcelona (Spain). Methods: A sample of participants in the Barcelona Health Survey of 2016 (N = 240) were interviewed face-to-face, gave blood, and underwent a physical exam. Concentrations of 50 chemical elements were analyzed by ICP-MS in whole blood samples. Results: All 50 chemicals studied, including 26 REE and minority elements, were detected. Lead, silver, arsenic, cadmium, mercury, antimony, strontium, thallium and six essential trace elements were detected in more than 70% of the population. The most frequently detected REE and minority elements were europium (62%), thulium (56%), gold (41%), indium (31%), ruthenium (24%), and tantalum (20%). Less affluent occupational social classes had higher percentages of detection of some REE. Median concentrations of silver, arsenic, cadmium and mercury were: 0.091, 3.01, 0.309, and 3.33 ng/mL, respectively. Women had lower median concentrations than men of lead (1.47 vs. 2.04 μg/dL, respectively), iron and zinc, and higher concentrations of copper and manganese. The influence of sociodemographic characteristics on chemical concentrations differed by sex. Conclusions: While well-known contaminants as lead, mercury, cadmium, or arsenic were detected in the majority of the population, numerous individuals had also detectable concentrations of chemicals as europium, indium, thulium, or gold. Sociodemographic and physical characteristics (sex, age, social class, weight change) influenced concentrations of some chemicals.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population

  • Echeverry-Quiceno, L.M.|||0000-0002-9799-0252
  • Llambrich, S.|||0000-0001-9980-0208
  • Heredia-Lidón, None|||0000-0001-6325-8744
  • Giménez, Sandra|||0000-0001-8031-2319
  • Aranha, Mateus|||0000-0001-9594-292X
  • Inampudi, P.
  • Heuzé, Y.|||0000-0002-0660-9613
  • Sevillano, X.|||0000-0002-6209-3033
  • Fortea, Juan|||0000-0002-1340-638X
  • Martínez-Abadías, N.|||0000-0003-3061-2123
Down syndrome (DS), caused by trisomy 21, is associated with an increased risk of Alzheimer's disease (AD) and obstructive sleep apnea (OSA). Traditional diagnostic methods for AD and OSA, like cerebrospinal fluid analysis and polysomnography, are invasive and challenging for people with DS. In this study, we assessed whether facial morphology could be used as a potential noninvasive biomarker for these conditions in both DS and the general population. We performed a comprehensive 3D analysis of facial shape variation by registering the 3D coordinates of 21 landmarks on facial models extracted from magnetic resonance images of 131 individuals with DS and 216 euploid (EU) adult controls, including AD and OSA cases. Procrustes ANOVA and MANOVA quantified shape variation by sex, age, and facial size, while geometric morphometrics assessed diagnostic group differences. Significant facial shape differences were observed between the DS and EU groups, indicating sex-dependent differences and altered age-related changes in DS, particularly in females. Facial shape correlated with the amyloid beta ratio (Aβ1-42/Aβ1-40), a key AD biomarker. In DS, facial shape differences by AD diagnosis were not significant after adjusting for age and facial size, but significant shape differences were detected in the EU population. For OSA, facial shape correlated with the apnea-hypopnea index (AHI), and DS individuals with severe OSA showed distinct facial morphology compared with those without OSA, suggesting an association between facial shape and sleep respiratory disturbances. These results highlight the potential of facial morphology as a noninvasive biomarker for AD and OSA detection and management.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Insulin resistance modulates gut microbiota and incretin response remodeling after bariatric surgery in severe obesity

  • Puig, Rocío
  • Rodríguez-Peña, M-Mar
  • Hernández-Montoliu, Laura
  • Astiarraga, Brenno|||0000-0003-2216-8974
  • Martínez, Eva
  • Balibrea Del Castillo, José María|||0000-0002-0764-7179
  • Llauradó, Gemma|||0000-0002-3237-6366
  • Tarascó, Jordi
  • Caballero, Albert
  • Joaquín, Clara|||0000-0002-9063-4853
  • Puig Domingo, Manuel|||0000-0002-6744-7195
  • Vilarrasa, Nuria|||0000-0003-3188-1990
  • Fernández-Veledo, Sonia|||0000-0003-2906-3788
  • Vendrell, Joan|||0000-0002-6994-6115
  • Pellitero, Silvia|||0000-0002-9510-7251
This study aims to assess the impact of insulin resistance (IR) on gut microbiota (GM) composition, incretin responses, and metabolic outcomes following sleeve gastrectomy (SG) in people with severe obesity who do not have diabetes. Methods: A prospective single-center study encompassed patients with severe obesity and normal glucose tolerance who underwent SG. Participants were stratified into two cohorts based on the magnitude of their insulin resistance state, as determined by the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) index: high-IR (Hi-IR; HOMA-IR 95th percentile) and low-IR (Lo-IR; HOMA-IR < 25th percentile). Body composition measurements, biochemical analyses, and microbiota assessments were performed before and six months post-surgery. Additionally, the responses to a standardized meal tolerance test (MTT) of glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) were evaluated. Results: The study cohort consisted of 18 patients (9 with Hi-IR and 9 with Lo-IR), with a mean age of 48.8 ± 9.2 years and a mean body mass index (BMI) of 45.03 ± 4.82 kg/m². Six months post-surgery, the mean percentage of total weight loss (WL) was 26.5 ± 6%, with both groups exhibiting enhanced secretion of GLP-1 and GLP-2 following MTT. At baseline, participants exhibited distinct microbiota profiles; the Hi-IR group showed a higher relative abundance of Prevotella species, which are previously associated with adverse metabolic and inflammatory profiles. Post-surgery, both groups exhibited positive incretin responses and significant modifications in GM composition. Notably Hi-IR people experienced more 146 pronounced changes in microbial diversity, including increases in Akkermansia and Veillonella species and decreases in Prevotella species. Enhanced GLP-1 and GLP-2 responses were correlated with WL and metabòlic improvement, particularly in the Lo-IR population. Conclusions: These findings underscore the role of GM in metabolic changes and surgical outcomes after SG. Targeting gut microbiota may offer a promising avenue for improving obesity treatment strategies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sleep-related changes in astrocytic biomarkers are modulated by APOE ε4 genotype in cognitively unimpaired adults

  • Zhu, Nuole|||0000-0002-0015-9455
  • Altuna-Azkargorta, Miren|||0000-0001-9709-5314
  • Arranz Martínez, Javier|||0000-0003-0891-1215
  • Rodríguez-Baz, Íñigo|||0000-0003-3039-9115
  • Sánchez-Saudinós, María Belén|||0000-0003-1795-1833
  • Videla Toro, Laura|||0000-0002-9748-8465
  • Valldeneu, Silvia|||0000-0003-3497-886X
  • Carreras-Vega, Mireia
  • Romero, Sergio
  • Fortea, Juan|||0000-0002-1340-638X
  • Lleó, Alberto|||0000-0002-2568-5478
  • Giménez, Sandra|||0000-0001-8031-2319
  • Alcolea, Daniel|||0000-0002-3819-3245
Astrocytes are key regulators of sleep and neuroinflammatory responses. However, the relationship between objective sleep parameters and astrocytic fluid biomarkers in cognitively unimpaired individuals remains unclear. We examined how sleep architecture relates to astrocytic, neuroaxonal and Alzheimer's disease-related fluid biomarkers in cognitively unimpaired adults, and whether age, sex and APOE ε4 moderate these associations. This cross-sectional study included 51 cognitively unimpaired participants from the Sant Pau Initiative on Neurodegeneration cohort. One-night in-lab polysomnography was used to quantify sleep architecture, fragmentation, slow-wave activity, and respiratory parameters. CSF biomarkers included glial fibrillary acidic protein (GFAP), chitinase-like-3 protein 1 (YKL-40), Aβ42, Aβ40, pTau181, and tTau; plasma biomarkers included GFAP and neurofilament light chain (NfL). Associations were analyzed using Spearman correlations, multiple linear regression, and moderation models, adjusting for age, sex, body mass index, APOE ε4 status, and sleep apnea. Lighter and more fragmented sleep, characterized by longer N1 duration, increased wake after sleep onset, frequent stage transitions, and elevated cortical arousal, was associated with higher CSF YKL-40, Aβ40, pTau181 and tTau (rho = 0.32 to 0.62, all p<0.05). In contrast, deeper, more consolidated sleep, indicated by longer total time of sleep, greater N3 duration, and higher slow-wave activity, was associated with lower CSF GFAP and YKL-40 (rho = -0.35 to -0.44, all p<0.05). These associations remained significant in adjusted regression models. Plasma GFAP and NfL exhibited an inverse profile, with positive associations with deeper sleep (β: 0.16 to 0.18, p < 0.05) and negative associations with lighter sleep stages (β: -0.23 to -0.29, p < 0.01). REM sleep was also associated with astrocytic fluid biomarkers, with negative correlations for CSF and plasma GFAP (rho = -0.49 and rho = -0.28, respectively, all p<0.05), while in regression models REM duration remained a negative predictor of plasma GFAP (β = -0.23, p = 0.003) and a positive predictor of CSF YKL-40 (β = 0.12, p = 0.037). Notably, APOE ε4 consistently moderated associations between sleep and CSF YKL-40 and GFAP, while age and sex influenced plasma GFAP and CSF YKL-40, respectively (all p<0.05). In cognitively unimpaired adults, sleep architecture is differentially associated with central and peripheral biomarkers of astrocytic activation, neuroaxonal integrity and Alzheimer's disease-related proteins. These findings support the importance of considering sleep as a key factor in the early pathophysiology of neurodegenerative disease.